run_id,metamodule,annotation,folder,run_index,program_index,program_name,description,supporting_genes,supporting_gene_count,significance_score,predicted_impacts
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,0,EMT-Driven Invasive Dispersal,"Epithelial-mesenchymal transition program enabling glioblastoma cells to escape the tumor core and infiltrate adjacent brain tissue. SERPINE1 and EMP1 regulate cell adhesion dynamics and directional migration through extracellular matrix interactions. FOSL1 maintains mesenchymal transcriptional identity, while HMGA2 sustains glioma-initiating cell properties required for sustained invasion. COL5A1 and FN1 remodel the extracellular matrix to facilitate cell movement.","[""SERPINE1"", ""EMP1"", ""COL5A1"", ""FN1"", ""FOSL1"", ""HMGA2"", ""SMOC2""]",7,0.92,"[""Enhanced directional cell migration through ECM with reduced dependence on focal adhesion stabilization"", ""Increased invasive capacity into surrounding brain parenchyma"", ""Sustained mesenchymal phenotype independent of differentiation signals"", ""Resistance to anoikis upon ECM detachment"", ""Enhanced self-renewal of glioma-initiating cell populations""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,1,Tryptophan-Pathway Immune Evasion,"Comprehensive immune suppression program centered on activation of the kynurenine pathway. IDO1 and TDO2 catalyze tryptophan degradation, producing immunosuppressive kynurenine metabolites that promote regulatory T cell expansion and cytotoxic T cell apoptosis. CHI3L1 (YKL-40) upregulates IDO1/TDO2 expression and coordinates with kynurenine to inhibit anti-tumor immunity. This program operates in coordination with IL-6 and IL-1β signaling to establish a profoundly immunosuppressive microenvironment.","[""IDO1"", ""CHI3L1"", ""SERPINE1""]",3,0.88,"[""Profound local tryptophan depletion creating selective pressure on tryptophan-dependent immune cells"", ""Expansion of immunosuppressive regulatory T cell populations"", ""Functional exhaustion and apoptosis of CD8+ cytotoxic T cells"", ""Reprogramming of infiltrating macrophages toward immunosuppressive phenotypes"", ""Recruitment of myeloid-derived suppressor cells through coordinated IDO1-AhR signaling"", ""Resistance to PD-1/PD-L1 checkpoint blockade through metabolic immune suppression""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,2,IL-6/IL-1β-NF-κB/STAT3 Signaling Axis,"Central pro-inflammatory yet immunosuppressive signaling loop driven by IL-6 and IL-1β cytokines. TNF-α activation of NF-κB induces IL-6 expression, which in turn activates STAT3 signaling. This creates a self-reinforcing autocrine loop that drives tumor cell proliferation, survival, and chemoresistance while simultaneously establishing an immunosuppressive microenvironment through recruitment of myeloid cells. TNFAIP2 and TNFAIP3 are downstream targets that modulate the intensity of this inflammatory response.","[""IL6"", ""IL1R1"", ""TNFAIP3"", ""TNFAIP2"", ""CXCL2"", ""CXCL8""]",6,0.9,"[""Enhanced tumor cell proliferation through NF-\u03baB-driven cyclin D1 expression"", ""Increased chemotherapy resistance through upregulation of anti-apoptotic proteins"", ""Sustained STAT3 activation creating feed-forward signaling loop"", ""Recruitment and polarization of tumor-associated macrophages toward immunosuppressive M2 phenotype"", ""Increased vascular permeability and endothelial cell migration promoting angiogenesis"", ""Elevated production of additional immunosuppressive cytokines creating cytokine storm""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,3,VEGFA-Driven Tumor Angiogenesis,"Hypoxia-driven pro-angiogenic program centered on VEGFA expression and signaling. VEGFA stimulates endothelial cell proliferation, migration, and tube formation, providing essential nutrient and oxygen supply to growing tumors. Cooperating factors including CXCL2, CXCL8, and ANGPTL4 enhance angiogenic responses. CAV1 (caveolin-1) regulates endothelial cell function in tumor vasculature. This program is essential for tumor growth beyond hypoxic diffusion limits and is associated with poor prognosis.","[""VEGFA"", ""CXCL2"", ""CXCL8"", ""ANGPTL4"", ""ICAM1"", ""CAV1""]",6,0.85,"[""Enhanced endothelial cell proliferation and migration toward hypoxic tumor regions"", ""Formation of new tumor vasculature enabling exponential tumor growth"", ""Increased vascular permeability and disrupted blood-brain barrier integrity"", ""Selective recruitment of immunosuppressive myeloid cells while excluding CD8+ T cells"", ""Metabolic reprogramming of endothelial cells toward glycolytic phenotype to support tumor-promoting endothelium"", ""Poor prognosis associated with high VEGFA expression""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,4,MET-Driven Stemness and Invasiveness,"Receptor tyrosine kinase signaling centered on MET activation, a critical driver of glioma stem cell self-renewal, invasiveness, and tumorigenicity. Recent evidence identifies a circular MET RNA (circMET) encoding MET404 variant that forms constitutively active receptor independent of ligand (HGF) stimulation. MET signaling promotes proliferation, survival, and migration while maintaining stem cell features. High MET404 expression predicts poor prognosis. This program is particularly important in primary GBMs with MET amplification or fusion events.","[""MET""]",1,0.83,"[""Enhanced glioma stem cell self-renewal independent of exogenous HGF stimulation"", ""Increased tumor growth rate particularly in xenograft models"", ""Enhanced invasion and migration through AKT/ERK signaling"", ""Resistance to conventional MET inhibitors due to ligand-independent activation"", ""Poor prognostic outcome with high MET404 expression"", ""Synergistic therapeutic response to combination of MET inhibitors targeting different MET isoforms""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,5,AXL-Mediated Mesenchymal Programming,"TAM receptor family member AXL-driven program promoting mesenchymal phenotype, invasion, metastasis, and immunosuppression. AXL is highly expressed in mesenchymal GBM subtype and activated by PROS1 (protein S) secreted from tumor-associated macrophages/microglia. AXL signaling activates NF-κB pathway promoting tumor growth while modifying immune microenvironment. Elevated AXL expression correlates with poor prognosis and is associated with epithelial-mesenchymal transition, stemness, and acquired therapeutic resistance.","[""AXL""]",1,0.8,"[""Enhanced invasive and migratory phenotype through EMT activation"", ""Increased stemness and resistance to therapeutic agents"", ""Sustained NF-\u03baB activation promoting proliferation and survival"", ""Enhanced recruitment of immunosuppressive myeloid cells"", ""Increased production of matrix metalloproteinases and metastasis-associated genes"", ""Poor prognostic outcome associated with high AXL expression""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,6,Apoptosis Evasion and Drug Resistance,"Multi-layered anti-apoptotic program centered on Inhibitor of Apoptosis (IAP) proteins BIRC3 and BAG3. BIRC3 (cIAP2) is uniquely prognostic of survival in GBM, with low expression associated with favorable outcomes and high expression correlating with shorter survival. BAG3 maintains HSP70-mediated suppression of BAX translocation to mitochondria, preventing apoptotic signaling. Both proteins are upregulated in response to standard therapy (temozolomide, radiation), contributing to therapeutic resistance. STAT3 and PI3K signaling pathways drive this therapy-induced resistance.","[""BIRC3"", ""BAG3""]",2,0.82,"[""Enhanced survival following exposure to DNA damaging chemotherapy"", ""Reduced apoptosis following ionizing radiation therapy"", ""Sustained proliferation despite conventional therapeutic insults"", ""Treatment-induced enrichment of therapy-resistant GBM cell populations"", ""Shorter overall survival in patients with high BIRC3 expression"", ""Potential synthetic lethality with dual inhibition of IAPs and complementary pathway components""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,7,Innate Immune Pattern Recognition,"Interferon-mediated innate immune response program centered on toll-like receptor signaling (TLR2) and interferon-stimulated gene expression. TLR2 expressed on glioma-associated microglia rapidly responds to tumor antigens and modulates inflammation-associated immune responses including phagocytosis. TLR2-MHC I axis on microglia contributes to CD8+ T cell proliferation and activation. GBP family proteins (GBP2, GBP5) are downstream effectors of interferon signaling involved in pathogen defense and tumor immunity. MX2 is interferon-induced antiviral protein with emerging roles in tumor immunogenicity.","[""TLR2"", ""GBP2"", ""GBP5"", ""MX2""]",4,0.72,"[""Enhanced innate immune recognition of glioblastoma antigens by resident and infiltrating immune cells"", ""Increased microglial phagocytosis activity in tumor-bearing brains"", ""Upregulation of MHC I on antigen-presenting cells supporting CD8+ T cell activation"", ""Coordinated activation of multiple interferon-responsive genes creating antiviral/anti-tumor state"", ""Potential for therapeutic enhancement through TLR2 agonists or interferon stimulation"", ""Complex relationship between interferon responses and immune evasion requiring careful pathway analysis""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,8,Extracellular Matrix Composition and Immunomodulation,"Comprehensive collagen-centered program remodeling the glioma extracellular matrix to establish immunosuppressive microenvironment. Six collagen genes (COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, COL5A2) collectively regulate immune infiltration and EMT processes. Collagen expression correlates positively with stromal and immune scores but creates immunosuppressive phenotype. SPP1 (osteopontin) participates in ECM remodeling and tumor progression. These genes collectively confer cell adhesion-mediated drug resistance and establish permissive microenvironment for tumor growth.","[""COL1A1"", ""COL1A2"", ""COL3A1"", ""COL4A1"", ""COL4A2"", ""COL5A2"", ""SPP1""]",7,0.79,"[""Establishment of dense collagen-rich microenvironment reducing immune cell mobility"", ""Enhanced integrin-FAK-AKT signaling promoting tumor cell survival and proliferation"", ""Conferred cell adhesion-mediated drug resistance through ECM interactions"", ""Paradoxical immune infiltration despite immunosuppressive function of collagen matrix"", ""Enhanced invasion and EMT through ECM-supported signaling"", ""Poor prognosis associated with high collagen expression despite immune cell presence"", ""Potential for matrix-targeting therapies to enhance immunotherapy""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,9,Stemness Maintenance and Self-Renewal,"Multi-component program sustaining glioma stem cell (GSC) properties including self-renewal, differentiation capacity, and tumorigenicity. HMGA2 is central transcriptional modulator maintaining GSC propagation and clonogenicity. ANGPTL4 promotes stemness enrichment through EGFR/AKT/4E-BP1 cascade, particularly in temozolomide-resistant populations. PROM1 (CD133) serves as GSC marker. This program is essential for tumor initiation, recurrence following therapy, and resistance to conventional treatments.","[""HMGA2"", ""ANGPTL4"", ""PROM1""]",3,0.78,"[""Enhanced capacity for unlimited self-renewal and differentiation into multiple cell types"", ""Increased resistance to chemotherapy, radiation, and targeted therapies"", ""Maintenance of tumor-initiating phenotype despite conventional treatment"", ""Enhanced invasive capacity and propensity for distant dissemination"", ""Tumor recurrence following initial therapy response"", ""Poor prognostic outcome associated with high HMGA2 or ANGPTL4 expression""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,10,Immune Checkpoint and T Cell Suppression,"Program establishing immune checkpoint-mediated suppression of anti-tumor T cell responses. PD-L1 (CD274) is upregulated on GBM cells and tumor-associated myeloid cells, interacting with PD-1 on T cells to inhibit proliferation and promote exhaustion. LIF (leukemia inhibitory factor) contributes to immunosuppressive signaling. SAA1 and SAA2 (serum amyloid A) are acute-phase proteins upregulated in GBM and involved in immune suppression. These factors collectively establish profound resistance to checkpoint blockade immunotherapy.","[""CD274"", ""LIF"", ""SAA1"", ""SAA2""]",4,0.75,"[""Suppression of effector T cell proliferation and cytokine production"", ""Promotion of CD8+ T cell exhaustion and functional impairment"", ""Expansion of immunosuppressive regulatory T cell populations"", ""Evasion of checkpoint inhibitor monotherapy despite PD-L1/PD-1 blockade"", ""Poor prognostic outcome associated with high CD274 expression"", ""Potential for combination strategies targeting multiple checkpoint pathways""]"
0_Gliosis_run1,0,Gliosis,0_Gliosis,1,11,mRNA-Based Mesenchymal Signaling,"Non-coding functional program where SERPINE1 mRNA itself, independent of protein-coding function, confers mesenchymal characteristics through sequestration of microRNAs and regulation of splicing factors. SERPINE1 mRNA binds to TRA2B splicing factor, downregulating immune response-associated genes. This program represents emerging evidence of regulatory RNAs functioning independently of protein translation, with implications for therapeutic targeting.","[""SERPINE1""]",1,0.68,"[""Enhanced cell migration and invasion independent of SERPINE1 protein expression"", ""Resistance to anoikis through mRNA-mediated sequestration of anti-survival miRNAs"", ""Increased glycolytic activity driven by mRNA signaling"", ""Suppression of immune response genes reducing anti-tumor immunity"", ""Reduced CD8+ T cell infiltration correlating with SERPINE1 mRNA expression"", ""Resistance to miRNA-based therapeutic approaches""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,0,EMT-Driven Invasion Program,"A coordinated gene program mediating epithelial-mesenchymal transition and cellular invasiveness in glioblastoma. This program includes transcriptional regulators (FOSL1, KLF5, NFATC2), extracellular matrix components and remodelers (SERPINE1, COL5A1, COL6A2, COL1A2, FN1, SMOC2, ITGBL1), and cell adhesion/migration effectors (EMP1, CAV1, MYOF, KANK4, ICAM1). The program drives mesenchymal identity, enhanced cell motility, and increased invasive capacity into surrounding brain tissue.","[""SERPINE1"", ""EMP1"", ""COL5A1"", ""COL6A2"", ""COL1A2"", ""FN1"", ""SMOC2"", ""ITGBL1"", ""FOSL1"", ""KLF5"", ""NFATC2"", ""CAV1"", ""MYOF"", ""KANK4"", ""ICAM1""]",15,0.92,"[""Enhanced cell migration and invasiveness into brain parenchyma"", ""Increased mesenchymal identity with reduced epithelial markers"", ""Remodeling of focal adhesion architecture"", ""Facilitated ECM degradation and rearrangement"", ""Acquisition of stem-like properties"", ""Enhanced resistance to conventional therapies""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,1,Pro-Inflammatory Cytokine Signaling,"A gene program centered on production and signaling of pro-inflammatory cytokines that drive GBM development and progression. This program includes IL-6, IL-8 (CXCL8), IL-1 receptor (IL1R1), IL-4 receptor (IL4R), leukemia inhibitory factor (LIF), and cardiotrophin-like cytokine factor 1 (CLCF1). These cytokines signal through receptors and downstream pathways (STAT3, NF-κB) to promote tumor cell proliferation, survival, and create an immunosuppressive microenvironment.","[""IL6"", ""CXCL8"", ""IL1R1"", ""IL4R"", ""LIF"", ""CLCF1"", ""TNFAIP3""]",7,0.88,"[""Enhanced proliferation via STAT3 and NF-\u03baB activation"", ""Increased cell survival and reduced apoptosis"", ""Promotion of immunosuppressive microenvironment"", ""Maintenance of cancer stem cell properties"", ""Enhanced angiogenesis through secondary signals"", ""Recruitment and polarization of myeloid cells""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,2,Angiogenesis and Vascular Signaling,"A gene program driving tumor neovascularization through VEGF and apelin signaling pathways. This program includes VEGFA, APLN (apelin), CHI3L1, PTX3, and CLCF1. These genes promote endothelial cell proliferation, migration, and vascular formation, particularly under hypoxic conditions. The program creates the highly vascularized phenotype characteristic of GBM and enables nutrient delivery to support rapid tumor growth.","[""VEGFA"", ""APLN"", ""CHI3L1"", ""PTX3"", ""CLCF1""]",5,0.85,"[""Enhanced vascular density and complexity within tumor"", ""Increased oxygen and nutrient delivery to tumor core"", ""Facilitation of tumor expansion into surrounding brain"", ""Promotion of aberrant vascular morphology (tortuous, leaky vessels)"", ""Enhanced BBB disruption and vasogenic edema"", ""Promotion of vascular-associated tumor cell invasion""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,3,Immune Evasion and Checkpoint Activation,"A gene program enabling GBM escape from anti-tumor immune surveillance through upregulation of checkpoint ligands, immunosuppressive factors, and immune cell reprogramming mechanisms. This program includes PD-L1 (CD274), IDO1, complement factor H (CFH), and chemokines (CXCL10, CXCL14, CXCL2). These genes create an immunosuppressive microenvironment through T cell exhaustion, regulatory T cell expansion, myeloid-derived suppressor cell recruitment, and complement inhibition.","[""CD274"", ""IDO1"", ""CFH"", ""CXCL10"", ""CXCL14"", ""CXCL2"", ""GBP2""]",7,0.87,"[""Impaired anti-tumor CD8+ T cell response"", ""Expansion of immunosuppressive regulatory T cells (Tregs)"", ""Increased immunosuppressive myeloid cell accumulation"", ""Enhanced complement resistance on tumor cell surface"", ""Reduced responsiveness to checkpoint inhibitor monotherapy"", ""Creation of immunosuppressive microenvironment resistant to immunotherapy""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,4,Extracellular Matrix Proteolysis,"A gene program controlling degradation and remodeling of extracellular matrix through multiple protease systems and their regulators. This program includes serine protease inhibitors and activators (SERPINE1, SAA1, SAA2, SAA4), metalloproteinase regulators (MYOF), and cross-linking enzymes (F13A1). These genes enable ECM degradation to facilitate tumor cell migration, invasion, and colonization of brain tissue.","[""SERPINE1"", ""SAA1"", ""SAA2"", ""SAA4"", ""MYOF"", ""F13A1"", ""ANPEP""]",7,0.82,"[""Increased ECM degradation facilitating invasion"", ""Enhanced migration through tissue barriers"", ""Facilitated epithelial-mesenchymal transition"", ""Increased availability of cryptic ECM epitopes"", ""Enhanced protease-mediated release of growth factors"", ""Support for basement membrane penetration""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,5,Glioma Stem Cell Maintenance,"A gene program sustaining cancer stem cell properties including self-renewal, pluripotency, and differentiation resistance. This program includes transcriptional regulators (HMGA2, KLF5, NFATC2), anti-apoptotic factors (BAG3, BIRC3), stem cell growth factors (LIF, ANGPTL4), and markers of stemness. These genes maintain the pool of tumor-initiating cells resistant to therapy and responsible for tumor recurrence.","[""HMGA2"", ""KLF5"", ""NFATC2"", ""BAG3"", ""BIRC3"", ""LIF"", ""ANGPTL4""]",7,0.86,"[""Enhanced self-renewal capacity of tumor-initiating cells"", ""Maintenance of pluripotency-related gene expression"", ""Increased resistance to differentiation signals"", ""Enhanced tumorigenicity in in vivo models"", ""Resistance to conventional chemotherapy and radiation"", ""Promotion of tumor recurrence and relapse""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,6,Hypoxia Adaptation and Response,"A gene program enabling GBM survival and proliferation in low-oxygen microenvironment through metabolic reprogramming and stress response mechanisms. This program includes hypoxia-regulated genes (NDRG1, IDO1), metabolic enzymes, and cell cycle regulators. These genes allow tumor cells to adapt to severe hypoxia in the tumor core and pseudopalisading regions.","[""NDRG1"", ""IDO1""]",2,0.76,"[""Survival in severely hypoxic tumor core (0.1-1% oxygen)"", ""Increased tolerance to oxidative stress"", ""Maintenance of proliferation despite oxygen deprivation"", ""Enhanced invasiveness at tumor periphery"", ""Transition between proneural and mesenchymal states"", ""Support for pseudopalisade formation and function""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,7,Macrophage/Microglia Reprogramming,"A gene program recruiting and reprogramming myeloid cells toward tumor-supporting phenotypes. This program includes toll-like receptor signaling (TLR2), chemokines (CXCL10, CXCL14, CXCL2), acute-phase proteins (SAA1, SAA2, SAA4, PTX3), and cell adhesion molecules (ICAM1, CCN1). These genes create a chemotactic gradient and provide signals that convert infiltrating macrophages and microglia into immunosuppressive, pro-tumoral cells.","[""TLR2"", ""CXCL10"", ""CXCL14"", ""CXCL2"", ""SAA1"", ""SAA2"", ""SAA4"", ""PTX3"", ""ICAM1"", ""CCN1"", ""GBP2""]",11,0.84,"[""Increased infiltration of macrophages and microglia into tumor"", ""Conversion to immunosuppressive M2-like phenotype"", ""Enhanced production of pro-tumoral cytokines"", ""Increased tumor-associated macrophage (TAM)-mediated angiogenesis"", ""Reduced CD8+ T cell activation and function"", ""Enhanced tumor cell invasion and metastatic potential""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,8,Apoptosis Resistance and Survival Signaling,"A gene program preventing programmed cell death and enabling survival under stress conditions through multiple anti-apoptotic mechanisms. This program includes inhibitor of apoptosis proteins (BIRC3, BAG3), TNF-regulated factors (TNFAIP3, TNFAIP2), and cell cycle checkpoint regulators (GADD45A). These genes suppress intrinsic and extrinsic apoptotic pathways while maintaining proliferative capacity.","[""BAG3"", ""BIRC3"", ""TNFAIP3"", ""TNFAIP2"", ""GADD45A"", ""FAS""]",6,0.8,"[""Resistance to intrinsic (mitochondrial) apoptosis pathway"", ""Reduced responsiveness to TNF-\u03b1 and FAS ligand"", ""Enhanced survival under therapeutic stress"", ""Reduced sensitivity to chemotherapy and radiotherapy"", ""Increased cell proliferation despite damage signals"", ""Resistance to immunogenic cell death""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,9,Growth Factor and Receptor Signaling,"A gene program coordinating mitogenic signaling through multiple growth factor receptors and their downstream effectors. This program includes receptor tyrosine kinases (MET, AXL), their ligands, and signaling molecules (SPP1, IL4R). These genes activate phosphoinositide-3-kinase/AKT/mTOR and mitogen-activated protein kinase/ERK pathways driving proliferation and survival.","[""MET"", ""AXL"", ""SPP1"", ""IL4R""]",4,0.78,"[""Enhanced proliferation via PI3K/AKT and MAPK/ERK pathways"", ""Increased cell survival and apoptosis resistance"", ""Enhanced migration and invasion"", ""Increased sensitivity to growth factors"", ""Sustained tumorigenic signaling independent of EGFR"", ""Potential escape from EGFR-targeted therapies""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,10,Transcriptional Master Regulation,"A gene program establishing core transcriptional networks governing GBM phenotype through master transcription factors and their regulatory complexes. This program includes FOSL1 (AP-1 family), KLF5 (zinc finger family), NFATC2 (calcineurin-dependent), and associated regulatory proteins (RCAN2). These transcription factors control chromatin accessibility and activate large cohorts of target genes driving mesenchymal identity and stemness.","[""FOSL1"", ""KLF5"", ""NFATC2"", ""RCAN2""]",4,0.83,"[""Coordinate regulation of large transcriptional programs"", ""Maintenance of mesenchymal gene signature"", ""Control of chromatin accessibility at key loci"", ""Integration of multiple signaling inputs into transcriptional response"", ""Establishment of GBM subtype identity"", ""Resistance to differentiation signals""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,11,Inflammatory Lipid Mediator Signaling,"A gene program centered on production and signaling of arachidonic acid-derived inflammatory mediators, particularly prostaglandins. This program includes cyclooxygenase-2 (PTGS2), its target prostaglandin E2 (PGE2), and downstream signaling through EP receptors. These genes create a pro-inflammatory microenvironment promoting tumor growth and therapeutic resistance.","[""PTGS2""]",1,0.75,"[""Increased local PGE2 concentration in tumor microenvironment"", ""Enhanced GBM cell proliferation via EP1 receptor"", ""Increased GBM cell survival and radiation resistance via EP2 and EP4"", ""Enhanced GBM cell migration"", ""Maintenance of cancer stem cell self-renewal"", ""Promotion of angiogenesis and immunosuppression""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,12,Cellularity and Structural Organization,"A gene program involving structural proteins and organizational factors contributing to GBM cellularity and architectural features. This program includes ribosomal proteins (RPS5, RPS18, RPS27), cell cycle regulators, and developmental morphogens (SLIT3). These genes support basic cellular infrastructure and mass while also modulating cell behavior.","[""RPS5"", ""RPS18"", ""RPS27"", ""SLIT3""]",4,0.65,"[""Enhanced protein synthesis capacity"", ""Increased ribosomal biogenesis"", ""Support for rapid proliferation"", ""Potentially altered cell morphology and migration"", ""Modified developmental signaling""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,13,Metabolic Adaptation and Nutrient Sensing,"A gene program enabling GBM cells to survive and proliferate in nutrient-poor, hypoxic tumor microenvironment through metabolic flexibility and nutrient scavenging. This program includes amino acid metabolism genes (IDO1, kynurenine pathway), lipid-handling genes (GPD1, DHRS3, LRAT), and nutrient transporters (SLC10A6, GPC5). These genes allow metabolic switching and nutrient acquisition to sustain tumor growth.","[""IDO1"", ""GPD1"", ""DHRS3"", ""LRAT"", ""SLC10A6"", ""GPC5""]",6,0.78,"[""Enhanced survival in nutrient-deprived microenvironment"", ""Increased biosynthetic capacity for rapid proliferation"", ""Metabolic flexibility enabling adaptation to regional microenvironmental variations"", ""Simultaneous immunosuppression through tryptophan depletion"", ""Acquisition of lipids for membrane biogenesis and signaling"", ""Reduced dependence on exogenous nutrient availability""]"
0_Gliosis_run2,0,Gliosis,0_Gliosis,2,14,DNA Damage Response and Genomic Stability,"A gene program responding to DNA damage and maintaining genomic stability under therapeutic and oxidative stress. This program includes DNA damage-inducible genes (GADD45A), cell cycle checkpoints (RRAD, NPR3), and oxidative stress responses. These genes enable GBM cells to survive DNA-damaging therapies and maintain proliferation despite accumulated genomic alterations.","[""GADD45A"", ""RRAD"", ""NPR3""]",3,0.7,"[""Enhanced tolerance of DNA damage from radiation and chemotherapy"", ""Continued proliferation despite checkpoint signals"", ""Maintenance of genomic stability despite accumulated mutations"", ""Reduced sensitivity to temozolomide"", ""Potential development of therapeutic resistance""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,0,CD44-mediated Invasive Adhesion,Coordinated regulation of cell-cell and cell-matrix adhesion through CD44 receptor interactions with hyaluronic acid and other extracellular matrix components. CD44 mediates formation of microtentacles and stabilizes migrating cell morphology during glioma invasion through orchestration of cytoskeletal dynamics and downstream signaling pathways.,"[""CD44"", ""ITGB4""]",2,0.92,"[""Enhanced dynamic adhesion enabling rapid migration through matrix-rich brain parenchyma"", ""Switching between individual and collective migration modes"", ""Increased tumor cell invasiveness and reduced chemoresistance through CD44-mediated multidrug transporter activation"", ""Resistance to conventional therapies through CD44-dependent survival signaling""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,1,Integrin-mediated Migration and EMT,"ITGB4 integrin functions as a mechanosensor promoting tumor migration and invasion through epithelial-mesenchymal transition (EMT) programs, activated by engagement with extracellular ligands and coordinated with growth factor receptor signaling via focal adhesion kinase and phosphoinositide 3-kinase pathways.","[""ITGB4""]",1,0.88,"[""Enhanced FAK-mediated signaling promoting migration and invasion capacity"", ""Coordinated activation of EMT programs enhancing mesenchymal phenotype"", ""Increased phosphorylation and activation of downstream AKT and ERK pathways"", ""Promotion of collective invasion through matrix-associated signaling""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,2,N-cadherin-dependent Context-specific Migration,"N-cadherin (CDH2) functions as a context-dependent regulator of glioma cell migration, promoting movement on neural cell surfaces while inhibiting migration through extracellular matrix. Intercellular homotypic N-cadherin interactions enable collective invasion through alternating engagement with different cellular environments.","[""CDH18""]",1,0.75,"[""Promotion of migration along white matter tracts and gray matter interfaces"", ""Facilitation of collective invasion with coordinated cell movement"", ""Dynamic switching between migration routes based on local environment"", ""Reduced individual cell migration capacity but enhanced coordinated advancement""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,3,Extracellular Matrix Remodeling,"Active ECM remodeling via ADAMTS family proteases, collagen biosynthesis and deposition, and tenascin-C expression in glioblastoma creates a permissive microenvironment for tumor progression. ECM components serve as both structural scaffolds and bioactive signaling molecules regulating tumor cell behavior.","[""ADAMTS5"", ""COL20A1"", ""TNR""]",3,0.83,"[""Enhanced tumor cell migration through enzymatic matrix degradation"", ""Creation of physical scaffolds supporting collective invasion"", ""Generation of bioactive ECM fragments promoting tumor cell signaling"", ""Promotion of vascular invasion and angiogenesis through TNC-mediated effects""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,4,Metabolic Reprogramming and Redox Homeostasis,"Coordinated upregulation of oxidative phosphorylation (via PPARGC1A), cystine-glutamate exchange (via SLC7A11), and DNA repair mechanisms (via EEPD1) enables glioblastoma cells to manage replication stress, maintain redox balance, and sustain proliferation under nutrient-limited conditions.","[""PPARGC1A"", ""SLC7A11"", ""EEPD1""]",3,0.81,"[""Enhanced ATP production supporting high energy demands of proliferation"", ""Maintenance of reducing potential enabling rapid biosynthesis"", ""Protection from ferroptosis and oxidative stress-induced apoptosis"", ""Sustained proliferation under nutrient-limited tumor microenvironment"", ""Increased resistance to oxidative therapy-induced damage""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,5,Immune Evasion and Checkpoint Regulation,Coordinated suppression of MHC class I antigen presentation via altered NLRC5 signaling and expression of immunomodulatory molecules enables glioblastoma cells to escape T cell recognition. Extracellular vesicle-mediated transfer of Arc protein facilitates intercellular communication within tumor cell networks and immune evasion.,"[""NLRC5"", ""ARC"", ""CD44""]",3,0.76,"[""Reduced MHC class I expression on tumor cell surface limiting CD8+ T cell recognition"", ""Enhanced intercellular communication through EV-mediated mRNA transfer"", ""Promotion of glioma cell heterogeneity and plasticity through Arc signaling"", ""Facilitation of adaptive immune evasion mechanisms""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,6,Ganglioside and Glycosylation-based Signaling,"Expression of ganglioside synthesis enzymes (ST8SIA1, ST8SIA5) and glycosyltransferases (CHST8, XYLT1) in glioblastoma promotes tumor progression through enhanced cell surface glycosylation. GD3 ganglioside and related glycosphingolipids activate oncogenic signaling cascades and promote stemness, angiogenesis, and immune evasion.","[""ST8SIA1"", ""ST8SIA5"", ""XYLT1"", ""CHST8""]",4,0.79,"[""Enhanced GD3 expression promoting glioma stemness and self-renewal capacity"", ""Activation of oncogenic RTK signaling through GD3-mediated receptor clustering"", ""Increased tumor angiogenesis through GD3-promoted VEGF release"", ""Enhanced immunosuppression through ganglioside-mediated T cell inhibition"", ""Altered cell adhesion and metastatic potential through modified cell surface glycosylation""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,7,Neural-like Developmental Signaling,"Coordinated expression of neuroligin/netrin receptor systems (LRRC4C, MDGA2, UNC5D) and guidance molecule receptors (RGMA, DAB1) in glioblastoma mimics developmental neural signaling pathways. These systems regulate glioma cell migration patterns, synaptic-like contacts, and interactions with host neural tissue.","[""LRRC4C"", ""MDGA2"", ""UNC5D"", ""RGMA"", ""DAB1""]",5,0.77,"[""Enhanced glioma cell migration through neural pathways along white matter tracts"", ""Formation of neuroglial synaptic-like contacts promoting tumor progression"", ""Escape from repulsive guidance cues enabling migration into neural tissue"", ""Exploitation of developmental neural wiring for dissemination""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,8,GFAP Isoform-dependent Malignancy,"Dynamic regulation of GFAP alternative splicing in glioblastoma, with increased GFAPδ expression and elevated GFAPδ/GFAPα ratio marking malignant transformation. GFAPδ-dependent signaling promotes invasiveness through MAPK pathway modulation and extracellular matrix interaction changes.","[""GFAP""]",1,0.74,"[""Enhanced tumor invasiveness through DUSP4-mediated MAPK modulation"", ""Increased risk for early recurrence and poor prognosis"", ""Altered ECM engagement promoting migration through brain parenchyma"", ""Enhanced malignant gene expression programs in high-grade tumors""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,9,Long Non-Coding RNA Regulatory Networks,"Dysregulated expression of multiple long non-coding RNAs (lncRNAs) in glioblastoma orchestrates tumor progression through competing endogenous RNA (ceRNA) networks, regulation of mRNA stability, and modulation of chromatin structure. lncRNAs serve as scaffolds for transcriptional regulation and affect immune cell infiltration.","[""LINC01727"", ""AC117464.1"", ""LINC02125"", ""LINC02246"", ""LINC01776"", ""LINC01117"", ""LINC02328"", ""AL353138.1"", ""AL356737.2"", ""AL159156.1"", ""AC077690.1"", ""AC019068.1"", ""AC013265.1"", ""AC233296.1"", ""AC124254.2"", ""AC007344.1"", ""MIR3681HG"", ""LUCAT1""]",18,0.68,"[""Dysregulated expression of tumor suppressor and oncogene networks"", ""Altered immune cell recruitment and infiltration patterns"", ""Enhanced tumor cell proliferation and survival through miRNA depletion"", ""Modulation of cell cycle checkpoints and apoptosis evasion"", ""Increased epithelial-mesenchymal transition and stemness programs""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,10,PI3K/AKT Signaling Modulation,"INPP4B phosphatase regulates PI3K/AKT signaling by converting PI(3,4)P2 to PI(3)P, with context-dependent effects on tumor progression. In PIK3CA-mutant ER+ breast cancers, INPP4B promotes Wnt/β-catenin signaling through late endosome formation, while in triple-negative breast cancers, INPP4B loss enhances AKT activation.","[""INPP4B""]",1,0.71,"[""Context-dependent modulation of AKT signaling strength"", ""Enhanced Wnt/\u03b2-catenin pathway activation in specific tumor contexts"", ""Altered response to PI3K inhibitor therapies"", ""Differential tumor suppressor versus oncogenic activities in different cancer subtypes""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,11,Calcium-dependent Cell Adhesion,CDH18 and DCHS2 encode calcium-dependent cadherins mediating neural cell adhesion and affecting tumor progression through modulation of adhesive properties and immune cell interactions. CDH18 associates with macrophages in tumor microenvironment and affects immunotherapy resistance.,"[""CDH18"", ""DCHS2""]",2,0.62,"[""Altered glioma cell adhesion and invasiveness based on calcium availability"", ""Modulation of immune cell-tumor cell interactions"", ""Effects on chemotherapy resistance through macrophage engagement"", ""Influence on tumor microenvironment composition and function""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,12,Transcriptional Co-regulator Activity,"MN1 meningioma-1 acts as essential co-factor in MLL fusion leukemias maintaining active transcription of HOXA cluster genes and their targets. MN1 high expression marks poor prognosis and its loss impairs leukemia proliferation, suggesting potential broader roles in glioblastoma transcriptional control.","[""MN1""]",1,0.58,"[""Maintenance of proliferative and survival gene expression programs"", ""Resistance to differentiation and apoptosis cues"", ""Altered chromatin architecture and transcriptional memory"", ""Poor prognosis association in affected tumors""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,13,Heparan Sulfate Proteoglycan Signaling,GPC5 glypican-5 heparan sulfate proteoglycan functions as tumor suppressor in glioblastoma and other cancers by promoting Sonic Hedgehog co-receptor activity and antagonizing Wnt/β-catenin signaling. Reduced GPC5 expression correlates with increased proliferation and poor prognosis.,"[""GPC5""]",1,0.65,"[""Reduced proliferation through Wnt/\u03b2-catenin pathway antagonism"", ""Decreased cell migration and invasiveness"", ""Impaired tumor growth in xenograft models"", ""Enhanced differentiation and reduced stemness""]"
1_OPC_AC_like_1_run1,1,OPC-AC-like 1,1_OPC_AC_like_1,1,14,Histamine Receptor Signaling,"HRH1 histamine H1-receptor promotes tumorigenesis through ERK/EGR1 signaling axis while HRH2 H2-receptor antagonizes these effects. The HRH2/HRH1 expression ratio predicts patient survival, suggesting bimodal histamine signaling roles in glioblastoma and other cancers.","[""HRH1""]",1,0.6,"[""Enhanced tumor cell proliferation and survival through H1R-mediated ERK signaling"", ""Increased chemokine-mediated immune cell recruitment and tumor-promoting inflammation"", ""Protective effects through H2R-mediated ERK suppression"", ""Bimodal regulation of tumor growth based on HRH2/HRH1 expression ratio""]"
2_NPC_neuronal_like_1_run1,2,NPC-neuronal-like 1,2_NPC_neuronal_like_1,1,0,Ciliary Dysfunction and Motility Defects,"Coordinated dysfunction of cilia and flagella structure and function through loss-of-function variants in axonemal dynein and associated proteins. In glioblastoma context, ciliary dysfunction may impair motile cilia-dependent signaling and cellular communication, particularly relevant given that mutations in CFAP43 and DNAH5 cause morphological abnormalities in motile cilia that result in hydrocephalus and primary ciliary dyskinesia. Multiple genes encoding dynein axonemal assembly factors (DNAAFs) and outer dynein arm components are present in this program.","[""CFAP43"", ""CFAP47"", ""CFAP52"", ""CFAP61"", ""CFAP73"", ""CFAP100"", ""CFAP157"", ""CFAP206"", ""CFAP221"", ""DNAH5"", ""DNAH12"", ""DNAAF1"", ""DCDC2"", ""TCTEX1D1"", ""RSPH1"", ""DRC1""]",16,0.55,"[""Impaired primary cilia formation and motility may disrupt hedgehog signaling transduction and cellular sensing of microenvironmental cues"", ""Loss of ciliary-mediated fluid flow and mechanotransduction may compromise cell-cell communication within tumor microenvironment"", ""Defective cilia may alter intraflagellar transport and affect localization of signaling proteins involved in tumor progression"", ""Ciliary dysfunction may disrupt planar cell polarity signaling, potentially affecting collective glioma cell migration and invasion patterns""]"
2_NPC_neuronal_like_1_run1,2,NPC-neuronal-like 1,2_NPC_neuronal_like_1,1,1,IL-6-Mediated Immunosuppression,"Coordinated immunosuppressive signaling driven by IL-6 axis and its regulation through NEGR1 and GABAergic receptor signaling. In glioblastoma, this program supports tumor growth through myeloid-cell polarization and T-cell exhaustion. IL6R activation drives STAT3-dependent immunosuppression, while NEGR1 negatively regulates IL-6 trans-signaling. GABAergic neurons provide depolarizing input to DMG cells through GABRA5-mediated signaling, promoting tumor growth.","[""IL6R"", ""NEGR1"", ""GABRA5"", ""GABRG3""]",4,0.82,"[""Enhanced IL-6 signaling promotes M2 macrophage polarization and increases PD-L1 expression on myeloid cells, suppressing CD8+ T cell function"", ""Increased circulating IL-6 and sIL-6R create systemic immunosuppressive environment; elevated IL-6 correlates with worse overall survival"", ""GABAergic synaptic input depolarizes glioma cells through GABA-A receptor activation, promoting depolarization-dependent tumor growth in diffuse midline gliomas"", ""Combined IL-6-driven myeloid suppression and GABA-mediated glioma cell depolarization create robust immunosuppressive niche resistant to checkpoint inhibitor monotherapy"", ""NEGR1-mediated negative regulation of IL-6 trans-signaling could serve as brake on immunosuppression but is likely downregulated in GBM""]"
2_NPC_neuronal_like_1_run1,2,NPC-neuronal-like 1,2_NPC_neuronal_like_1,1,2,Tumor-Suppressive Chromatin Remodeling,"CHD5 and related chromatin remodeling factors mediate tumor suppression through histone binding and transcriptional regulation of cell cycle inhibitors and differentiation programs. CHD5 is a member of the chromatin remodeling complex family mapping to 1p36, a region frequently deleted in cancer. CHD5 binds unmodified histone H3 through its PHD domains and regulates expression of p16 and p19 tumor suppressors. Loss of CHD5 or its functional domains abrogates tumor suppression and promotes gliomagenesis.","[""CHD5"", ""ZNF521""]",2,0.78,"[""Loss or functional impairment of CHD5 removes critical brake on glioma cell proliferation and blocks differentiation programs protective against transformation"", ""Intact CHD5 function maintains expression of p16 and p19 tumor suppressors, preventing aberrant cell cycle progression"", ""ZNF521 overexpression in SHH-pathway-driven gliomas promotes stemness maintenance and migration through enhanced Hedgehog signaling"", ""Combined CHD5 loss and ZNF521 upregulation would create permissive environment for glioma initiation and maintenance of stem cell properties""]"
2_NPC_neuronal_like_1_run1,2,NPC-neuronal-like 1,2_NPC_neuronal_like_1,1,3,Extracellular Matrix Remodeling and Invasion,"POSTN, THBS1, and collagen genes coordinate extracellular matrix remodeling to promote glioma cell invasion, angiogenesis, and immune suppression. POSTN secreted by glioma stem cells recruits tumor-associated macrophages (TAMs) and promotes invasive phenotype through NF-κB signaling. THBS1 is upregulated with glioma grade and mediates both angiogenesis and invasion while contributing to immune suppression. Collagen genes define mesenchymal GBM subtype with prognostic implications.","[""POSTN"", ""THBS1"", ""COL21A1"", ""COL13A1"", ""COL23A1"", ""COL26A1"", ""CDH7""]",7,0.85,"[""POSTN-mediated TAM recruitment creates immunosuppressive microenvironment enriched in M2 macrophages expressing immunosuppressive cytokines and PD-L1"", ""POSTN-driven NF-\u03baB activation in glioma cells enhances EMT, invasiveness, and chemoresistance"", ""THBS1 upregulation promotes both angiogenesis and invasion while simultaneously suppressing CD8+ T cell proliferation through TNF-\u03b2-mediated mechanisms"", ""Elevated collagen deposition creates physical barrier to immune infiltration and promotes mesenchymal GBM phenotype associated with poor prognosis"", ""N-cadherin dynamics enable context-dependent migration on neural cells versus inhibited invasion into ECM-rich regions, allowing differential spatial invasion patterns""]"
2_NPC_neuronal_like_1_run1,2,NPC-neuronal-like 1,2_NPC_neuronal_like_1,1,4,Metabolic Reprogramming and Energy Homeostasis,"KSR2, ADCY8, SLC22A3, and ion channel proteins coordinate metabolic reprogramming of glioma cells to enhance proliferation and chemoresistance. KSR2 integrates mitogenic and metabolic signaling through AMPK, regulating both glycolytic and oxidative metabolism. ADCY8 polymorphisms correlate with glioma risk in sex-specific manner through cAMP pathway modulation. SLC22A3 functions as tumor suppressor through metabolic homeostasis. Ion channels including KCNJ3 and CACNA2D1 regulate cell volume, calcium signaling, and metabolic capacity.","[""KSR2"", ""ADCY8"", ""SLC22A3"", ""SLC14A1"", ""KCNJ3"", ""CACNA2D1""]",6,0.76,"[""Loss of KSR2 through praja2-mediated degradation shifts glioma metabolism toward glycolysis and away from oxidative phosphorylation, reducing AMPK activity and metabolic flexibility"", ""ADCY8 dysregulation creates sex-biased susceptibility to glioma with enhanced cAMP suppression promoting female glioma development"", ""Reduced SLC22A3 expression and function impairs organic cation homeostasis and promotes metabolic dysfunction favoring tumor growth"", ""Enhanced potassium and calcium channel activity facilitates regulatory volume decrease enabling glioma cell invasion through confined CNS spaces"", ""Coordinated metabolic reprogramming reduces energy expenditure on antitumor immune responses while enhancing biosynthetic capacity for rapid proliferation""]"
2_NPC_neuronal_like_1_run1,2,NPC-neuronal-like 1,2_NPC_neuronal_like_1,1,5,Neurotransmitter Signaling and Synaptic Communication,GRM1 and GRM4 metabotropic glutamate receptors mediate pro-tumor glutamatergic signaling that drives glioma proliferation and suppresses antitumor immunity. NRG3 neuregulin ligand activates ErbB4 receptors involved in glial differentiation and survival signaling. Dysregulation of these synaptic communication pathways enables glioma cells to integrate signals from surrounding neurons and facilitate tumor progression through glutamate-calcium signaling and neuregulin-ErbB crosstalk.,"[""GRM1"", ""GRM4"", ""NRG3""]",3,0.7,"[""Elevated mGluR1/5 signaling in glioma cells activates PI3K/AKT/mTOR pro-survival axis and drives proliferation through positive feedback enhancement of glutamate release"", ""mGluR2/3 signaling suppresses G1/S transition in subset of GBM cells, potentially promoting quiescent glioma stem cell population resistant to cytotoxic therapy"", ""GRM4 upregulation in glioma creates immunosuppressive microenvironment by suppressing NK and T cell antitumor immunity through cAMP modulation"", ""NRG3-ErbB4 signaling enhances glial cell differentiation and survival while simultaneously promoting expression of neurotransmitter receptors that sensitize glioma cells to neuronal input"", ""Coordinated dysregulation of mGluR and neuregulin signaling enables glioma cells to parasitize neuron-derived glutamate and neuregulin signals for self-promotion while suppressing immune surveillance""]"
2_NPC_neuronal_like_1_run1,2,NPC-neuronal-like 1,2_NPC_neuronal_like_1,1,6,BMP-Mediated Developmental Signaling,BMP6 and related bone morphogenetic protein signaling promotes quiescent glioma stem cell phenotype while conferring resistance to radiation and chemotherapy. BMP pathway activation induces differentiation while suppressing proliferation through ID protein modulation. BMP signaling defines population of slow-cycling glioma stem cells that may represent reservoir for tumor recurrence following cytotoxic therapy.,"[""BMP6""]",1,0.62,"[""BMP6 signaling promotes and maintains quiescent glioma stem cell population resistant to proliferation-targeting therapeutics"", ""BMP-induced ID1 activity suppresses differentiation, preserving stem cell properties and long-term tumorigenic potential"", ""Enhanced MGMT and ATM expression through BMP signaling confers chemoresistance and radioresistance, reducing efficacy of adjuvant therapy"", ""BMP-positive GSC population may serve as cellular reservoir for tumor recurrence following cytotoxic therapy targeting proliferative population"", ""Slow-cycling BMP-positive GSCs remain chemosensitive to differentiation-inducing drugs but resistant to cell-cycle-targeting agents""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,0,Extracellular Matrix Remodeling and Invasion,"Coordinated secretion and degradation of extracellular matrix components to facilitate glioblastoma cell invasion through brain tissue. This program includes collagen synthesis and deposition (COL3A1, COL6A3), matrix metalloproteinase activity (ADAMTS3, PRSS12), ECM-binding proteins (SMOC2, POSTN, TGFBI), and regulatory proteins (GREM2, VWC2L). In GBM, this program promotes escape from the tumor core and infiltration into surrounding brain parenchyma, supporting mesenchymal transition and treatment-resistant phenotypes.","[""COL3A1"", ""COL6A3"", ""ADAMTS3"", ""PRSS12"", ""SMOC2"", ""POSTN"", ""TGFBI"", ""GREM2"", ""VWC2L"", ""SERPINI1"", ""PAPPA2"", ""EDIL3"", ""RASGEF1B"", ""FGD4""]",14,0.92,"[""Enhanced invasive migration into infiltrated brain tissue"", ""Acquisition of mesenchymal gene expression signature"", ""Increased mechanical stiffness of local microenvironment"", ""Reduced chemotherapy penetration through ECM barrier"", ""Promotion of bevacizumab-resistant phenotype""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,1,Cell Adhesion and Synaptic-Like Junctions,"Classical and non-classical cell adhesion molecules that mediate cell-cell contacts and establish specialized junction zones. This program includes classical cadherins (CDH4, CDH9, CDH13, CDH18), contactin-associated proteins (CNTNAP4, CNTN5), and adhesion receptors (LRFN5, TENM2, EFNA5). In GBM, dysregulation of these molecules contributes to loss of normal cell polarity, altered migration dynamics, and altered response to developmental cues that normally restrict proliferation.","[""CDH4"", ""CDH9"", ""CDH13"", ""CDH18"", ""CNTNAP4"", ""CNTN5"", ""LRFN5"", ""TENM2"", ""EFNA5"", ""GFRA1""]",10,0.85,"[""Altered cell-cell contact dynamics affecting proliferation control"", ""Loss of normal neuronal polarity cues"", ""Enhanced migratory behavior through reduced adhesive restraint"", ""Increased cellular plasticity and phenotypic switching"", ""Dysregulated response to developmental guidance molecules""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,2,Growth Factor Receptor Signaling,"Receptor tyrosine kinases and associated signaling molecules that drive proliferation, survival, and differentiation in GBM. This program includes FGFR2 (fibroblast growth factor receptor), KIT (stem cell growth factor receptor), GFRA1 (GDNF family receptor alpha-1), and downstream signaling mediators. GBM frequently exhibits aberrant RTK signaling which activates Ras/MAPK and PI3K/AKT/mTOR pathways, driving rapid proliferation and therapy resistance.","[""FGFR2"", ""KIT"", ""GFRA1"", ""RASGEF1B"", ""FGD4""]",5,0.88,"[""Enhanced proliferation through Ras/MAPK and PI3K/AKT signaling"", ""Increased survival signaling and resistance to apoptosis"", ""Promotion of stemness and self-renewal in cancer stem cells"", ""Enhanced migration and invasion capabilities"", ""Reduced responsiveness to differentiation cues""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,3,Ion Channel-Mediated Cellular Signaling,"Voltage-gated and ligand-gated ion channels that regulate intracellular calcium, potassium, and chloride dynamics. This program includes NMDA receptors (GRIN2A), GABA receptors (GABBR2, GLRA2), ion channels (TRPM3, TRPC5, KCNC2, KCNJ6), and calcium-dependent enzymes (PDE1A, PDE1C). In GBM, ion channel activity regulates cell proliferation, migration, survival, and response to chemotherapy through calcium signaling and electrical properties.","[""GRIN2A"", ""TRPM3"", ""TRPC5"", ""KCNC2"", ""KCNJ6"", ""DPP10"", ""GABBR2"", ""GLRA2"", ""PDE1A"", ""PDE1C"", ""SYT1"", ""SYNPR"", ""RPH3A"", ""SLC17A6"", ""ANO4"", ""CPNE4""]",16,0.76,"[""Altered intracellular calcium dynamics affecting proliferation"", ""Modified excitability and electrical properties of GBM cells"", ""Dysregulated response to neurotransmitter signals"", ""Enhanced or reduced drug sensitivity depending on channel status"", ""Altered cell-cell communication through gap junctions and synaptic-like contacts""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,4,Axon Guidance and Repulsive Signaling,"Molecules mediating repulsive and attractive axon guidance cues that direct neuronal migration and process outgrowth. This program includes semaphorins (SEMA3C), ephrin ligands (EFNA5), netrin receptors (UNC5C, UNC5D), and associated signaling molecules (LINGO2, NDNF). In GBM, aberrant expression of guidance molecules contributes to altered cell migration patterns, invasion into surrounding brain tissue, and escape from normal developmental constraints.","[""SEMA3C"", ""EFNA5"", ""UNC5C"", ""UNC5D"", ""LINGO2"", ""NDNF"", ""FGD4"", ""RASGEF1B"", ""CPNE4""]",9,0.72,"[""Altered migration direction and invasive behavior"", ""Loss of normal developmental constraints on cell movement"", ""Escape from peri-tumoral zones and infiltration into normal brain"", ""Reprogramming of guidance molecule responses"", ""Dysregulation of growth cone dynamics""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,5,RNA Binding and Post-transcriptional Regulation,"RNA binding proteins and regulatory mechanisms controlling mRNA stability, localization, and translation. This program includes RBFOX1 (regulates alternative splicing), LIN28B (suppresses let-7 miRNAs and promotes oncogene translation), and SRRM4 (serine/arginine repetitive matrix protein). In GBM, dysregulation of these RNA binding programs drives stemness, proliferation, metabolic reprogramming, and therapy resistance through altered gene expression.","[""LIN28B"", ""RBFOX1"", ""SRRM4""]",3,0.84,"[""Altered splicing of genes encoding adhesion and cytoskeletal proteins"", ""Derepression of multiple oncogenes through let-7 suppression"", ""Enhanced de novo lipid synthesis supporting rapid proliferation"", ""Activation of TGF-\u03b2 signaling and mesenchymal phenotype"", ""Increased metabolic flexibility and therapy resistance""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,6,Transcriptional Control of Neural Differentiation,"Transcription factors that specify neuronal identity and regulate differentiation versus proliferation decisions. This program includes EBF family proteins (EBF1, EBF2), MYT1L (myelin transcription factor 1-like), CUX2 (cut-like homeobox 2), RUNX1T1 (runt-related transcription factor), and POU6F2 (POU class 6 homeobox). In GBM, dysregulation or loss of these differentiation-promoting transcription factors maintains stemness and proliferative capacity while blocking maturation.","[""EBF1"", ""EBF2"", ""MYT1L"", ""CUX2"", ""RUNX1T1"", ""POU6F2""]",6,0.81,"[""Resistance to terminal differentiation and maturation"", ""Maintenance of stem cell-like transcriptional signatures"", ""Continued expression of proliferation-promoting genes"", ""Loss of normal developmental growth arrest signals"", ""Dysregulation of glial vs. neuronal cell fate decisions""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,7,Glioma Stem Cell Maintenance and Stemness,"Programs supporting cancer stem cell (CSC) properties including self-renewal, multipotency, and therapy resistance. This program involves LIN28B-mediated repression of let-7 miRNAs, altered metabolism (MTAP, PIP5K1B), and signaling from growth factor receptors (FGFR2, KIT, GFRA1). GBM stem cells exhibit increased invasive potential and resistance to radiotherapy and chemotherapy, and are thought to be key drivers of tumor recurrence and progression.","[""LIN28B"", ""FGFR2"", ""KIT"", ""GFRA1"", ""EBF1"", ""EBF2"", ""MYT1L"", ""COL6A3"", ""ADAMTS3"", ""POSTN"", ""CDH9"", ""CDH18"", ""TENM2"", ""MTAP"", ""PIP5K1B""]",15,0.79,"[""Self-renewal and multipotency despite differentiation cues"", ""Increased tumor-initiating capacity"", ""Enhanced resistance to chemotherapy and radiotherapy"", ""Promotion of tumor recurrence and progression"", ""Heterogeneous tumor composition with multiple cell states""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,8,Spatial Gene Expression Heterogeneity,"Genes supporting distinct gene expression programs in different tumor microenvironments—tumor core vs. infiltrated brain tissue. This program includes genes upregulated in proneural vs. mesenchymal cores (EBF1, EBF2, CDH genes), genes associated with hypoxic/necrotic regions (HIF-pathway related), and genes enriched in infiltrating cells (AC/OPC/NPC-like state markers). In GBM, spatial heterogeneity reflects both genomic alterations and microenvironmental influences that shape tumor cell behavior.","[""COL6A3"", ""TGFBI"", ""POSTN"", ""ADAMTS3"", ""CDH9"", ""CDH18"", ""CDH4"", ""EBF1"", ""EBF2"", ""MYT1L"", ""EFNA5"", ""SEMA3C""]",12,0.75,"[""Distinct proliferation and migration strategies in different microenvironments"", ""Phenotypic plasticity responding to hypoxia and nutrient availability"", ""Differential therapy response across tumor regions"", ""Regional heterogeneity in immune infiltration and inflammatory responses"", ""Spatial segregation of proneural and mesenchymal phenotypes""]"
3_NPC_neuronal_like_2_run1,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,1,9,Metabolic Reprogramming and Lipid Synthesis,"Genes supporting altered metabolic states in GBM including enhanced glycolysis, de novo lipid synthesis, and alternative nutrient utilization. LIN28B drives fatty acid synthesis through SREBP-1 pathway; MTAP and associated genes support purine metabolism; metabolic enzymes support rapid biomass accumulation. In GBM, metabolic reprogramming enables rapid proliferation and supports therapy resistance through ER stress evasion and lipid-dependent membrane expansion.","[""LIN28B"", ""MTAP"", ""PIP5K1B"", ""SLC38A11""]",4,0.68,"[""Enhanced de novo lipid synthesis supporting rapid membrane expansion"", ""Increased biomass production enabling rapid proliferation"", ""Altered cellular stress responses and ER homeostasis"", ""Metabolic flexibility supporting survival under nutrient restriction"", ""Enhanced therapy resistance through metabolic adaptation""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,0,Extracellular Matrix Remodeling,"This program comprises genes encoding secreted proteins and proteases that modify the glioblastoma microenvironment. The program includes collagen deposition, proteoglycan synthesis, and matrix metalloproteinase regulation. In GBM, dysregulation of this program promotes invasive phenotype, particularly in hypoxic and bevacizumab-resistant tumors. Collagen VI (COL6A3) and collagen III (COL3A1) accumulation stiffens the tumor microenvironment, enhancing β-catenin signaling and mesenchymal marker expression. Periostin (POSTN) expression correlates with glioma grade and poor prognosis. Heparan sulfate proteoglycans (NDST4/HS3ST2) regulate growth factor binding and cell migration. Fibulin-like proteins (FSTL4, FSTL5) promote matrix scaffold formation. Matrix metalloproteinase regulation through FAP and ADAMTS3 enables invasion through brain tissue.","[""COL3A1"", ""COL6A3"", ""POSTN"", ""TGFBI"", ""ADAMTS3"", ""SMOC2"", ""FAP"", ""FSTL4"", ""FSTL5"", ""FRAS1"", ""NDST4"", ""HS3ST2"", ""PAPPA2"", ""SERPINI1"", ""EDIL3""]",15,0.92,"[""Increased tumor stiffness promoting mechanotransduction and \u03b2-catenin signaling"", ""Enhanced migration and invasion through brain tissue via matrix degradation"", ""Reduced response to anti-angiogenic therapy through altered matrix composition"", ""Support for tumor-associated immune cell infiltration and M2 macrophage recruitment"", ""Maintenance of hypoxic microenvironment through altered matrix density""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,1,Cadherin-Mediated Cell Adhesion,"This program encompasses classical cadherins and associated adherens junction proteins that mediate homophilic and heterophilic cell-cell adhesion. In GBM, cadherin expression undergoes dynamic changes that facilitate epithelial-to-mesenchymal transition (EMT). E-cadherin (CDH1, not in input) is downregulated in high-grade gliomas through promoter methylation, particularly in microvascular proliferation regions. N-cadherin (not in input) undergoes proteolytic cleavage by ADAM10 at significantly higher rates in GBM than normal brain, with cleavage facilitating migration. The program includes multiple classical cadherins (CDH4, CDH9, CDH13, CDH18) with distinct adhesion patterns and downstream signaling. NEDD4L ubiquitinates Dishevelled proteins to negatively regulate Wnt/β-catenin signaling, a pathway that promotes GBM proliferation and stemness. Cadherin switching and shedding are hallmarks of GBM invasive phenotype.","[""CDH4"", ""CDH9"", ""CDH13"", ""CDH18"", ""NEDD4L"", ""GREM2""]",6,0.85,"[""Loss of epithelial adhesion properties and gain of mesenchymal phenotype"", ""Enhanced cell motility through cadherin shedding and membrane redistribution"", ""Increased Wnt/\u03b2-catenin signaling promoting proliferation and stemness maintenance"", ""Altered actin cytoskeleton dynamics facilitating 3D invasion"", ""Heterotypic adhesion with stromal cells promoting local invasion""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,2,Calcium Signaling Through Ion Channels,"This program comprises genes encoding ion channels and calcium-dependent signaling molecules that regulate intracellular calcium concentrations and downstream effectors. Transient Receptor Potential (TRP) channels including TRPM3, TRPM7, TRPM8, and TRPC5 are dysregulated in glioma cells and drive proliferation, migration, and invasion. TRPC1 channels are essential for chemotactic migration in response to EGF and PDGF through lipid raft-dependent mechanisms. TRPC6 is upregulated in hypoxic GBM cells via Notch signaling and promotes proliferation through calcineurin-NFAT pathway activation. TRPM7 suppression significantly inhibits GBM cell growth and invasion through miR-28-5p-mediated pathways and JAK2/STAT3 signaling. TRPM8 expression correlates with GBM aggressiveness and poor survival. Voltage-gated potassium channels (KCNJ6, KCNC2) maintain resting membrane potential. Anoctamins (ANO4) are calcium-activated chloride channels affecting calcium compartmentalization. Phosphodiesterases (PDE1A, PDE1C) regulate store-operated calcium entry (SOCE) and cAMP signaling affecting cell motility. GABBR2 (GABA B receptor) modulates inhibitory neurotransmitter signaling affecting network-level GBM behavior.","[""TRPM3"", ""TRPC5"", ""KCNJ6"", ""KCNC2"", ""ANO4"", ""PDE1A"", ""PDE1C"", ""GABBR2"", ""ADRA1B""]",9,0.88,"[""Increased intracellular calcium promoting proliferation through calcineurin-NFAT pathway"", ""Enhanced migratory capacity through TRPC-mediated lipid raft signaling"", ""Altered response to growth factors (EGF, PDGF) through TRP-mediated chemotaxis"", ""Maintained hypoxic phenotype through TRPC6-Notch signaling in low-oxygen regions"", ""Dysregulated cAMP-dependent motility through PDE1C-SOCE coupling"", ""Modified inhibitory neurotransmitter signaling affecting network-level tumor behavior"", ""Survival advantage through reduced apoptosis via calcium-dependent survival pathways""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,3,Synaptic Development and Adhesion,"This program comprises genes encoding synaptic adhesion molecules, calcium sensors for neurotransmitter release, and axon guidance cues. The program includes contactin-associated protein-like molecules (CNTNAP4, CNTNAP5), contactins (CNTN5), teneurins (TENM2), synaptotagmins (SYT1), and semaphorins (SEMA3C). TENM2 forms nanoclusters at presynaptic active zones and is essential for synaptic connectivity, particularly in hippocampal projections. SYT1 serves as the primary calcium sensor for fast neurotransmitter release and is involved in vesicle recycling. Contactins mediate cell-cell adhesion at synaptic cleft. CNTNAP4 regulates synaptic development and maturation. Semaphorins (SEMA3C) act as axon guidance cues affecting neurite outgrowth and axonal pathfinding. In GBM context, this program may be dysregulated to suppress pro-differentiation signaling or alternatively utilized to support GBM cell-cell interactions and network formation.","[""TENM2"", ""SYT1"", ""CNTNAP4"", ""CNTN5"", ""SEMA3C"", ""UNC5D"", ""UNC5C"", ""SHISA6"", ""PRSS12""]",9,0.75,"[""Altered synaptic connectivity potentially suppressing pro-differentiation signals"", ""Enhanced cell-cell adhesion through synaptic adhesion molecules"", ""Modified calcium signaling through synaptotagmin-mediated mechanisms"", ""Potential maintenance of progenitor-like state through altered axon guidance signals"", ""Support for neural-like network formation within GBM tumors""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,4,Receptor Tyrosine Kinase Signaling,"This program comprises genes encoding receptor tyrosine kinases (RTKs) and their signaling intermediates that drive proliferation, survival, angiogenesis, and migration in GBM. The program includes FGFR2 (fibroblast growth factor receptor), KIT (c-KIT/stem cell factor receptor), and GFRA1 (GDNF co-receptor). RTKs activate downstream MAPK/ERK and PI3K/Akt/mTOR pathways controlling cell cycle progression and survival. FGFR2 mutations and amplifications are detected in GBM; FGFR signaling promotes both proliferation and mesenchymal differentiation. KIT is normally expressed during CNS development in endothelial and mast cell progenitors; KIT overexpression in GBM promotes angiogenesis and contributes to tumor growth. GFRA1 is the co-receptor for GDNF (glial cell line-derived neurotrophic factor), which promotes neuron survival and differentiation; deletion of GFRA1 and nearby genes may contribute to GBM pathogenesis. RTK signaling is also modulated by N-cadherin complexes (CDH2 not in input) that decrease FGFR1 internalization sustaining proliferation.","[""FGFR2"", ""KIT"", ""GFRA1"", ""HS3ST2"", ""NDST4""]",5,0.8,"[""Enhanced proliferation through sustained MAPK/ERK pathway activation"", ""Improved survival through PI3K/Akt anti-apoptotic signaling"", ""Increased angiogenesis through KIT-mediated endothelial cell recruitment"", ""Maintenance of stemness and self-renewal capacity"", ""Resistance to differentiation signals through continued growth factor signaling""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,5,Transcriptional Repression of Neural Differentiation,"This program comprises transcription factors and RNA-binding proteins that regulate neuronal differentiation, splicing, and transcriptional networks. The program includes MYT1L (myelin transcription factor 1-like), EBF1/EBF2 (early B-cell factors), RBFOX1 (RNA-binding fox-1), CUX2 (cut-like homeobox 2), SRRM4 (serine/arginine repetitive matrix 4), POU6F2, and RUNX1T1. MYT1L directly represses YAP1 expression, reducing GBM cell proliferation and promoting neural differentiation; MYT1L expression inversely correlates with YAP1 expression in GBM. Reduced MYT1L expression associates with GBM progression and poor survival. EBF factors regulate cortical neuron development and are downregulated in GBM. RBFOX1 regulates both splicing and transcriptional networks important for neuronal development; RBFOX1 is implicated in autism and developmental delay with relevance to neural cell fate determination. CUX2 is expressed in cortical development and marks mature neuronal populations. SRRM4 promotes neuronal splicing programs. RUNX1T1 negatively influences transcription through HDAC recruitment. In GBM, suppression of this differentiation program maintains proliferative capacity and stemness.","[""MYT1L"", ""EBF1"", ""EBF2"", ""RBFOX1"", ""CUX2"", ""SRRM4"", ""POU6F2"", ""RUNX1T1""]",8,0.82,"[""Suppression of neural differentiation through MYT1L inactivation"", ""Maintenance of proliferative capacity through YAP1-mediated signaling"", ""Altered splicing of synaptic and adhesion proteins favoring undifferentiated state"", ""Loss of early differentiation signals through reduced EBF activity"", ""Enhanced stemness and self-renewal through suppressed differentiation programs""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,6,Neuropeptide and Neurosecretion Pathways,"This program comprises genes encoding secreted neuropeptides, hormones, and components of the secretory pathway that package and release bioactive peptides. The program includes SCG2 (secretogranin II), GCG (glucagon), CCK (cholecystokinin), and secretory pathway components including SLC38A11 (amino acid transporter for vesicle loading). SCG2 is a chromogranin/secretogranin family member processed into bioactive peptides EM66 and secretoneurin. SCG2 promotes neuronal differentiation and survival by counteracting nitric oxide-induced toxicity. SCG2 is regulated by REST (repressor element 1 silencing transcription factor) in neural progenitors with non-cell-autonomous differentiation-enhancing activity. SCG2-derived secretoneurin has angiogenic activity and modulates leukocyte transendothelial migration. In reduced SCG2 expression, tumor angiogenesis and aggressive behavior increase. GCG encodes proglucagon processed to GLP-1 and other peptides; GLP-1 neurons show emerging roles in metabolic and stress regulation. CCK encodes cholecystokinin processed to active peptides. In GBM, dysregulation of this program may alter neuroendocrine differentiation capacity and support tumor immune modulation.","[""SCG2"", ""GCG"", ""CCK"", ""SLC38A11"", ""PAPPA2""]",5,0.68,"[""Enhanced neuronal differentiation through SCG2-mediated non-cell-autonomous signaling"", ""Increased angiogenesis through secretoneurin-mediated endothelial signaling"", ""Altered immune cell infiltration through leukocyte migration modulation"", ""Reduced tumor aggressiveness in conditions of high SCG2 expression"", ""Potential neuroendocrine differentiation capacity affecting GBM heterogeneity""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,7,Cyclic Nucleotide Signaling and Cell Motility,"This program comprises genes regulating cyclic nucleotide metabolism, calcium signaling coupling, and cell motility through cAMP/cGMP and calcium-dependent pathways. The program includes phosphodiesterases (PDE1A, PDE1C), adrenergic receptors (ADRA1B), and store-operated calcium entry (SOCE) components. PDE1A and PDE1C are calcium/calmodulin-dependent phosphodiesterases with dual specificity for cAMP and cGMP. PDE1C selectively regulates cAMP during SOCE, affecting leading-edge protrusions (LEP) formation critical for cell migration. Inhibition of PDE1C reduces SOCE-dependent ADCY8 activation, decreasing cAMP accumulation and LEP formation. PDE1C couples calcium signals to cAMP dynamics in spatially restricted signalosomes. ADRA1B (α1B-adrenergic receptor) is a G protein-coupled receptor activating PKC and influencing neuronal differentiation and cell migration. In GBM, dysregulation of this program alters cell motility and invasive phenotype.","[""PDE1A"", ""PDE1C"", ""ADRA1B"", ""PALM2-AKAP2""]",4,0.65,"[""Altered leading-edge protrusion dynamics affecting cell migration speed and direction"", ""Dysregulated cAMP signaling affecting cell motility and proliferation"", ""Enhanced SOCE-dependent signaling promoting calcium-driven invasion"", ""Modified adrenergic receptor signaling affecting neuronal differentiation capacity"", ""Spatial restriction of calcium-cAMP coupling promoting localized migration signals""]"
3_NPC_neuronal_like_2_run2,3,NPC-neuronal-like 2,3_NPC_neuronal_like_2,2,8,RNA-Binding and Post-Transcriptional Control,"This program comprises RNA-binding proteins and splicing factors that regulate post-transcriptional gene expression affecting mRNA stability, localization, and translation. The program includes RBFOX1 (RNA-binding fox-1), SRRM4 (serine/arginine repetitive matrix 4), and long non-coding RNAs (lncRNAs). RBFOX1 binds to GCAUG motifs in nascent RNA during splicing and also in 3' UTRs affecting mRNA stability and translation. Cytoplasmic RBFOX1 increases target mRNA stability and translation; cytoplasmic RBFOX1 targets are enriched in cortical development and autism-related genes. RBFOX1 knockout mice show altered synaptic transmission, increased membrane excitability, and seizure predisposition. Reduced RBFOX1 expression correlates with autism and developmental delay. SRRM4 is a neuron-specific splicing regulator. Multiple lncRNAs in the input list (LINC01033, LINC01344, LINC02607, LINC01949, LINC00862, LINC02378, LINC00470, LINC00707, LINC01965) may function as competing endogenous RNAs (ceRNAs) or direct regulators of gene expression. In GBM, dysregulation of RNA-binding protein networks could suppress neuronal differentiation programs.","[""RBFOX1"", ""SRRM4"", ""LINC01033"", ""LINC01344"", ""LINC02607"", ""LINC01949"", ""LINC00862"", ""LINC02378"", ""LINC00470"", ""LINC00707"", ""LINC01965"", ""MIR3681HG""]",12,0.7,"[""Altered splicing of synaptic and developmental genes affecting differentiation capacity"", ""Enhanced mRNA stability of proliferation-promoting transcripts"", ""Disrupted competition between RBFOX1 and miRNAs affecting target mRNA stability"", ""Dysregulation of autism-related and cortical development gene networks"", ""Modified translation efficiency of key developmental regulators""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,0,Osmotic Cell Volume Regulation and Migration,"Coordinated expression of aquaporins and ion transporters that regulate intracellular osmolarity, enabling rapid water flux and cell volume changes required for glioma cell migration through brain parenchyma. This program couples water channel activity (AQP1, AQP4, SLC14A1) with potassium and sodium channels (KCNN3, ATP1A2, SCN7A) to create osmotic gradients that drive lamellipodia formation and invasion through restricted extracellular spaces.","[""AQP1"", ""AQP4"", ""SLC14A1"", ""KCNN3"", ""ATP1A2"", ""SCN7A"", ""TTYH1""]",7,0.92,"[""Enabled rapid water influx at leading edge supporting lamellipodia protrusion"", ""Enhanced cell volume changes permitting traversal through narrow extracellular spaces"", ""Increased invasive capacity through osmotic-driven cell shrinkage and shape deformation"", ""Polarized ion and water transport creating directional migration cues""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,1,Extracellular Matrix Proteolysis and Invasiveness,"Coordinated expression of proteases (serine proteases, metalloproteinases, transmembrane proteases) and protease inhibitors that remodel the neural extracellular matrix. This program enables glioma cells to degrade neural ECM components (aggrecan, brevican, hyaluronic acid) and replace them with mesenchymal matrix proteins (fibronectin, collagens), switching from an inhibitory to a permissive microenvironment for cell migration and dissemination.","[""SERPINA3"", ""ADAMTS8"", ""ADAMTS15"", ""HAS2"", ""BCAN"", ""FBLN5"", ""TIMP3"", ""ITGB4"", ""CD44"", ""CFI"", ""MASP1""]",11,0.88,"[""Enhanced degradation of inhibitory neural ECM components"", ""Secretion of mesenchymal ECM proteins promoting adhesion and motility"", ""Increased matrix metalloproteinase activity through positive feedback loops"", ""Altered cell-ECM interactions promoting invasion-permissive phenotype"", ""Resistance to chemotherapy through ECM-mediated signaling""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,2,Glioma Stem Cell Identity and State Plasticity,"Regulatory network controlling differentiation, stemness markers, and phenotypic plasticity in glioma stem-like cells (GSCs). This program includes transcription factors that suppress differentiation (ID3, ID4, HOPX), stemness markers (CD44, CD38), glial differentiation markers (GFAP, ALDH1L1), and signaling pathways that maintain GSC self-renewal while permitting transitions to proneural, neural progenitor, and mesenchymal states depending on microenvironmental cues.","[""ID3"", ""ID4"", ""HOPX"", ""CD44"", ""CD38"", ""GFAP"", ""ALDH1L1""]",7,0.85,"[""Maintenance of undifferentiated, self-renewing GSC state"", ""Reduced commitment to terminal astrocyte differentiation"", ""Enhanced tumorigenicity and therapy resistance"", ""Preserved capacity for phenotypic plasticity in response to microenvironmental signals"", ""Increased resistance to differentiation-inducing therapies""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,3,Endothelin Signaling and Proneural-Mesenchymal Transition,"G-protein-coupled receptor (GPCR) signaling through endothelin receptors (EDNRA, EDNRB) that regulates phenotypic plasticity between proneural and mesenchymal states. EDNRB is predominantly expressed in astrocyte-like cells and suppresses proliferation while promoting migration and mesenchymal transition. EDNRA expression is restricted to perivascular populations. This signaling integrates with calcium-dependent pathways (KCNN3) and transcriptional regulators to modulate cell fate decisions in response to oxygenation and cytokine gradients.","[""EDNRA"", ""EDNRB"", ""KCNN3"", ""ADAMTS8"", ""ADAMTS15""]",5,0.78,"[""Regulated transition between proliferative proneural and invasive mesenchymal states"", ""Suppression of proliferation coupled with enhanced migration capacity"", ""Calcium signaling activation promoting cellular plasticity"", ""Context-dependent phenotype determined by oxygen tension and cytokine gradients"", ""Maintained GSC characteristics through autocrine endothelin signaling""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,4,Glycolytic Metabolism and Warburg Effect,"Metabolic reprogramming toward aerobic glycolysis to support rapid proliferation and survival. This program includes rate-limiting glycolytic enzymes (PFKFB3), upstream regulators of glycolytic flux, and cofactors involved in one-carbon metabolism and nucleotide biosynthesis (ALDH1L1). The program also coordinates with hypoxic signaling and glucose availability sensing to shift metabolism from oxidative phosphorylation to glucose-dependent glycolysis.","[""PFKFB3"", ""HAS2"", ""ALDH1L1""]",3,0.72,"[""Enhanced glycolytic flux supporting rapid ATP and biosynthetic precursor production"", ""Increased glucose-dependent survival with enhanced sensitivity to glucose withdrawal"", ""Accumulation of hyaluronic acid supporting ECM remodeling and chemoresistance"", ""Balanced nucleotide synthesis supporting rapid proliferation"", ""Metabolic flexibility through splice variant-specific PFKFB3 effects""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,5,Complement Cascade Activation and Immune Evasion,"Dysregulation of the complement system to promote tumor growth, immune evasion, and therapy resistance. This program includes components of the complement cascade (C3, CFI, MASP1, COLEC12) that shift from immune surveillance toward pro-tumoral immune signaling. Complement activation in the tumor microenvironment promotes myeloid cell recruitment, T cell exhaustion, and immunosuppression while providing survival and proliferative signals to tumor cells.","[""C3"", ""CFI"", ""MASP1"", ""COLEC12"", ""CD38"", ""CHI3L2"", ""CD44""]",7,0.75,"[""Sustained complement activation promoting pro-tumoral inflammation"", ""Recruitment and polarization of tumor-associated macrophages toward M2 phenotype"", ""Suppression of anti-tumor CD8+ T cell responses"", ""Enhanced tumor cell survival and proliferation through C3a/C3aR signaling"", ""Angiogenic response promoting tumor vascularization"", ""Resistance to conventional immunotherapies""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,6,Cell Polarity and Junctional Adhesion,"Establishment and maintenance of cell polarity complex proteins that regulate epithelial-like cell surface organization and cell-cell contacts through gap junctions and tight junction components. This program includes Crumbs polarity complex components (CRB2, MARVELD3) and connexins (GJA1) that mediate both cell-cell communication and regulation of paracrine signaling within the tumor microenvironment. Loss or redistribution of these proteins contributes to epithelial-to-mesenchymal transition and altered tumor-stromal communication.","[""GJA1"", ""CRB2"", ""MARVELD3"", ""ZFP36""]",4,0.68,"[""Altered cell polarity promoting loss of epithelial characteristics"", ""Enhanced GBM-astrocyte communication through functional gap junctions"", ""Transfer of pro-invasive miRNAs from tumor to stromal cells"", ""Increased invasiveness at tumor-brain interface through miRNA-mediated remodeling of astrocyte adhesion"", ""Context-dependent tumor-suppressive vs tumor-promoting effects depending on localization""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,7,Renin-Angiotensin System and Vascular Signaling,"Local renin-angiotensin system (RAS) expression and function in glioblastoma, including synthesis of angiotensinogen (AGT), renin, and angiotensin peptides. This program regulates tumor vascularity, angiogenesis, and may influence tumor cell survival through receptor-mediated signaling. While systemic RAS inhibitors have shown modest effects, selective renin inhibitors reduce GBM cell proliferation and survival independent of angiotensin peptide production.","[""AGT""]",1,0.55,"[""Direct anti-proliferative effects of renin independent of angiotensin signaling"", ""Potential regulation of tumor-associated angiogenesis through angiotensin-mediated vascular effects"", ""Heterogeneous RAS expression between tumors potentially affecting therapy response"", ""Resistance to ACE inhibitors but sensitivity to selective renin inhibitors""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,8,Pericyte-Mediated Tumor Angiogenesis and Vascular Remodeling,"Pericyte recruitment and molecular reprogramming toward proliferative and pro-angiogenic phenotypes during early glioblastoma progression. This program involves PDGF receptor signaling (PDGFRB) in pericytes and endothelial cells, with dual localization showing regional enrichment at the tumor-brain interface and focal positioning at vascular branch points. Early pericyte functions promote angiogenesis; late functions promote tumor growth, representing stage-dependent effects critical for vascular remodeling.","[""PDGFRB""]",1,0.62,"[""Increased angiogenic sprouting from existing vasculature during early tumor development"", ""Vascular co-option followed by neovascularization transition"", ""Endothelial cell reprogramming toward mesenchymal phenotype reducing VEGFR-2 expression"", ""Stage-dependent therapeutic targeting opportunities"", ""Enhanced anti-VEGF resistance through pericyte-mediated vascular support""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,9,Epigenetic and Transcriptional Heterogeneity,"Dysregulation of epigenetic modifiers and transcriptional regulators controlling glioma differentiation states and therapy resistance. This program encompasses HOX gene dysregulation (HOXA cluster involvement), transcription factors maintaining stemness (HOPX, ID family), and associated metabolic consequences. HOX genes are virtually absent in normal adult brain but aberrantly expressed in gliomas, correlating with chromosome 7 gain and worse prognosis.","[""HOPX""]",1,0.65,"[""Aberrant HOX expression driving proliferation and metabolic reprogramming"", ""Dysregulated cell cycle and DNA repair through HOX-mediated transcription"", ""Correlation with chromosome 7 gain indicating genetic instability"", ""Enhanced radiotherapy resistance through HOXA-mediated mechanisms"", ""Prognostic implications through HOXA9-WNT6 co-expression signatures""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,10,EGF Receptor Signaling and Metastatic Cascade,"Aberrant epidermal growth factor (EGF) and EGFR signaling driving glioblastoma proliferation, migration, and invasion through multiple downstream effector pathways. EGF and EGFR are upregulated in GBM tumor regions and edema zones. Signaling proceeds through PI3K/AKT and ERK1/2 pathways to activate matrix metalloproteinase-9 (MMP-9) and drive EMT-related processes. EGFR amplification occurs in ~36-40% of GBMs, often with constitutively active EGFRvIII variant.","[""EGF""]",1,0.7,"[""Enhanced proliferation through sustained EGFR signaling"", ""Increased migration and invasion via MMP-9 upregulation"", ""Epithelial-mesenchymal transition program activation"", ""Chemoresistance through survival pathway activation"", ""Postoperative elevation of EGF correlating with edema formation"", ""EGFR as therapeutic target with resistance mechanisms""]"
4_AC_gliosis_like_1_run1,4,AC-gliosis-like 1,4_AC_gliosis_like_1,1,11,Innate Immune Activation and Interferon Response,"Activation of RIG-I-like receptors (RLRs) including RIG-I and MDA5, triggering innate immune responses and direct glioma cell apoptosis. This emerging therapeutic strategy stimulates both innate and adaptive immune responses through type I interferon production and cytokine/chemokine secretion, countering tumor-mediated immunosuppression and targeting heterogeneous GSC populations.",[],0,0.68,"[""Direct apoptosis of diverse glioma populations including GSCs"", ""Type I interferon production creating anti-tumor state"", ""Recruitment and activation of cytotoxic NK cells and CD8+ T cells"", ""Macrophage activation and polarization toward M1 phenotype"", ""Enhanced tumor infiltration by anti-tumor immune cells"", ""Potential overcoming of immunotherapy resistance""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,0,Aquaporin-mediated osmotic water transport and migration,"Water channel proteins (AQP1, AQP4) regulate osmotic gradients essential for glioma cell migration and edema formation. AQP4 localizes to leading edges of migrating cells and lamellipodia, facilitating volume changes during invasion through narrow extracellular spaces. Coordinated with ion transporters (KCNN3, ATP1A2, SLC14A1) that maintain ion gradients driving osmotic water flux. Dysregulation contributes to both tumor-associated vasogenic edema and enhanced invasive capability.","[""AQP1"", ""AQP4"", ""KCNN3"", ""ATP1A2"", ""SLC14A1""]",5,0.92,"[""Enhanced directional cell migration through osmotic volume regulation"", ""Increased infiltration of tumor cells through brain parenchyma"", ""Promotion of vasogenic edema formation at tumor-brain interface"", ""Support for invasive cell membrane protrusions (lamellipodia formation)"", ""Maintenance of perivascular migration along blood vessel corridors""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,1,Aerobic glycolysis-dependent nutrient acquisition,"Glioblastomas exhibit constitutive aerobic glycolysis despite adequate oxygen (Warburg effect), characterized by upregulation of glycolytic enzymes and glucose transporters. PFKFB3 is the most highly expressed glycolytic regulator in GBM, controlling the rate-limiting step through F-2,6-BP production. This metabolic state is driven by hypoxic microenvironments and genetic alterations (EGFR amplification, PTEN loss). Elevated glycolysis supports both energy production and anabolic biosynthesis, driving tumor cell proliferation and survival. This program is inseparable from invasion, as perivascular glioma cells show peak glycolytic enzyme expression including AQP1, LDH, and cathepsin B.","[""PFKFB3"", ""AQP1""]",2,0.88,"[""Enhanced ATP production supporting tumor growth and proliferation"", ""Increased lactate and H+ secretion promoting acidic tumor microenvironment"", ""Support for anabolic pathways (nucleotide, lipid, amino acid synthesis)"", ""Hypoxia adaptation and maintenance of hypoxic metabolic state"", ""Coupling with angiogenic escape mechanisms to overcome anti-VEGF therapy""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,2,Extracellular matrix remodeling and invasive phenotype,"Glioma cells exhibit dynamic ECM remodeling through coordinated synthesis (HAS2, HAS3 driving hyaluronic acid accumulation) and degradation (ADAMTS8, TIMP3, matrix metalloproteinases). CD44 serves as the primary HA receptor, engaging osteopontin (OPN/SPP1) signaling to promote migration, invasion, and stemness. IGFBP7 promotes glioma cell migration through AKT-ERK pathway activation. Increased ECM deposition (particularly brevican/BCAN and other proteoglycans) creates a denser, more resistant tumor microenvironment. HAS2 expression correlates with poor prognosis and GBM subtype (IDH-WT, non-1p/19q codeletion). Loss of ADAMTS8 (an inhibitory protease) contributes to glioma progression.","[""HAS2"", ""CD44"", ""ITGB4"", ""IGFBP7"", ""TIMP3"", ""ADAMTS8"", ""ID4"", ""BCAN"", ""FBLN5""]",9,0.89,"[""Enhanced tumor cell migration and invasion through remodeled ECM"", ""Increased stemness and self-renewal via CD44-osteopontin signaling"", ""Promotion of epithelial-mesenchymal transition (EMT)"", ""Increased resistance to anti-angiogenic therapy through altered ECM composition"", ""Support for perivascular migration and vascular co-option"", ""Enhanced mechanotransduction signaling through integrin-FAK pathways""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,3,Complement system activation and immune modulation,"The complement cascade is activated within gliomas through multiple pathways (classical via C1q, alternative, and lectin pathways via MASP1/MASP2/COLEC12). Complement components C3 and C5 generate potent anaphylatoxins (C3a, C5a) that promote M2 macrophage polarization and immunosuppression. C3a-C3aR signaling in glioma stem cells (GSCs) maintains stemness through STAT-3 and Wnt/SOX2 pathways. CD38 functions as an ectoenzyme converting NAD+ to immunosuppressive adenosine and ADPR. CHI3L2 (YKL40) is secreted by tumor and immune cells, promoting inflammatory responses and inducing CD8+ T cell apoptosis. This program collectively shifts the immune microenvironment toward M2/immunosuppressive phenotypes.","[""C3"", ""CD38"", ""CHI3L2"", ""MASP1"", ""COLEC12"", ""CFI""]",6,0.87,"[""Polarization of infiltrating macrophages/microglia toward M2 (immunosuppressive) phenotype"", ""Maintenance of glioma stem cell phenotype through C3a-STAT3-SOX2 signaling"", ""Suppression of CD8+ T cell function and promotion of regulatory T cell (Treg) differentiation"", ""Promotion of tumor angiogenesis through complement-endothelial cell interactions"", ""Enhanced resistance to complement-mediated lysis via CD46/CD55/CD59 upregulation"", ""Conversion of adaptive immune responses from Th1 to Th2/immunosuppressive phenotype""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,4,Glioma stem cell self-renewal and maintenance,Glioma stem cells (GSCs) reside in perivascular and hypoxic niches where they maintain multipotency and self-renewal capacity. Endothelin-3 (EDN3) and endothelin receptor B (EDNRB) autocrine signaling is essential for GSC maintenance; blocking EDNRB induces apoptosis and impairs tumor-sphere formation. HOPX marks radial progenitor-like cells in glioma. CD44 and osteopontin (OPN) signaling within the perivascular niche promotes stem cell phenotypes and tumor growth. Complement C3a signaling through C3aR maintains GSCs via STAT-3 and Wnt/SOX2 activation. IGFBP7 and growth factor signaling support GSC migration along blood vessels. ID3 and ID4 (inhibitors of differentiation) regulate GSC proliferation and maintain undifferentiated state.,"[""EDNRA"", ""EDNRB"", ""CD44"", ""C3"", ""HOPX"", ""ID3"", ""ID4"", ""IGFBP7""]",8,0.85,"[""Maintenance of undifferentiated GSC phenotype and multipotency"", ""Enhanced self-renewal capacity and tumor-sphere formation"", ""Increased resistance to differentiation-inducing signals"", ""Support for perivascular localization and niche interaction"", ""Enhanced survival signaling through multiple pathways (EDN, complement, CD44)"", ""Promotion of tumor recurrence through GSC persistence""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,5,Tumor-associated astrocyte and glial cell reprogramming,"Peritumoral and tumor-resident astrocytes undergo reactive transformation (gliosis) characterized by GFAP upregulation. Tumor-associated astrocytes (TAAs) display distinct morphology and transcriptomic profiles depending on anatomical location (tumor core, periphery, perivascular niche, border). ALDH1L1 marks gliogenic precursors and mature astrocytes. TAAs enhance glioma cell viability and migration by upregulating CD44 expression in tumor cells through paracrine mechanisms. Reactive astrocytes modulate immune cell recruitment through purinergic signaling (ATP/adenosine metabolism, CD73). This program represents a critical stromal-tumor interaction that supports malignancy.","[""GFAP"", ""ALDH1L1"", ""CD44"", ""ATP1A2""]",4,0.8,"[""Enhanced glioma cell migration and viability through astrocyte-derived paracrine factors"", ""Upregulation of stemness-promoting genes (CD44) in adjacent tumor cells"", ""Promotion of M1 macrophage infiltration and immune cell recruitment"", ""Increased extracellular adenosine production creating immunosuppressive microenvironment"", ""Support for perivascular tumor cell positioning and angiogenic cooperation"", ""Modulation of blood-brain barrier permeability""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,6,Gap junction communication and chemoresistance,"Connexin 43 (GJA1) forms gap junctions enabling intercellular communication but also confers chemoresistance to temozolomide (TMZ) and other chemotherapeutic agents. Cx43 is highly expressed in a subpopulation of GBM; Cx43 mRNA strongly correlates with poor prognosis and chemoresistance. Cx43 activates PI3K (specifically PIK3CB/p110β) signaling independent of its channel function (non-channel function). CD38 ectoenzyme activity may modulate adenosine levels affecting gap junction function. Combining Cx43 inhibition (αCT1 peptide) with PI3K inhibitors (TGX-221, GSK2636771) sensitizes GBM to TMZ.","[""GJA1"", ""CD38""]",2,0.82,"[""Enhanced intercellular communication enabling collective tumor behavior"", ""Activation of PI3K/AKT survival signaling independent of chemotherapy"", ""Increased resistance to temozolomide and other chemotherapeutic agents"", ""Poor treatment response and shortened progression-free survival"", ""Maintenance of tumor cell viability despite DNA-damaging therapies""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,7,Pericyte recruitment and vascular stability,"Pericytes (mural cells) are recruited to glioma vasculature through PDGF-B/PDGFR-β signaling. Pericytes play paradoxical roles: structurally supporting vessel formation but also promoting treatment resistance. NG2 (a pericyte marker not in input list) isoforms in proliferative perivascular pericytes promote early angiogenesis and vasculogenic mimicry. PDGFRB signaling activates PI3K, promoting pericyte recruitment to hypoxic tumor regions. Two pericyte subtypes exist: Type-1 (non-contributing to new vessel formation; can differentiate to tumor-associated fibroblasts) and Type-2 (pro-angiogenic). Hypoxia induces HIF-1α-mediated PDGF-β expression in endothelial cells, recruiting pericytes. Anti-VEGF therapies lead to increased pericyte vessel coverage, promoting vascular stabilization and therapy resistance.","[""PDGFRB""]",1,0.76,"[""Enhanced tumor vascular network formation and stabilization"", ""Recruitment of pericytes to hypoxic tumor regions"", ""Support for glioma stem cell maintenance in perivascular niche"", ""Increased resistance to anti-angiogenic therapies (bevacizumab)"", ""Promotion of vascular invasion and infiltration"", ""Development of abnormal vascular patterns with atypical pericyte coverage""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,8,Immune cell infiltration and M2 macrophage polarization,"Multiple genes in this list promote M1-to-M2 macrophage polarization and creation of an immunosuppressive tumor microenvironment. CHI3L2 (YKL40) is secreted by tumor cells and immune cells (particularly macrophages), promoting M2-like activation. COLEC12 (C-type lectin) functions as a scavenger receptor upregulated on M2 macrophages. ZFP36L2 correlates with immune infiltration and is positively associated with M2 macrophage markers. Complement components (C3, C3a) promote M2 polarization through C3aR signaling on macrophages. NMB (neuromedin B) expression correlates with immune infiltration and improved GBM survival. OSMR and other cytokine receptors on myeloid cells support immune cell recruitment and polarization.","[""CHI3L2"", ""COLEC12"", ""ZFP36L2"", ""C3"", ""NMB""]",5,0.83,"[""Recruitment and infiltration of macrophages/microglia into tumor microenvironment"", ""Shift of macrophage phenotype from pro-inflammatory (M1) to immunosuppressive (M2) state"", ""Increased expression of immunosuppressive cytokines (IL-10, TGF-\u03b2)"", ""Enhanced T cell exhaustion and impaired anti-tumor immunity"", ""Support for tumor angiogenesis and invasive phenotype"", ""Creation of permissive microenvironment for GSC maintenance""]"
4_AC_gliosis_like_1_run2,4,AC-gliosis-like 1,4_AC_gliosis_like_1,2,9,Metabolic reprogramming and hypoxia adaptation,"Gliomas undergo profound metabolic rewiring to survive hypoxic microenvironments and aggressive selection pressures. Hypoxia-inducible factor-1α (HIF-1α) is a master regulator activating genes for glycolysis, angiogenesis, and stemness. PFKFB3 is the most highly expressed glycolytic enzyme and undergoes post-translational modifications (O-GlcNAcylation, phosphorylation) in response to hypoxia. HAS2 and HAS3 (hyaluronic acid synthases) are upregulated under hypoxia and glycolytic conditions. Endothelin signaling (EDNRA/EDNRB) is hypoxia-responsive and promotes both metabolic adaptation and GSC stemness. This program bridges metabolic, signaling, and stemness programs, reflecting the integrated nature of GBM adaptation.","[""PFKFB3"", ""HAS2"", ""EDNRA"", ""EDNRB""]",4,0.78,"[""Coordinated upregulation of glycolytic pathway under hypoxia"", ""Maintenance of tumor cell viability in oxygen-deprived regions"", ""Enhanced stemness signaling through hypoxia-responsive pathways"", ""Increased ECM synthesis supporting tumor architecture"", ""Metabolic adaptation supporting rapid proliferation and invasion"", ""Coupling of metabolic and stemness programs through HIF-1\u03b1 and endothelin signaling""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,0,Immune Checkpoint Signaling,A gene program mediating immune escape through checkpoint molecule expression and T-cell exhaustion pathways. CD96 functions as an immune checkpoint regulating CD8+ T-cell antitumor function. STAT4 regulates PD-L1 expression and immune evasion. CD163 and MSR1 mark pro-tumoral macrophage populations. OLR1 associates with immune cell infiltration and immunosuppression. TLR2 initiates pathogen recognition signaling in innate immune cells. This program collectively enables glioblastoma immune evasion via checkpoint activation and immunosuppressive microenvironment establishment.,"[""CD96"", ""STAT4"", ""CD163"", ""MSR1"", ""OLR1"", ""TLR2""]",6,0.85,"[""Enhanced CD8+ T-cell exhaustion and reduced anti-tumor immunity"", ""Increased PD-L1 expression on tumor cells and immune cells"", ""Macrophage skewing toward pro-tumoral M2 phenotype"", ""Reduced interferon-gamma production and T-cell activation"", ""Increased IL-10 and TGF-\u03b2 secretion""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,1,Receptor Tyrosine Kinase Signaling,"A gene program comprising components of receptor tyrosine kinase (RTK) signaling pathways that drive glioblastoma proliferation, survival, and invasion. TEK (Tie2) mediates angiopoietin signaling and vessel maturation. DOCK2, DOCK8, and downstream SYK coordinate Rho GTPase activation for cytoskeletal reorganization. WIPF1 facilitates FAK-mediated actin polymerization. This program collectively enhances receptor-mediated signaling critical for glioblastoma growth and angiogenesis.","[""TEK"", ""DOCK2"", ""DOCK8"", ""SYK"", ""WIPF1""]",5,0.82,"[""Enhanced angiogenic signaling through Tie2 activation"", ""Increased Rac and Cdc42 GTPase activity driving cell migration"", ""Enhanced focal adhesion signaling and invasive capacity"", ""Elevated MAPK and PI3K/AKT pathway activation"", ""Increased cytoskeletal remodeling and invadopodia formation""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,2,Synaptic Adhesion and Neuronal Communication,"A gene program mediating cell-cell adhesion at synapses and neuron-neuron interactions through adhesion molecules and signaling proteins. CNTNAP2 is essential for synaptic function and neuronal migration; loss impairs E/I balance and cortical development. IL1RAPL1 is a synaptic adhesion molecule recruiting PTPδ and inducing excitatory synapse formation. NLGN4X encodes neuroligin-4, crucial for synaptic organization and neurotransmission. PCDH7 and PCDH11X are protocadherins involved in cell-cell recognition. SYT1 and SYN3 mediate neurotransmitter release and synaptic plasticity. This program regulates the synaptic connectivity landscape that glioma cells aberrantly reactivate.","[""CNTNAP2"", ""IL1RAPL1"", ""NLGN4X"", ""PCDH7"", ""PCDH11X"", ""SYT1"", ""SYN3"", ""SLIT2"", ""RELN"", ""CHRNA7""]",10,0.78,"[""Aberrant reactivation of synaptic adhesion programs in glioma cells"", ""Enhanced intercellular communication and adhesion between tumor cells"", ""Altered calcium signaling through synaptic-like connections"", ""Increased neurotransmitter-like signaling in tumor microenvironment"", ""Formation of tumor cell-neuron hybrid synaptic structures""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,3,Ion Channel Dysregulation and Excitotoxicity,"A gene program mediating alterations in ion channel expression and calcium homeostasis that promote glioma proliferation and seizure activity. TRPV4 elevates intracellular calcium and promotes invadopodia formation via Cdc42/N-wasp signaling. TRPM8 and TRPM3 modulate calcium and cation fluxes. KCNH7, KCNIP4, RYR2, and RYR3 regulate potassium and ryanodine-sensitive calcium channels. GRIN2B encodes NMDA receptor subunit 2B, contributing to glutamate-mediated calcium signaling. FXYD5 regulates Na+/K+-ATPase. This program collectively dysregulates ion homeostasis, promoting both tumor progression and neuronal hyperexcitability manifesting as glioma-related epilepsy.","[""TRPV4"", ""TRPM8"", ""TRPM3"", ""KCNH7"", ""KCNIP4"", ""RYR2"", ""RYR3"", ""GRIN2B"", ""FXYD5""]",9,0.81,"[""Increased intracellular free calcium concentration"", ""Enhanced invadopodia formation and invasion capacity"", ""Dysregulated potassium buffering and loss of ion homeostasis"", ""Amplified glutamate-mediated excitatory signaling"", ""Glioma-related seizures and epileptiform activity"", ""Metabolic reprogramming via calcium-dependent kinases""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,4,Extracellular Matrix Remodeling and Invasion,"A gene program controlling extracellular matrix (ECM) degradation, remodeling, and production that facilitates glioma invasion and infiltration into normal brain parenchyma. ADAMTS3, ADAMTS14, and ADAMTS18 are metalloproteases cleaving lecticans and other ECM components. POSTN (periostin) is upregulated in cancer-associated fibroblasts and promotes ECM remodeling and invasion. SULF1 modifies heparan sulfate proteoglycans. COL4A6, COL12A1, COL19A1 are collagen scaffolds. SMOC2 and other matricellular proteins regulate cell-matrix interactions. This program collectively restructures the brain microenvironment to enable glioma cell dissemination.","[""ADAMTS3"", ""ADAMTS14"", ""ADAMTS18"", ""POSTN"", ""SULF1"", ""COL4A6"", ""COL12A1"", ""COL19A1"", ""SMOC2""]",9,0.8,"[""Enhanced ECM degradation and proteolytic remodeling"", ""Increased invasive capacity into surrounding brain parenchyma"", ""Altered collagen fiber alignment facilitating migration"", ""Enhanced cell-matrix interactions promoting dissemination"", ""Reduced ECM mechanical impedance to tumor infiltration""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,5,Angiogenesis and Vascular Development,A gene program regulating blood vessel formation and vascular endothelial cell function that supports glioma growth. VEGFD (VEGF-D) is secreted by tumor cells and activates VEGFR-2 and VEGFR-3 on endothelial cells. TEK (Tie2) mediates angiopoietin signaling for vessel maturation and stabilization. KLF5 promotes glioblastoma angiogenesis by inducing AGGF1 gene transcription in glioma-associated endothelial cells. This program collectively drives pathological neovascularization that perfuses the tumor and enables growth beyond diffusion limits.,"[""VEGFD"", ""TEK"", ""KLF5""]",3,0.77,"[""Increased endothelial cell proliferation and vascular sprouting"", ""Enhanced vascular permeability and blood-brain barrier dysfunction"", ""Vessel stabilization and reduced hemorrhagic necrosis"", ""Increased oxygen and nutrient delivery to tumor"", ""Promotion of glioma cell intravasation and dissemination""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,6,Wnt/β-Catenin Self-Renewal Signaling,"A gene program mediating Wnt signaling pathway activation that promotes glioma stem cell self-renewal and inhibits differentiation. WNT16 is a Wnt ligand activating canonical β-catenin signaling. This program drives stemness maintenance and chemotherapy resistance characteristic of glioblastoma stem cells (GSCs), which are responsible for tumor recurrence.","[""WNT16""]",1,0.72,"[""Increased glioma stem cell self-renewal capacity"", ""Enhanced resistance to differentiation signals"", ""Improved tumor growth and propagation"", ""Enhanced chemotherapy and radiotherapy resistance"", ""Tumor recurrence and regrowth after standard therapy""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,7,Epithelial-Mesenchymal Transition and Invasion,"A gene program regulating epithelial-mesenchymal transition (EMT) that enables glioma cell migration, invasion, and dissemination. EMT transcription factors (TWIST-family, SNAIL-family, ZEB-family, SOX2) promote acquisition of mesenchymal phenotype and down-regulation of epithelial markers. TGM2 (tissue transglutaminase) is upregulated during EMT and promotes invasion. POSTN supports EMT through CAF interactions. This program collectively drives the phenotypic plasticity enabling glioma cells to invade adjacent brain tissue and metastasize.","[""TGM2"", ""POSTN""]",2,0.75,"[""Increased cell motility and migration capacity"", ""Enhanced invasive capability into surrounding brain parenchyma"", ""Reduced intercellular adhesion and increased dissemination"", ""Acquisition of stem cell-like properties"", ""Increased resistance to chemotherapy and radiotherapy""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,8,Hypoxia-Responsive Transcription,"A gene program activated under hypoxic conditions (low oxygen) in glioblastoma that drives metabolic reprogramming, angiogenesis, and stemness maintenance. This program includes HIF-1α and HIF-2α-dependent transcriptional responses, though HIFs themselves are not in the input list. VEGFD, TEK, and KLF5 are key HIF-target genes promoting angiogenesis. Downstream metabolic enzymes (ME1 for gluconeogenesis; SUCLG2 for TCA cycle) support hypoxic metabolism. This program collectively enables tumor survival and growth in the hypoxic glioblastoma microenvironment.","[""VEGFD"", ""TEK"", ""KLF5"", ""ME1"", ""SUCLG2""]",5,0.74,"[""Enhanced survival under hypoxic stress"", ""Increased VEGF production and angiogenesis"", ""Metabolic shift toward glycolysis and amino acid metabolism"", ""Enhanced glioma stem cell self-renewal"", ""Resistance to hypoxia-induced apoptosis""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,9,Lipid Metabolism and Signaling,"A gene program regulating lipid metabolism, storage, and signaling that supports glioblastoma proliferation and stemness. PLD1 (phospholipase D1) catalyzes phosphatidic acid production, acting as both an enzymatic catalyst and scaffolding protein in Wnt/β-catenin, PI3K/Akt, and HIF signaling. OLR1 (LOX-1) is a scavenger receptor mediating oxidized lipid uptake and promoting EMT and stemness. ACER2 (alkaline ceramidase 2) regulates ceramide metabolism. This program collectively integrates lipid signaling into core oncogenic pathways.","[""PLD1"", ""OLR1"", ""ACER2""]",3,0.71,"[""Enhanced PI3K/Akt and mTOR signaling"", ""Increased Wnt/\u03b2-catenin pathway activation"", ""Enhanced stemness and self-renewal capacity"", ""Improved metabolic flexibility under diverse nutrient conditions"", ""Reduced immune cell infiltration and T-cell activation""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,10,Tumor-Associated Macrophage Polarization,A gene program regulating polarization and activation of tumor-associated macrophages (TAMs) that create an immunosuppressive microenvironment. CD163 identifies M2-like pro-tumor macrophages enriched in glioblastoma. MSR1 (CD204) is a macrophage-specific receptor involved in pro-inflammatory phenotype. OLR1 is overexpressed in myeloid-derived suppressor cells (MDSCs) and promotes immunosuppression. LCP2 and FYB1 facilitate leukocyte signaling. VSIG4 is an immunosuppressive receptor on macrophages. This program collectively recruits and polarizes TAMs toward anti-tumor immunity suppression.,"[""CD163"", ""MSR1"", ""OLR1"", ""LCP2"", ""FYB1"", ""VSIG4""]",6,0.79,"[""Increased macrophage infiltration into glioblastoma"", ""Polarization toward pro-tumor M2 phenotype"", ""Enhanced IL-10 and TGF-\u03b2 secretion"", ""Reduced CD8+ T-cell activation and infiltration"", ""Increased glioma stem cell maintenance via IL-33""]"
5_AC_neuronal_like_run1,5,AC-neuronal-like,5_AC_neuronal_like,1,11,GTPase Activation and Cytoskeletal Remodeling,"A gene program regulating small GTPase (Rho, Rac, Cdc42) activation and actin cytoskeleton reorganization that enables glioma cell migration and invasion. DOCK2 and DOCK8 are guanine nucleotide exchange factors (GEFs) that activate Rac (DOCK2) and Cdc42 (DOCK8). Downstream effectors (N-WASP, WAVE) nucleate actin filaments. WIPF1 facilitates FAK-Rac coupling. STAC and RCAN2 coordinate Cdc42 and calcium signaling. This program collectively enables rapid morphological changes and invasion-promoting cellular protrusions.","[""DOCK2"", ""DOCK8"", ""WIPF1"", ""STAC"", ""RCAN2"", ""TRPV4""]",6,0.76,"[""Enhanced Rac1 activation and lamellipodia formation"", ""Enhanced Cdc42 activation and filopodia formation"", ""Increased actin polymerization and cytoskeletal reorganization"", ""Enhanced cell migration velocity and invasiveness"", ""Increased invadopodia formation for ECM degradation""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,0,Calcium-mediated cell migration,"Transient receptor potential (TRP) and ryanodine receptor channels regulate calcium influx and signaling cascades that control glioblastoma cell migration, invasion, and chemotaxis. Multiple TRP channels (TRPM8, TRPV4, TRPM3) and ryanodine receptors (RYR2, RYR3) work in concert with potassium channels to modulate intracellular calcium levels, activate kinases like CaMKII, and regulate cytoskeletal dynamics through BK channel-dependent pathways. This calcium signaling promotes volume changes necessary for lamellipodium extension and cell migration, and radiation-induced calcium signaling through TRPM8 confers radioresistance.","[""TRPV4"", ""TRPM8"", ""TRPM3"", ""RYR2"", ""RYR3"", ""KCNH7"", ""KCNIP4"", ""KCNMB4"", ""KCNE4""]",9,0.89,"[""Enhanced cell migration and chemotaxis through calcium-mediated cytoskeletal reorganization"", ""Increased radioresistance via radiation-induced TRPM8 upregulation and impaired DNA repair"", ""Promotion of cell cycle progression through calcium-dependent kinase activation"", ""Facilitated transmigration through extracellular matrix barriers""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,1,Extracellular matrix degradation and invasion,"ADAMTS metalloproteinases, along with regulatory factors including periostin, reelin, and collagens, control extracellular matrix architecture and remodeling. ADAMTS3, ADAMTS14, and ADAMTS18 proteolytically cleave ECM components including aggrecan and versican, generating bioactive matrikines that promote tumor cell motility and invasion. Periostin (POSTN) interacts with integrins to promote invasion and resistance to anti-angiogenic therapy. In contrast, reelin acts as a natural inhibitor of glioma cell migration and invasion by disrupting integrin-matrix interactions. This program is critical for infiltrative behavior characteristic of GBM.","[""ADAMTS3"", ""ADAMTS14"", ""ADAMTS18"", ""POSTN"", ""RELN"", ""COL4A6"", ""COL12A1"", ""COL19A1"", ""SPOCK3"", ""EMILIN2""]",10,0.85,"[""Degradation of basement membrane and perivascular ECM enabling infiltration of brain parenchyma"", ""Generation of pro-invasive matrikines from cleaved ECM components"", ""Enhanced integrin-mediated signaling promoting EMT and migration"", ""Resistance to anti-angiogenic therapy through POSTN-mediated pathway activation"", ""Countervailing anti-invasive effects from reelin that limit infiltration""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,2,Cell adhesion and synaptic protein scaffolding,"Protocadherin and cadherin family proteins (PCDH7, PCDH11X, PCDH11Y, CDH13, CDH18), along with synaptic adhesion molecules (NLGN4X, CNTNAP2, SYT1, SYN3), organize cellular junctions and synaptic contacts. These proteins regulate intercellular adhesion, cell migration, proliferation, and survival through calcium-dependent signaling and interactions with the actin cytoskeleton. CNTNAP2 functions in neurite outgrowth, dendritic spine stability, and synaptic transmission, while NLGN4X serves as a glioma-associated tumor antigen. Dysregulation of adhesion molecules contributes to epithelial-mesenchymal transition (EMT) and glioma stem cell (GSC) maintenance.","[""PCDH7"", ""PCDH11X"", ""PCDH11Y"", ""CDH13"", ""CDH18"", ""NLGN4X"", ""CNTNAP2"", ""SYT1"", ""SYN3""]",9,0.82,"[""Altered cell-cell adhesion affecting glioma cell migration and invasiveness"", ""Enhanced synaptic integration with neuronal circuits driving proliferation"", ""Dysregulation of EMT programs through altered cadherin function"", ""Formation of neuron-glioma synaptic contacts enabling BDNF and other paracrine factor exchange"", ""Therapeutic vulnerability through NLGN4X as tumor-associated antigen for CAR-T approaches""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,3,Tumor-associated macrophage polarization and immune suppression,"Scavenger receptors (CD163/MSR1, OLR1/LOX-1) and pattern recognition receptors (TLR2, LY96/MD2) direct monocyte-derived macrophages (MDMs) toward pro-tumoral M2-like phenotypes in the GBM microenvironment. CD163+ macrophages and M2-polarized tumor-associated macrophages (TAMs) accumulate in perivascular and peritumoral regions, expressing immunosuppressive genes including complement inhibitors and producing pro-tumoral cytokines. LY96 associates with TLR4 activation of NF-κB pathway promoting pro-inflammatory cytokine production and TAM recruitment. MSR1/CD204 expression marks M2 macrophages and contributes to immunosuppression. CD96 and VSIG4 provide inhibitory signals to T cells, while other immune modifiers limit anti-tumor immunity.","[""CD163"", ""MSR1"", ""OLR1"", ""LY96"", ""TLR2"", ""CD96"", ""SYK"", ""VSIG4"", ""CFH"", ""IL7"", ""IL12RB2""]",11,0.88,"[""Accumulation of pro-tumoral M2-like macrophages in GBM microenvironment"", ""Enhanced TLR4 signaling promoting MDM recruitment and inflammatory responses"", ""Suppression of CD8+ T cell proliferation and anti-tumor immunity"", ""Production of immunosuppressive cytokines and complement inhibitors by TAMs"", ""Poor response to checkpoint blockade immunotherapy due to macrophage-mediated immune suppression"", ""Perivascular and peritumoral niche establishment promoting GSC maintenance""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,4,Wnt/β-catenin pathway and stemness maintenance,"PLD1, WNT16, KLF5, and associated signaling components regulate canonical Wnt/β-catenin pathway that maintains glioblastoma stem cell (GSC) self-renewal and pluripotency. PLD1 promotes Wnt/β-catenin signaling through phospholipase D activity and cross-talk with PI3K/Akt pathway, affecting GSC stemness and chemoresistance. KLF5 transcription factor functions downstream in GSC maintenance. STAT4 and MEOX2 provide additional transcriptional regulation. This pathway is essential for GSC maintenance, resistance to temozolomide (TMZ), and intrinsic tumorigenicity distinct from proliferating tumor core.","[""PLD1"", ""WNT16"", ""KLF5"", ""STAT4"", ""MEOX2""]",5,0.83,"[""Enhanced GSC self-renewal and undifferentiated state maintenance"", ""Increased resistance to temozolomide chemotherapy"", ""Promotion of tumor initiation and heterogeneity"", ""Activation of pluripotency programs and multi-lineage differentiation potential"", ""Cross-talk with other stemness pathways (Notch, Hedgehog, BMP)""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,5,Cholinergic immune modulation,"CHRNA7 (alpha 7 nicotinic acetylcholine receptor) and downstream signaling mediate anti-inflammatory effects through the cholinergic anti-inflammatory pathway (CAP). Activation of α7nAChR on macrophages and other immune cells suppresses pro-inflammatory cytokine production (IL-1, IL-6, TNF-α) via JAK2/STAT3 and NF-κB inhibition. This pathway provides immune regulatory function that may be co-opted by GBM to establish immunosuppressive microenvironment. CHRNA7 signaling represents intersection of neuronal and immune function relevant to glioma-neural circuit interactions.","[""CHRNA7""]",1,0.72,"[""Suppression of pro-inflammatory cytokine production in macrophages and microglia"", ""Modulation of microglia polarization from M1 to less inflammatory states"", ""Reduced infiltration of inflammatory immune cells into tumor"", ""Establishment of immunotolerant microenvironment favoring tumor growth"", ""Neuronal-immune cell coupling promoting tumor-supportive cross-talk""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,6,DOCK protein-mediated immune synapse formation,"DOCK2 and DOCK8 proteins function as guanine nucleotide exchange factors (GEFs) for Rho GTPases (CDC42, RAC1, RHO) controlling cytoskeleton dynamics and immune cell function. DOCK8 is particularly critical for T cell, B cell, and NK cell function through regulation of immune synapse formation, lymphocyte migration, and survival. DOCK proteins connect T cell receptor (TCR) signaling to actin cytoskeleton reorganization through WASP pathway. Loss of DOCK function impairs immune surveillance and increases cancer susceptibility. DOCK5 provides additional GEF function in cellular contexts.","[""DOCK2"", ""DOCK8"", ""DOCK5""]",3,0.78,"[""Impaired T cell immune synapse formation reducing anti-tumor T cell killing"", ""Decreased lymphocyte migration into tumor reducing immune infiltration"", ""Reduced B cell function and antibody production affecting tumor surveillance"", ""Impaired NK cell-mediated cytotoxicity"", ""Compromised antigen presentation and immune activation""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,7,Long non-coding RNA regulation of GBM processes,"Long non-coding RNAs (lncRNAs) from the LINC family, including LINC-PINT, MIR222HG, RMST, and numerous other LINC species, function as regulatory nodes controlling invasion, epithelial-mesenchymal transition (EMT), stemness, and therapeutic resistance. LINC-PINT suppresses cell proliferation, invasion, and EMT by blocking Wnt/β-catenin signaling. LINC species show dysregulation in GBM tumors compared to normal brain and associate with aggressive phenotypes. These lncRNAs regulate EMT-related genes (N-cadherin, Vimentin, Slug), interact with miRNAs, and coordinate signaling pathway activation.","[""LINC02235"", ""LINC01829"", ""LINC01467"", ""LINC01725"", ""LINC00944"", ""LINC01122"", ""LINC01091"", ""LINC00504"", ""LINC00355"", ""LINC01135"", ""LINC00299"", ""LINC00886"", ""LINC00607"", ""LINC01163"", ""LINC02234"", ""LINC01182"", ""LINC01923"", ""LINC02246"", ""LINC02300"", ""LINC02306"", ""LINC02378"", ""LINC02664"", ""LINC02775"", ""LINC02798"", ""LINC02821"", ""LINC01934"", ""LINC01877"", ""LINC01208"", ""LINC01876"", ""LINC01842"", ""LINC01798"", ""LINC01579"", ""LINC01357"", ""LINC02055"", ""LINC01241"", ""MIR222HG"", ""MIR548XHG"", ""RMST""]",38,0.81,"[""Reduced epithelial-mesenchymal transition and invasive capacity when lncRNAs are upregulated"", ""Suppression of Wnt/\u03b2-catenin stemness pathway and cancer stem cell self-renewal"", ""Modulation of miRNA availability and post-transcriptional gene regulation"", ""Alteration of chromatin states affecting gene expression programs"", ""Potential therapeutic targets through lncRNA modulation""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,8,Neuron-glioma synaptic plasticity,"Glioblastoma cells form functional synapses with neurons through BDNF-TrkB signaling and other activity-dependent mechanisms. NLGN4X, CNTNAP2, SYT1, and SYN3 are core synaptic proteins mediating these interactions. BDNF secretion from neurons in response to activity increases glutamate-evoked currents in glioma cells through AMPA receptor trafficking, promoting tumor proliferation and progression. Glioma cells integrate into neural circuits at cancer-neuron interface, with activity-dependent synaptic plasticity regulating tumor behavior. This malignant plasticity represents cooption of normal adaptive mechanisms by tumor.","[""NLGN4X"", ""CNTNAP2"", ""SYT1"", ""SYN3""]",4,0.84,"[""Integration of glioma cells into functional neural circuits"", ""Activity-dependent enhancement of glioma proliferation and migration"", ""Increased glutamate-evoked depolarization promoting tumor progression"", ""Glioma-induced neuronal hyperexcitability and glioma-associated epilepsy"", ""Coordinated glioma-neuron network activity propagating through tumor microtubes via gap junctions""]"
5_AC_neuronal_like_run2,5,AC-neuronal-like,5_AC_neuronal_like,2,9,Scavenger receptor and pattern recognition signaling,"Scavenger receptors (OLR1/LOX-1, MSR1/CD204, CD163) and pattern recognition receptors (TLR2, LY96/MD2) recognize pathogen-associated molecular patterns and oxidized ligands, activating NF-κB and inflammatory pathways. OLR1 upregulation in cancer cells promotes NF-κB activation leading to suppression of apoptosis and stimulation of proliferation. LY96 associates with TLR4, and TLR2 activates innate immunity. These receptors shape macrophage phenotype and promote pro-tumoral inflammation. In GBM context, scavenger receptor signaling establishes immunosuppressive microenvironment and promotes intrinsic tumor cell growth.","[""OLR1"", ""MSR1"", ""CD163"", ""LY96"", ""TLR2""]",5,0.8,"[""Sustained NF-\u03baB signaling promoting proliferation and suppressing apoptosis"", ""Pro-inflammatory cytokine production supporting tumor growth"", ""Macrophage polarization toward pro-tumoral M2 phenotype"", ""Enhanced migration and invasive capacity through NF-\u03baB-dependent mechanisms"", ""Resistance to cell death and therapy""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,0,Hypoxia-Driven Angiogenesis,"HIF-1α-dependent pathway driving vascular endothelial growth factor (VEGF) expression, vessel density increases, and hypoxic adaptation in glioblastoma. This program enables tumor cells to promote neovascularization in response to inadequate oxygen tension, supporting rapid tumor growth despite poor vascularization.","[""HILPDA"", ""NOX4"", ""HMOX1"", ""BNIP3L"", ""PTGS2"", ""ANGPTL4"", ""GPC5"", ""TRIB3""]",8,0.92,"[""Increased expression of pro-angiogenic factors (VEGF, ANGPTL4) promoting microvessel density"", ""Enhanced metabolic adaptation to hypoxic stress through autophagy induction"", ""Survival advantage in tumor core regions with limited oxygen availability"", ""Reduced dependence on vasculature for nutrient supply through metabolic shift""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,1,Epithelial-Mesenchymal Transition and Invasion,"Coordinated remodeling of cell-cell adhesion, extracellular matrix composition, and cytoskeletal architecture enabling glioblastoma cells to acquire migratory and invasive capacity. This program involves loss of epithelial markers (E-cadherin, claudins) and gain of mesenchymal markers (N-cadherin, vimentin, MMPs), facilitating tumor cell dissemination and invasion of surrounding brain parenchyma.","[""COL5A1"", ""COL13A1"", ""COL24A1"", ""LTBP2"", ""ABI3BP"", ""CHSY3"", ""NDRG1"", ""FAT4"", ""GCNT1"", ""ITGB3"", ""ABLIM3"", ""CAV1"", ""EPHA3"", ""SPNS2"", ""PRKCH"", ""GRK5""]",16,0.89,"[""Enhanced extracellular matrix degradation through increased MMP secretion"", ""Increased migratory velocity and invasive capacity through actin reorganization"", ""Altered expression of adhesion molecules (reduced E-cadherin, increased N-cadherin)"", ""Enhanced integrin-mediated signaling driving survival and proliferation signals"", ""Immune evasion through altered glycosylation of cell surface molecules"", ""Reduced responsiveness to contact inhibition signals""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,2,Aberrant Receptor Tyrosine Kinase Signaling,"Dysregulation of multiple receptor tyrosine kinases (RTKs) including MET, EGFR, and Eph receptors driving constitutive activation of downstream proliferation and survival pathways. These receptors activate PI3K/AKT/mTOR and MAPK/ERK cascades, promoting glioblastoma cell growth, survival, and acquisition of drug resistance.","[""MET"", ""EPHA3"", ""EPHA1-AS1"", ""PRKCH"", ""GRK5"", ""ERRFI1""]",6,0.85,"[""Constitutive activation of survival and proliferation signals"", ""Enhanced chemotherapy and radiotherapy resistance through DNA repair pathway activation"", ""Increased glucose uptake and metabolic reprogramming"", ""Promotion of glioma stem cell self-renewal and maintenance"", ""Enhanced invasive capacity through EMT-associated pathways"", ""Reduced dependence on growth factor availability""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,3,Inflammatory Signaling and Immune Evasion,Coordinated upregulation of cyclooxygenase-2 and prostaglandin E2 signaling coupled with exploitation of altered glycosylation patterns to evade immune surveillance. This program enables glioblastoma cells to create an immunosuppressive tumor microenvironment by recruiting and polarizing immune cells toward protumorigenic phenotypes.,"[""PTGS2"", ""HMOX1"", ""NOX4"", ""GCNT1"", ""CHSY3"", ""MX2""]",6,0.88,"[""Robust production of immunosuppressive mediators (IL-6, IL-10, GM-CSF)"", ""Preferential recruitment of protumorigenic macrophages and myeloid-derived suppressor cells"", ""Downregulation of MHC class II reducing T-cell activation capacity"", ""Enhanced tumor cell survival against immune attack through altered glycocode recognition"", ""Induction of regulatory T cells further dampening antitumor immunity"", ""Increased resistance to immune checkpoint inhibitor therapy""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,4,Autophagy and Cellular Stress Response,"Activation of macroautophagy and selective autophagy pathways in response to metabolic stress, hypoxia, and endoplasmic reticulum stress. This program enables glioblastoma cells to maintain survival under nutrient-poor conditions, contributes to therapy resistance, and regulates immune cell infiltration.","[""BNIP3L"", ""TRIB3"", ""HMOX1"", ""AMPD3""]",4,0.82,"[""Enhanced survival under nutrient deprivation through selective protein degradation"", ""Increased resistance to hypoxic stress through metabolic reprogramming"", ""Enhanced chemotherapy and radiotherapy resistance through autophagy-mediated survival"", ""Suppression of anti-tumor immune responses through autophagy-mediated degradation of immune effector molecules"", ""Maintenance of glioma stem cell phenotype through selective autophagy"", ""Metabolic adaptability enabling rapid response to microenvironmental changes""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,5,Integrin-Mediated Cell Adhesion and Survival,"Dysregulated integrin-extracellular matrix interactions promoting cell survival, proliferation, and drug resistance through activation of focal adhesion kinase and associated survival pathways. Integrin αvβ3 and α5β1 are particularly important in glioblastoma, mediating interactions with vitronectin, fibronectin, and other matrix proteins.","[""ITGB3"", ""FAT4"", ""ABLIM3"", ""ANGPTL4"", ""COL5A1"", ""COL13A1"", ""COL24A1"", ""LTBP2""]",8,0.81,"[""Enhanced GSC maintenance and self-renewal through focal adhesion signaling"", ""Increased chemotherapy resistance through anchorage-independent survival signals"", ""Reduced sensitivity to cell detachment-induced apoptosis (anoikis)"", ""Enhanced migration and invasion through integrin-mediated adhesion"", ""Metabolic reprogramming through integrin-AKT signaling"", ""Promotion of GSC differentiation or stemness maintenance depending on matrix composition""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,6,Metabolic Enzyme Dysregulation,"Altered expression of glycolytic, lipid metabolic, and amino acid metabolic enzymes supporting rapid tumor growth and adaptation to hypoxic and nutrient-poor conditions. Dysregulation includes increased glucose transporter expression, glycogen accumulation pathways, and enhanced fatty acid oxidation.","[""MGAM"", ""PPP1R3C"", ""EHHADH"", ""SLC39A14"", ""SLC6A6"", ""AMPD3""]",6,0.75,"[""Enhanced energy production through multiple metabolic pathways (glycolysis, fatty acid oxidation, glutaminolysis)"", ""Rapid adaptation to hypoxic conditions through metabolic switching"", ""Reduced sensitivity to metabolic pathway inhibitors through metabolic redundancy"", ""Increased nucleotide production supporting rapid proliferation"", ""Enhanced survival under nutrient-poor conditions through alternative metabolic routes"", ""Adaptation to antiangiogenic therapy through metabolic reprogramming""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,7,Long Non-Coding RNA Regulatory Networks,"Dysregulation of multiple long non-coding RNAs that regulate glioblastoma cell proliferation, invasion, drug resistance, and stem cell maintenance. These lncRNAs function as competing endogenous RNAs, scaffold proteins, and transcriptional regulators modulating key oncogenic pathways.","[""LUCAT1"", ""LINC02615"", ""POT1-AS1"", ""LINC01705"", ""LINC01376"", ""LINC00240"", ""AC051619.5"", ""AC083837.1"", ""AC092944.1"", ""AC008014.1"", ""AL158064.1"", ""AL390957.1"", ""AC099681.1"", ""VLDLR-AS1"", ""EPHA1-AS1"", ""NECTIN3-AS1"", ""RPL34-AS1"", ""OSMR-AS1"", ""RNF217-AS1"", ""AP006545.3"", ""AP001528.1"", ""LINC02340""]",22,0.72,"[""Enhanced RAS pathway signaling driving proliferation and invasion"", ""Dysregulated microRNA function through competing endogenous RNA networks"", ""Altered transcriptional landscape supporting GSC maintenance"", ""Enhanced drug resistance through regulation of ABC transporters"", ""Promotion of epithelial-mesenchymal transition phenotypes"", ""Increased tumor aggressiveness and invasion capacity""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,8,Transcriptional Control of Differentiation and Stemness,"Dysregulation of transcription factors and co-regulators controlling glioblastoma stem cell maintenance versus differentiation transitions. RUNX2 drives malignant progression through increased proliferation and expression of invasion-associated genes, while NDRG1 acts as a metastasis suppressor maintaining differentiated epithelial phenotype.","[""RUNX2"", ""NDRG1"", ""RCAN2"", ""ERRFI1"", ""FAT4""]",5,0.84,"[""RUNX2-driven increase in proliferative capacity and expression of invasion-associated MMPs"", ""NDRG1 loss associated with EMT transition, increased invasiveness, and poor prognosis"", ""RCAN2-mediated effects on differentiation through calcineurin-NFAT axis"", ""Context-dependent growth effects of ERRFI1 based on EGFR expression level"", ""Dysregulation of cell cycle checkpoint control"", ""Altered response to differentiation signals""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,9,Redox Homeostasis and Oxidative Stress Response,"Dysregulation of antioxidant defense systems and oxidative stress sensors affecting tumor progression, drug resistance, and immune evasion. HO-1 and NOX4 represent dual-faced regulators that maintain cellular redox balance while promoting cancer progression through complex, context-dependent mechanisms.","[""HMOX1"", ""NOX4"", ""ANGPTL4""]",3,0.78,"[""Enhanced cellular survival under oxidative stress conditions"", ""Reduced response to ROS-generating chemotherapy agents"", ""Nuclear HO-1 translocation associated with poor prognosis and therapy resistance"", ""NOX4-derived ROS driving metabolic reprogramming and FOXM1 expression"", ""ANGPTL4-mediated anoikis resistance through ROS-dependent signaling"", ""Altered immune cell function through ROS modulation and adenosine accumulation""]"
8_Gliosis_hypoxia_run1,8,Gliosis-hypoxia,8_Gliosis_hypoxia,1,10,Extracellular Matrix Composition and Immune Targeting,Dysregulation of glycosaminoglycan and proteoglycan synthesis enzymes altering extracellular matrix composition to promote immune evasion and support tumor growth. This program involves specific glycosylation modifications that reduce immune recognition while maintaining structural integrity of the tumor microenvironment.,"[""GCNT1"", ""CHSY3""]",2,0.76,"[""Altered cell surface glycosylation pattern reducing MHC peptide presentation efficiency"", ""Preferential recruitment of immunosuppressive macrophages through glycan-lectin interactions"", ""Decreased recognition by cytotoxic T lymphocytes and NK cells"", ""Enhanced immune checkpoint engagement (PD-L1 interactions)"", ""Maintenance of ECM structural integrity supporting tumor architecture"", ""Protection from complement-mediated lysis""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,0,DNA Replication Licensing and Origin Recognition,MCM2-7 complex assembly and licensing of replication origins during G1 phase. CDC45 and GINS1 form the CMG (Cdc45-MCM2-7-GINS) helicase complex required for replication fork progression. ORC6 and RFC proteins coordinate origin licensing and replication factor loading. This program is dysregulated in glioblastoma where origins fire aberrantly during S-phase.,"[""MCM6"", ""MCM5"", ""MCM4"", ""MCM8"", ""MCM10"", ""CDC45"", ""GINS1"", ""ORC6"", ""RFC2"", ""RFC3""]",10,0.92,"[""Aberrant firing of replication origins in glioblastoma leading to increased replication stress"", ""Enhanced MCM10-dependent compensatory activation of dormant origins to tolerate replication stress"", ""Temporal alterations in replication timing with early-replicating GC-rich regions showing different kinetics than normal cells""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,1,DNA Polymerase Alpha-Primase Priming,"Initiation of DNA synthesis through primase complex (POLA1, POLA2, PRIM1, PRIM2) that generates RNA-DNA primers on both leading and lagging strands. The polymerase alpha complex acts at the replication fork initiation site before handoff to processive polymerases (Polδ and Polε). PRIM2 and POLA2 subunits are essential for geminiviral and cellular DNA replication initiation.","[""POLA1"", ""POLA2"", ""PRIM2""]",3,0.75,"[""Dysregulated primer synthesis leading to increased lagging strand discontinuities"", ""Accumulation of Okazaki fragment intermediates requiring increased nucleotide metabolism"", ""Potential vulnerability to primase inhibition as therapeutic target in glioblastoma""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,2,Leading and Lagging Strand DNA Synthesis,"Processive DNA polymerases (POLE2, DNA polymerase delta subunits, PCNA) catalyze bulk DNA synthesis on leading and lagging strands. POLE2 is the catalytic subunit of polymerase epsilon. PCNA serves as the processivity factor and platform for recruitment of replication accessory proteins. Flap processing by DNA2, FEN1, and other nucleases is required for Okazaki fragment maturation.","[""POLE2"", ""PCNA"", ""DNA2"", ""EXO1"", ""LIG1"", ""RRM2""]",6,0.88,"[""POLE2 overexpression enhances glioblastoma proliferation and EMT through AURKA-FOXM1 axis"", ""Increased nucleotide demand from elevated DNA synthesis rates necessitating RRM2 upregulation"", ""Impaired Okazaki fragment maturation when DNA2 is depleted leads to accumulation of ssDNA flaps and DNA damage response activation""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,3,Nucleotide Metabolism and dNTP Synthesis,"Ribonucleotide reductase (RRM2) catalyzes conversion of ribonucleotides to deoxyribonucleotides, providing dNTP pools for DNA replication. RRM2 is transcriptionally regulated by BRCA1 in glioblastoma cells and is essential for replication fork progression and protection from replication stress. DHFR provides NADPH cofactor required for RRM2 catalytic function.","[""RRM2"", ""DHFR"", ""BRCA1""]",3,0.85,"[""BRCA1-mediated RRM2 upregulation protects glioblastoma cells from endogenous replication stress despite genomic instability"", ""Increased dNTP pools enable rapid proliferation and DNA synthesis in glioblastoma"", ""RRM2 expression correlates with higher grade gliomas and shorter survival, marking BRCA1-RRM2 axis as negative prognostic factor"", ""Potential therapeutic vulnerability via RRM2 inhibition to sensitize glioblastoma to replication stress""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,4,DNA Damage Response and Cell Cycle Checkpoints,"ATM and ATR kinases detect DNA damage and activate checkpoint kinases CHK1 and CHK2 to halt cell cycle progression. CLSPN (Claspin) mediates ATR-CHK1 signaling. CDC25 phosphatases are inhibited by CHK1/CHK2, preventing CDK dephosphorylation and cell cycle progression. WEE1 kinase maintains CDK inactivation through inhibitory phosphorylation. In glioblastoma, these checkpoint pathways are frequently dysregulated.","[""CHEK1"", ""CLSPN""]",2,0.89,"[""Enhanced ATR-CHK1 signaling in glioblastoma stem-like cells provides radioresistance through maintained G2 checkpoint"", ""Mismatch repair-dependent ssDNA generation recruits RAD18 for trans-lesion synthesis, enabling temozolomide tolerance"", ""CHK1 inhibition abrogates G2 checkpoint but causes unequal effects in bulk glioblastoma versus stem-like cells"", ""Combined ATR and PARP inhibition maximally radiosensitizes glioblastoma by inhibiting both checkpoint and DNA repair"", ""CHEK2 depletion enhances glioblastoma immunotherapy response via STING-mediated type I interferon activation""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,5,Homologous Recombination DNA Repair,"High-fidelity double-strand break repair through homologous recombination mediated by BRCA1, BRCA2, RAD51, and accessory factors including BRIP1 (FANCJ), FANCI, FANCD2, XRCC2, MND1, RAD54L. RAD51 catalyzes strand invasion and homology searching. Fanconi anemia proteins coordinate RAD51 loading. This pathway is restricted to S and G2 phases when sister chromatids are available as repair templates.","[""BRCA1"", ""BRCA2"", ""RAD51AP1"", ""XRCC2"", ""FANCA"", ""FANCB"", ""FANCI"", ""FANCD2"", ""BRIP1"", ""EXO1"", ""DNA2"", ""HELLS"", ""MND1"", ""MND1""]",14,0.91,"[""HR pathway overexpression in glioblastoma enables survival despite high levels of endogenous and therapy-induced DNA damage"", ""BRCA1-mediated RRM2 upregulation and HR gene expression collectively protect glioblastoma from temozolomide-induced cytotoxicity"", ""Fanconi anemia gene re-expression (FANCD2) in glioblastoma compared to normal brain suggests tumor-specific HR dependence"", ""IDH-mutant gliomas exhibit 'BRCAness' phenotype with impaired HR but enhanced sensitivity to PARP and ATR inhibitors"", ""BRCA1 abrogation impairs glioblastoma tumorigenicity and enhances radiosensitivity through combined replication stress and HR deficiency""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,6,Fanconi Anemia Pathway and Interstrand Crosslink Repair,"Fanconi anemia (FA) proteins coordinate repair of interstrand crosslinks (ICLs) and other DNA lesions through formation of the FA core complex, monoubiquitination of FANCD2 and FANCI, and recruitment of structure-specific nucleases. The pathway intersects with homologous recombination and translesion synthesis. FANCD2 re-expression in glioblastoma compared to normal brain is associated with higher tumor grade.","[""FANCA"", ""FANCB"", ""FANCI"", ""FANCD2""]",4,0.78,"[""Enhanced FA pathway activity in glioblastoma provides resistance to DNA alkylating agents including temozolomide"", ""FANCD2 re-expression distinguishes high-grade from low-grade gliomas, suggesting tumor-grade-dependent activation"", ""Targeting FA pathway components may sensitize alkylating agent-resistant glioblastoma"", ""FA pathway synergizes with HR pathway to enable glioblastoma survival under replication stress""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,7,Trans-Lesion Synthesis and Post-Replication Repair,"Error-prone DNA polymerases (Polη, Polι, Polκ, REV1) specialized for bypass of DNA lesions through trans-lesion synthesis (TLS). RAD18-mediated monoubiquitination of PCNA recruits Y-family polymerases to damaged sites. Mismatch repair (MMR) processing of temozolomide lesions generates ssDNA gaps filled by TLS. This mechanism enables glioblastoma tolerance of temozolomide genotoxicity.","[""RAD18"", ""PCNA"", ""EXO1"", ""POLQ""]",4,0.87,"[""RAD18-dependent TLS enables glioblastoma tolerance of temozolomide-induced DNA damage"", ""Error-free bypass of O6-methylguanine through RAD18 reduces temozolomide-induced mutagenesis"", ""RAD18 expression correlates inversely with hypermutation in recurrent glioblastoma patient samples"", ""Mismatch repair-mediated ssDNA generation simultaneously activates ATR-CHK1 checkpoint and RAD18-TLS pathway for dual damage tolerance"", ""RAD18 inhibition combined with temozolomide or MMR pathway targeting may overcome glioblastoma chemoresistance"", ""Low RAD18 expression in recurrent gliomas associates with hypermutation phenotype from unrepaired lesions""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,8,G1/S Cell Cycle Checkpoint and E2F-Dependent Proliferation,"E2F transcription factors (E2F1, E2F7) regulate S-phase entry through cyclin E-CDK2 complex-mediated hyperphosphorylation of retinoblastoma (RB) protein. MYBL2 (B-Myb) and E2F7/E2F8 drive G2/M genes for continued proliferation. CCNE2 (Cyclin E2) and cell cycle checkpoint regulators coordinate G1/S transition. Elevated E2F and cyclin expression drives aggressive glioblastoma proliferation.","[""E2F1"", ""E2F7"", ""CCNE2"", ""MYBL2"", ""FOXM1""]",5,0.9,"[""E2F7 overexpression drives glioblastoma proliferation and predicts poor radiotherapy response"", ""E2F7-EZH2 axis activates AKT/mTOR signaling to promote cell proliferation and EMT"", ""MYBL2 upregulation in glioblastoma enables continuous cell cycle progression through coordinated G1/S and G2/M regulation"", ""High E2F7 expression correlates with epithelial-mesenchymal transition markers and tumor invasiveness"", ""E2F7 silencing enhances radiosensitivity through reduced EZH2-mediated radioresistance""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,9,FOXM1-ADAM17 Feedback Loop and Epithelial-Mesenchymal Transition,"FOXM1 is a proliferation-specific transcription factor driving glioblastoma progression through regulation of cell cycle genes, EMT factors, and ADAM17 (a sheddase for EGFR ligands). FOXM1-ADAM17 axis activates EGFR/AKT/GSK3β signaling, which in turn stabilizes FOXM1 through the feedback loop. FoxM1 also regulates VEGF expression for angiogenesis and promotes invasion through TGF-β signaling modulation.","[""FOXM1"", ""MYBL2""]",2,0.88,"[""FOXM1 expression drives glioblastoma proliferation, invasion, and mesenchymal differentiation"", ""FOXM1-ADAM17-EGFR feedback loop establishes self-sustaining proliferation and EMT program"", ""High FOXM1 levels correlate with shorter survival and increased tumor invasiveness"", ""FOXM1-mediated VEGF upregulation promotes angiogenesis enabling nutrient delivery for tumor growth"", ""FOXM1 modulation of TGF-\u03b2 signaling through interaction with SMAD3/4 enhances EMT"", ""FOXM1 contributes to temozolomide and radiotherapy resistance through EMT-associated mechanisms""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,10,Centrosome Organization and Centriole Duplication,"Polo-like kinase 4 (PLK4) is the master regulator of centriole duplication through phosphorylation of STIL. Centrosome proteins (SPC24, SPC25, CENPU, CENPK, CENPI, CENPP) organize the pericentriolar material. CEP152 recruits PLK4 to centrosomes. Proper centrosome duplication is essential for bipolar spindle formation. Overexpression of PLK4 causes centrosome amplification, chromosomal instability, and tumor formation.","[""PLK4"", ""CEP152"", ""SPC24"", ""SPC25"", ""CENPU"", ""CENPK"", ""CENPI"", ""CENPP""]",8,0.76,"[""PLK4 overexpression in glioblastoma may cause centrosome amplification and chromosomal instability"", ""Centrosome amplification leads to errors in spindle formation and chromosome missegregation during mitosis"", ""Supernumerary centrosomes contribute to aneuploidy characteristic of glioblastoma"", ""Enhanced centrosome nucleation in glioblastoma may support rapid proliferation and migration"", ""CRL4DCAF1-mediated PLK4 degradation in G2 is therapeutic target to prevent mitotic defects""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,11,Centromeric and Kinetochore Function,"Centromeric protein CENP-A (centromeric histone H3 variant) maintains centromere identity and is essential for chromosome segregation during mitosis. Overexpression of CENP-A causes ectopic deposition and chromosomal instability. Kinetochore proteins including SPC24, SPC25, SKA3, and KNTC1 coordinate spindle attachment and checkpoint control. High CENP-A expression predicts poor prognosis in gliomas.","[""CENPU"", ""CENPK"", ""CENPI"", ""CENPP"", ""SPC24"", ""SPC25"", ""SKA3"", ""KNTC1""]",8,0.82,"[""High CENP-A expression in glioblastoma correlates with worse prognosis and higher tumor grade"", ""CENP-A overexpression causes ectopic centrosome formation and chromosomal instability"", ""Aneuploidy from CENP-A mislocalization contributes to glioblastoma genomic instability and tumor evolution"", ""Kinetochore dysfunction from dysregulated CENP-A impairs spindle checkpoint and promotes mitotic errors"", ""CENP-A-induced aneuploidy may increase mutational burden and immunogenicity in glioblastoma""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,12,Chromatin Remodeling and Histone Chaperones,"ASF1B (anti-silencing function 1B) is a histone chaperone involved in histone H3/H4 deposition and nucleosome assembly during DNA replication. HELLS (helicase, lymphoid-specific) is a SNF2-like chromatin remodeller promoting DNA end-resection and homologous recombination during G2 phase. Chromatin remodellers including DTL, CHAF1A, CHAF1B coordinate chromatin dynamics during replication and DNA repair.","[""ASF1B"", ""HELLS"", ""CHAF1A"", ""CHAF1B"", ""ATAD2"", ""DTL""]",6,0.8,"[""High ASF1B expression in glioblastoma enables rapid DNA synthesis and proliferation through efficient histone deposition"", ""ASF1B expression predicts poor prognosis and correlates with high-grade glioma and wild-type IDH status"", ""HELLS-mediated chromatin remodeling facilitates efficient DNA repair in heterochromatin during glioblastoma growth"", ""Chromatin remodelers coordinate replication fork progression with chromatin dynamics in replicating glioblastoma cells"", ""Targeting ASF1B or HELLS may impair glioblastoma proliferation and sensitize to DNA-damaging therapy""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,13,Sister Chromatid Cohesion and Separation,Cohesin complex maintains sister chromatid cohesion from S phase through metaphase. Separase (ESPL1) cleaves cohesin at anaphase onset to allow chromatid separation. Securin regulates separase until metaphase-anaphase transition when APC/C-mediated degradation releases separase. Proper cohesion/separation is essential for error-free chromosome segregation.,"[""ESPL1""]",1,0.68,"[""Aberrant separase expression in glioblastoma leads to errors in sister chromatid separation"", ""Dysregulated cohesin-separase interactions contribute to chromosome missegregation and aneuploidy"", ""Abnormal separase regulation may facilitate rapid cell division in glioblastoma"", ""Separase-securin-cyclin B1 dysregulation in glioblastoma suggests therapeutic vulnerability""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,14,Aurora Kinase B and Mitotic Checkpoint Regulation,"Aurora kinase B (AURKB) is component of chromosomal passenger complex (CPC) mediating chromatin modification, spindle checkpoint regulation, cytokinesis, and kinetochore-microtubule attachment. AURKB polymorphisms associate with altered glioblastoma risk. AURKB overexpression induces chromosomal instability and aneuploidy.","[""AURKB""]",1,0.72,"[""AURKB genetic variations influence glioblastoma risk through altered checkpoint kinase function"", ""AURKB overexpression causes chromosomal instability and aneuploidy in glioblastoma"", ""AURKB-mediated spindle checkpoint dysfunction enables rapid mitotic progression"", ""AURKB targeting may impair glioblastoma proliferation and induce mitotic failure""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,15,Epigenetic Modifier Targeting and Cell Cycle Inhibition,"Onametostat targets protein arginine methyltransferase PRMT5, an epigenetic writer regulating gene expression and nucleolar functions. Cell cycle kinase inhibitors (CDK, Aurora, PLK) impair glioblastoma proliferation under both normoxic and hypoxic conditions. Combination of epigenetic and cell cycle targeting shows synergistic effects in glioblastoma treatment.","[""AURKB""]",1,0.65,"[""PRMT5 inhibition impairs glioblastoma proliferation even in chemotherapy-resistant cells"", ""Cell cycle kinase inhibition shows efficacy in glioblastoma under both normoxic and hypoxic conditions"", ""Combined epigenetic and cell cycle targeting achieves synergistic glioblastoma growth inhibition"", ""PRMT5 inhibition represents viable strategy for glioblastoma treatment with reduced toxicity to normal cells""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,16,Mitotic Spindle Assembly and Checkpoint Control,"Mitotic spindle checkpoint (spindle assembly checkpoint, SAC) genes including KNTC1 coordinate kinetochore-spindle microtubule attachments and checkpoint signaling. TTK (monopolar spindle 1-like kinase) is essential for chromosome alignment and centrosome duplication. Spindle checkpoint activation prevents cell cycle progression until proper chromosome alignment is achieved.","[""KNTC1"", ""SKA3""]",2,0.7,"[""Mitotic checkpoint impairment in glioblastoma enables rapid mitotic progression despite chromosomal misalignment"", ""Checkpoint gene dysregulation contributes to chromosomal instability and aneuploidy in glioblastoma"", ""TTK overexpression in glioblastoma promotes proliferation and resistance to therapy"", ""Targeting spindle checkpoint may induce mitotic catastrophe in glioblastoma cells""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,17,FAM111B-PI3K/AKT Pathway and Glioma Malignancy,"FAM111B (Family with sequence similarity 111, member B) is overexpressed in glioma tissues and associated with poor prognosis. FAM111B enhances glioma cell proliferation, invasion, and migration through activation of PI3K/AKT signaling pathway. PI3K/AKT inhibition reverses FAM111B-induced malignant phenotypes.","[""FAM111B""]",1,0.79,"[""FAM111B overexpression drives glioblastoma proliferation, invasion, and poor prognosis"", ""PI3K/AKT pathway hyperactivation from FAM111B upregulation promotes tumor growth"", ""FAM111B serves as potential therapeutic target to sensitize glioblastoma to PI3K/AKT inhibitors"", ""FAM111B expression correlates with disease stage and predicts overall survival""]"
9_Proliferative_2_run2,9,Proliferative 2,9_Proliferative_2,2,18,Antigen Presentation and Immunotherapy Response,"CHEK2 depletion in glioblastoma activates STING pathway and enhances antigen presentation genes (B2M, H2 molecules), leading to increased type I interferon response. Enhanced MHC-I expression sensitizes glioblastoma to PD-1 checkpoint blockade. CHEK2 loss paradoxically enhances immunotherapy efficacy despite impairing DNA repair.","[""CHEK1""]",1,0.77,"[""CHEK2 inhibition sensitizes glioblastoma to PD-1 blockade immunotherapy"", ""STING pathway activation from CHEK2 loss drives type I interferon response"", ""Enhanced MHC-I expression increases CD8 T cell recognition of tumor cells"", ""CHEK2-targeted therapy combined with immune checkpoint blockade shows synergistic efficacy"", ""CHEK2 depletion generates long-term survivors in immunotherapy-treated glioblastoma models""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,0,Extracellular Matrix Remodeling and Invasion,"Gene program coordinating degradation and remodeling of the extracellular matrix to promote glioblastoma cell invasion and migration through brain tissue. This program includes collagen deposition, matrix metalloproteinase regulation, and integrin-mediated adhesion dynamics that facilitate the invasive phenotype characteristic of GBM mesenchymal subtypes. The program is particularly enriched in the tumor center where invasive mesenchymal-like cells drive aggressive progression.","[""COL22A1"", ""COL19A1"", ""COL23A1"", ""COL25A1"", ""COL27A1"", ""POSTN"", ""SERPINE1"", ""ITGA3"", ""ADAMTS9-AS1"", ""SPRY4"", ""SPRY1"", ""IQGAP2"", ""ARHGAP26"", ""ARHGAP6"", ""CDH4"", ""PLAT"", ""RHOJ"", ""VAV3""]",18,0.92,"[""Enhanced degradation of basement membrane barriers enabling invasion into surrounding brain tissue"", ""Increased cell motility through integrin-mediated adhesion dynamics"", ""Promotion of partial epithelial-mesenchymal transition (pEMT) phenotype in glioblastoma cells"", ""Remodeling of tumor microenvironment to support vascular infiltration and immune cell trafficking"", ""Enrichment of invasive mesenchymal-like cell populations in tumor center""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,1,RTK/MAPK Signaling Inhibition and Feedback,"Gene program regulating receptor tyrosine kinase (RTK) signaling cascades through negative feedback loops and pathway suppression mechanisms. The SPRY family genes encode classical negative feedback inhibitors of MAPK signaling downstream of growth factor receptors (EGFR, PDGFRA, FGFR). This program is dysregulated in GBM where SPRY expression is often reduced, allowing unopposed RTK signaling that drives proliferation and EMT. RGS proteins provide additional negative feedback on G-protein coupled receptor signaling.","[""SPRY1"", ""SPRY2"", ""SPRY4"", ""CAMK2B"", ""CAMK2A"", ""RGS6"", ""RGS20""]",7,0.85,"[""Suppression of Ras/MAPK/ERK cascade that promotes GBM proliferation and migration"", ""Inhibition of PI3K/Akt pathway activation downstream of RTK signaling"", ""Reduced responsiveness to growth factors (PDGF, FGF, EGF) that activate RTKs"", ""Decreased EMT-associated transcriptional programs (SNAIL, TWIST upregulation)"", ""Normalization of cell cycle progression and reduced clonal expansion""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,2,Wnt/β-catenin Pathway Activation,"Gene program governing canonical Wnt signaling through LEF1 and associated transcriptional regulation. Wnt/β-catenin pathway promotes stemness, migration, angiogenesis, and therapy resistance in glioblastoma. In GBM, this pathway is often overactive particularly in mesenchymal subtypes, allowing cells to recapitulate embryonic developmental programs that result in characteristic proliferation and invasiveness. WNT16 and LEF1 coordinate transcriptional responses downstream of β-catenin stabilization.","[""LEF1"", ""WNT16""]",2,0.68,"[""Enhanced transcription of stemness-maintaining genes and glioma stem cell markers"", ""Promotion of epithelial-mesenchymal transition through upregulation of EMT-inducing transcription factors"", ""Increased angiogenesis via VEGF upregulation"", ""Enhanced cell motility and invasive capacity"", ""Maintenance of chemotherapy resistance phenotype""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,3,Angiogenesis and Vascular Remodeling,"Gene program promoting tumor angiogenesis and vascular network formation through growth factor signaling and endothelial-tumor crosstalk. ANGPT1 (angiopoietin-1) and GDF15 (growth differentiation factor-15) coordinate pro-angiogenic signaling. GDF15 is induced by radiation and drives VEGFA expression through MAPK/SP1 pathway in glioblastoma cells. High degree of tumor vascularization through increased VEGF production is a hallmark of GBM progression. Carbonic anhydrases (CA2, CA10) support hypoxia-driven angiogenesis through metabolic regulation.","[""ANGPT1"", ""GDF15"", ""CA2"", ""CA10"", ""SLC4A4""]",5,0.78,"[""Enhanced secretion of pro-angiogenic factors from both tumor and endothelial cells"", ""Increased vascular endothelial growth factor (VEGF) expression and signaling"", ""Promotion of endothelial cell migration and tube formation"", ""Establishment of abnormal vascular network with enhanced permeability"", ""Creation of perivascular niche supporting glioblastoma stem cell populations"", ""Enhanced tumor hypoxia through aberrant vascular architecture""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,4,Glioma Stem Cell Maintenance and Self-Renewal,"Gene program maintaining stemness properties of glioblastoma stem cells (GSCs) through transcriptional and signaling mechanisms that preserve self-renewal capacity and multipotency. This program includes transcription factors (TFCP2L1, BNC2, EGR1, SOX1-OT) that coordinate expression of stemness markers and suppress differentiation. EGR1 orchestrates a PDGFA-dependent growth-stimulatory loop and activates genes (SHH, GLI1, NANOG) critical for GSC maintenance. The program is dysregulated in GBM to maintain tumor-initiating capacity and therapy resistance.","[""EGR1"", ""TFCP2L1"", ""BNC2"", ""JAG1"", ""SOX1-OT""]",5,0.82,"[""Maintenance of self-renewal capacity and resistance to differentiation cues"", ""Sustained expression of stemness markers (CD133, SOX2, NANOG, OCT4)"", ""Preservation of multipotency for differentiation into proneural or mesenchymal lineages"", ""Enhanced therapy resistance through quiescence and reduced proliferation"", ""Support for tumor-initiating capacity in serial xenografting experiments""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,5,Calcium Signaling and Ion Homeostasis,"Gene program regulating intracellular calcium dynamics and ion channel activity that modulates glioblastoma cell survival, migration, and radioresistance. TRPM8 (transient receptor potential melastatin 8) and TRPM3 are cation channels that regulate calcium influx and cell excitability. CAMK2A and CAMK2B are calcium/calmodulin-dependent protein kinases that transduce calcium signals into phosphorylation cascades controlling proliferation and invasion. SLC24A2 and SLC4A4 regulate sodium-potassium and sodium-bicarbonate transport maintaining ionic gradients.","[""TRPM8"", ""TRPM3"", ""CAMK2A"", ""CAMK2B"", ""SLC24A2"", ""SLC4A4"", ""CA2"", ""CA10""]",8,0.76,"[""Enhanced intracellular calcium dynamics supporting cell survival and migration"", ""Increased radioresistance through TRPM8-mediated calcium signaling"", ""Reduced proliferation and invasion when CAMK2B expression is high"", ""Maintenance of intracellular pH and ionic balance in tumor microenvironment"", ""Modulation of calcium-dependent gene expression programs""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,6,Mesenchymal Differentiation and Epithelial-Mesenchymal Transition,"Gene program driving epithelial-mesenchymal transition (EMT) and commitment to mesenchymal phenotype characteristic of aggressive GBM. This program includes transcription factors (BNC2) and signaling molecules that promote loss of epithelial characteristics and acquisition of migratory and invasive properties. The mesenchymal program is enriched in the GBM center where invasive cells cluster, and is associated with poor prognosis. Multiple regulatory mechanisms including Wnt/β-catenin, TGF-β, Notch, and NF-κB pathways converge to drive sustained mesenchymal differentiation.","[""BNC2"", ""SERPINE1"", ""POSTN"", ""COL22A1"", ""COL19A1"", ""COL23A1"", ""COL25A1"", ""COL27A1"", ""IRAK2"", ""GDF15"", ""ANGPT1""]",11,0.8,"[""Loss of epithelial cell-cell adhesion and acquisition of migratory capacity"", ""Downregulation of E-cadherin and upregulation of mesenchymal markers (vimentin, N-cadherin)"", ""Enhanced ECM remodeling and invasion into surrounding tissue"", ""Increased angiogenesis through VEGF and angiopoietin production"", ""Enrichment of tumor-promoting signaling pathways (PI3K/AKT, Wnt/\u03b2-catenin, Notch, NF-\u03baB)"", ""Promotion of therapy resistance and poor clinical prognosis""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,7,Hypoxia Response and Metabolic Adaptation,"Gene program coordinating cellular responses to hypoxia and metabolic adaptation in the tumor microenvironment. Carbonic anhydrases (CA2, CA10) buffer pH changes and support glycolytic metabolism under hypoxia. SLC4A4 regulates sodium-bicarbonate transport supporting metabolic homeostasis. This program is activated in response to the hypoxic microenvironment characteristic of GBM tumors, where HIF1α and HIF2α upregulate angiogenic factors (VEGF, PDGF, angiopoietins) and shift metabolism toward glycolysis. The program supports glioblastoma progression by enabling tumor cell survival and invasiveness under low oxygen tension.","[""CA2"", ""CA10"", ""SLC4A4"", ""ANGPT1"", ""GDF15""]",5,0.74,"[""Maintenance of intracellular pH despite lactic acid accumulation from anaerobic glycolysis"", ""Support for HIF-driven angiogenic and metabolic gene expression programs"", ""Enhanced tumor cell survival and radioresistance under hypoxic stress"", ""Promotion of invasiveness through hypoxia-induced EMT pathways"", ""Creation of microenvironmental niche supporting glioblastoma stem cell populations in perivascular hypoxic regions""]"
10_AC_gliosis_like_2_run1,10,AC-gliosis-like 2,10_AC_gliosis_like_2,1,8,Immune Modulation and Inflammatory Signaling,"Gene program regulating immune cell recruitment, polarization, and immunosuppressive signaling in the glioblastoma microenvironment. IL1RAP, IL27RA, and IRAK2 coordinate interleukin signaling cascades that modulate innate and adaptive immunity. Neuropeptide receptors (NPY1R, NPR3) and other neuroimmune mediators influence microglial and macrophage phenotype. The program reflects the highly immunosuppressive glioblastoma microenvironment where tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) promote tumor progression and therapy resistance.","[""IL1RAP"", ""IL27RA"", ""IRAK2"", ""NPY1R"", ""NPR3"", ""GALR1"", ""NTSR1"", ""GABBR2""]",8,0.66,"[""Promotion of pro-tumor interleukin signaling (IL-1\u03b2, IL-27) supporting macrophage and myeloid-derived suppressor cell activation"", ""Enhanced NF-\u03baB pathway activity in tumor-associated myeloid cells"", ""Neuroimmune modulation of microglial polarization toward pro-tumor M2 phenotype"", ""Recruitment and infiltration of immunosuppressive myeloid populations into tumor microenvironment"", ""Establishment of immunosuppressive tumor microenvironment limiting T cell infiltration and anti-tumor immunity""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,0,Epithelial-Mesenchymal Transition,"Coordinated upregulation of mesenchymal transcription factors and downregulation of epithelial adhesion molecules, driving acquisition of migratory and invasive phenotypes in GBM. This program involves transcriptional reprogramming through WNT pathway activation, canonical EMT transcription factors, and matrix remodeling, representing a reversible plastic state induced by microenvironmental cues such as hypoxia and inflammatory signals.","[""LEF1"", ""HOPX"", ""HMGA2"", ""VAV3"", ""ITGA3"", ""IQGAP2"", ""RHOJ"", ""ARHGAP26"", ""ARHGAP6"", ""ADAM19"", ""ADAMTS9-AS1"", ""SERPINE1"", ""PLAT"", ""CDH4"", ""SPRY1"", ""SPRY2"", ""SPRY4"", ""WNT16""]",18,0.92,"[""Shift from epithelial-like to mesenchymal phenotype with enhanced motility"", ""Increased expression of invasion-promoting proteases and reduced cell-cell adhesion"", ""Acquisition of stemness markers and therapeutic resistance"", ""Enhanced propensity for migration into surrounding brain tissue""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,1,Calcium-Mediated Proliferation and Survival,"Coordinated activation of calcium/calmodulin-dependent signaling pathways that promote GBM cell proliferation, invasion, and therapeutic resistance. Involves calcium-permeable glutamate receptor activation, calcium/calmodulin-dependent protein kinases, and downstream effector pathways including MAPK/ERK and PI3K/AKT signaling. This program couples cellular excitability to oncogenic signaling.","[""CAMK2B"", ""CAMK2A"", ""GRM7"", ""GABBR2"", ""TRPM8"", ""TRPM3"", ""CA2"", ""CA10"", ""SLC4A4"", ""SLC24A2"", ""SLC18A1"", ""RCAN1"", ""GLRA2""]",13,0.88,"[""Enhanced intracellular calcium dynamics and sustained calcium signaling"", ""Activation of MAPK/ERK and AKT/mTOR proliferative pathways"", ""Increased cell proliferation and reduced apoptosis"", ""Enhanced invasive and migratory capacity of tumor cells"", ""Coupling of neuronal signaling to glioma survival and growth""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,2,Glioma Stem Cell Maintenance,"Transcriptional and post-transcriptional regulation of self-renewal capacity, stemness marker expression, and resistance to differentiation in glioblastoma stem cells. This program involves transcription factors that maintain pluripotency-like states, Wnt/Notch signaling, and epigenetic regulation. Glioma stem cells are characterized by high tumorigenicity, self-renewal, invasiveness, and therapy resistance.","[""HMGA2"", ""EGR1"", ""EGR3"", ""LEF1"", ""HOPX"", ""WNT16"", ""JAG1"", ""SOX1-OT"", ""PDGFD"", ""CAMK2B"", ""CAMK2A""]",11,0.85,"[""Sustained self-renewal and clonogenic capacity of GBM stem cells"", ""Resistance to differentiation and maintenance of pluripotency-like state"", ""Enhanced tumorigenicity and intracranial tumor formation"", ""Increased invasiveness and metastatic potential"", ""Elevated resistance to chemo- and radiotherapy""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,3,Integrin-Mediated Cell Invasion,"Coordinated signaling through integrin receptors and their interaction with extracellular matrix components to promote GBM cell migration, invasion, and adhesion dynamics. Involves integrin clustering, focal adhesion kinase signaling, and activation of downstream kinase cascades that control cytoskeletal organization and enable penetration through tissue barriers.","[""ITGA3"", ""SNED1"", ""IQGAP2"", ""RHOJ"", ""ARHGAP26"", ""ARHGAP6"", ""WIPF3"", ""SPRY1"", ""SPRY2"", ""SPRY4"", ""CAMK2B""]",11,0.8,"[""Enhanced migration and invasion through ECM"", ""Increased focal adhesion dynamics enabling rapid cell motility"", ""Sustained ERK1/2 signaling promoting invasive phenotype"", ""Penetration of blood-brain barrier and peritumoral invasion"", ""Dynamic regulation of cell adhesion-deadhesion cycles""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,4,Extracellular Matrix Remodeling,"Coordinated expression and modification of extracellular matrix proteins including collagens, proteoglycans, and matricellular proteins, coupled with protease activity to reshape the tumor microenvironment. This program supports cell adhesion turnover, angiogenesis, immune infiltration, and establishment of a permissive environment for tumor progression and invasion.","[""COL22A1"", ""COL23A1"", ""COL25A1"", ""COL27A1"", ""COL19A1"", ""POSTN"", ""SNED1"", ""ADAM19"", ""ADAMTS9-AS1"", ""HS3ST5"", ""SERPINE1""]",11,0.82,"[""Enhanced deposition of collagen scaffold around tumor cells"", ""Increased proteolytic activity remodeling ECM architecture"", ""Modified heparan sulfate composition affecting growth factor bioavailability"", ""Creation of permissive microenvironment for tumor cell migration and invasion"", ""Altered immune cell infiltration through ECM remodeling""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,5,Receptor Tyrosine Kinase Signaling,"Coordinated regulation of growth factor signaling through EGFR, PDGFR, ALK, and related receptor tyrosine kinases coupled with feedback inhibition mechanisms. This program drives proliferation, survival, and invasion through MAPK/ERK and PI3K/AKT pathways, with importance for maintaining tumor growth and establishing therapeutic resistance.","[""FHL2"", ""EGR1"", ""ALK"", ""SPRY1"", ""SPRY2"", ""SPRY4"", ""CAMK2B"", ""CAMK2A"", ""PDGFD"", ""TFCP2L1"", ""PCSK5""]",11,0.83,"[""Enhanced growth factor-driven proliferation via MAPK/ERK activation"", ""Sustained survival signaling through PI3K/AKT pathways"", ""Increased invasive and migratory capacity"", ""Resistance to differentiation and maintenance of stemness"", ""Therapeutic resistance through redundant signaling pathways""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,6,Immune Microenvironment Modulation,"Expression of immunomodulatory genes that suppress anti-tumor immune responses and promote immune cell recruitment to create an immunosuppressive tumor microenvironment. Includes genes encoding cytokines, cytokine receptors, immune checkpoint molecules, and factors affecting immune cell differentiation and function.","[""GDF15"", ""METTL7B"", ""IL27RA"", ""IL1RAP"", ""IRAK2""]",5,0.78,"[""Recruitment and polarization of immunosuppressive myeloid cells"", ""Reduced anti-tumor T cell and NK cell function"", ""Enhanced tumor escape from immune surveillance"", ""Increased expression of immune checkpoint ligands"", ""Establishment of immunosuppressive tumor microenvironment supporting tumor progression""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,7,Cuproptosis and Metabolic Reprogramming,"Regulation of copper-dependent cell death pathways (cuproptosis) and metabolic shifts supporting tumor aggressiveness. Involves genes regulating copper homeostasis, lipoylation of metabolic enzymes, and mitochondrial function. Recent evidence suggests cuproptosis as alternative tumor suppression mechanism distinct from apoptosis and ferroptosis.","[""COL22A1""]",1,0.62,"[""Enhanced sensitivity to copper-induced cell death pathways"", ""Altered mitochondrial metabolism and oxidative stress"", ""Potential therapeutic vulnerability through cuproptosis induction"", ""Metabolic reprogramming supporting tumor growth""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,8,Tetraspanin-Mediated Cell Adhesion,"Coordinated regulation of tetraspanin proteins that mediate cell-cell adhesion, cell-ECM interactions, and formation of specialized membrane microdomains. Tetraspanins function as adaptor proteins connecting surface receptors to cytoskeletal and signaling machinery, with roles in tumor heterogeneity and immune microenvironment formation.","[""TSPAN18""]",1,0.75,"[""Enhanced cell-ECM adhesion through integrin-tetraspanin complexes"", ""Facilitation of EMT through tetraspanin-mediated signaling"", ""Regulation of immune cell infiltration patterns"", ""Promotion of cell migration and invasion"", ""Modulation of tumor microenvironment composition""]"
10_AC_gliosis_like_2_run2,10,AC-gliosis-like 2,10_AC_gliosis_like_2,2,9,Transcriptional Regulation of Differentiation,"Control of neural differentiation states and lineage specification through transcription factors that balance stem cell maintenance with differentiation. Involves genes regulating neural progenitor fate decisions, astrocytic differentiation, and oligodendrocytic commitment, which determine tumor cell plasticity and phenotypic heterogeneity in GBM.","[""HOPX"", ""SOX1-OT""]",2,0.7,"[""Balanced control of stem cell maintenance versus differentiation"", ""Phenotypic heterogeneity within tumor cell population"", ""Plasticity enabling adaptation to environmental stresses"", ""Modulation of mesenchymal versus proneural differentiation states"", ""Potential for therapeutic targeting of differentiation pathways""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,0,Oligodendrocyte differentiation and myelin formation,"A developmental transcriptional program that specifies cells toward the oligodendrocyte lineage and promotes myelination. This program includes master transcriptional regulators (MYRF, SOX6), structural myelin proteins (MOG, OMG, BCAS1, CLDN11), and enzymes essential for myelin lipid synthesis (UGT8, FA2H). In GBM context, dysregulation of this program reflects aberrant recapitulation of developmental processes and may be associated with cells occupying an uncommitted developmental state.","[""MYRF"", ""MOG"", ""OMG"", ""BCAS1"", ""CLDN11"", ""UGT8"", ""FA2H"", ""SOX6"", ""GPR17"", ""LAMB4""]",10,0.92,"[""Dysregulated recapitulation of developmental oligodendrocyte specification in infiltrative tumor regions"", ""Aberrant myelin lipid synthesis contributing to altered membrane composition and metabolic dependence"", ""Enhanced stemness and reduced differentiation commitment in infiltrative GBM cells"", ""Potential metabolic reprogramming toward lipid synthesis over classic oligodendrocyte functions""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,1,Notch signaling and neural stem cell maintenance,"The Notch pathway acts as a critical regulator of neural progenitor self-renewal and inhibition of differentiation in developing CNS. In GBM, elevated Notch signaling through ligands DLL1 and DLL3 maintains cancer stem cell properties and is particularly enriched in infiltrative tumor regions. This program operates downstream of ASCL1 and OLIG2, which are co-expressed transcriptional regulators that determine cellular plasticity and lineage specification in GBM.","[""DLL1"", ""DLL3"", ""LIN28B""]",3,0.88,"[""Enhanced maintenance of tumor-initiating cell populations with stem-like properties"", ""Resistance to differentiation cues and reduced lineage commitment"", ""Increased self-renewal capacity enabling recurrence and treatment resistance"", ""Spatial enrichment in infiltrative regions promoting brain invasion"", ""Activation of growth factor receptor pathways (EGFR, FGFR) downstream of Notch""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,2,Synaptic adhesion and neuronal crosstalk,"GBM cells establish bidirectional communication with neurons through synaptic adhesion molecules and neurotrophic factors. This program includes cell adhesion molecules (ALCAM, LRRC7, MDGA2), guidance molecules (SLIT1, SEMA3E), and neuropeptide receptors (TACR1) that mediate neuron-tumor interactions. Active neuronal activity promotes GBM proliferation through secretion of factors including neuroligin-3 (NLGN3) and activation of growth factor pathways, establishing a tumor microenvironment permissive for GBM growth.","[""LRRC7"", ""ALCAM"", ""MDGA2"", ""SLIT1"", ""SEMA3E"", ""KIF21B"", ""TACR1"", ""TNR"", ""LRRC3B""]",9,0.85,"[""Enhanced responsiveness to neuronal activity-dependent paracrine signals"", ""Increased proliferation in cortical regions with high neuronal density"", ""Spatial preference for infiltration toward neurons with high synaptic activity"", ""Establishment of stable neuron-tumor synaptic contacts promoting tumor growth"", ""Activation of growth factor signaling cascades (PI3K-mTOR) downstream of neuronal ligands"", ""GBM recurrence in deep brain structures with lower synaptic density but localized neuronal hyperactivity""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,3,Ion homeostasis and osmotic cell volume regulation,"GBM cells rely on ion channels and water transporters to regulate intracellular osmolarity and cell volume during migration through confined brain parenchyma and at leading edge of invasion. This program includes aquaporins (AQP4), cation channels (ANO3, ANO4, TRPC4, CACNA1E), anion channels, and ion exchangers (SLC8A3, SLC5A4, SLC26A7). Proper ion homeostasis is essential for lamellipodial dynamics, cell shape changes, and migration through narrow extracellular spaces.","[""AQP4"", ""ANO3"", ""ANO4"", ""CACNA1E"", ""TRPC4"", ""SLC8A3"", ""SLC5A4"", ""SLC26A7""]",8,0.82,"[""Enhanced cell volume changes enabling invasion through narrow extracellular spaces"", ""Rapid osmotic adjustment at tumor cell leading edge during migration"", ""Dysregulated calcium signaling supporting proliferation and migration"", ""Contribution to GBM-associated cerebral edema through altered water transport"", ""Reduced migratory capacity if ion channel function is impaired"", ""Calcium dysregulation potentially driving metabolic reprogramming""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,4,Cell cycle progression and proliferation,"Cell cycle regulation in GBM is controlled by cyclin-CDK complexes, with cyclin D1 (CCND1) being a proto-oncogene frequently dysregulated in GBM. CCND1 drives progression from G1 to S phase by phosphorylating retinoblastoma protein (pRb). CDCA7L (cell division cycle-associated 7 like) is a c-MYC target that promotes proliferation by upregulating CCND1. Elevated cyclin D1 is associated with poor prognosis, enhanced invasiveness, and reduced apoptosis in GBM.","[""CCND1"", ""CDCA7L""]",2,0.78,"[""Accelerated progression through G1/S checkpoint in GBM cells"", ""Enhanced proliferative capacity and increased tumor growth rate"", ""Increased drug resistance through upregulation of multidrug resistance proteins"", ""Reduced apoptotic sensitivity to pro-death signals"", ""Contribution to poor clinical prognosis and shorter survival""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,5,Extracellular matrix remodeling and vasculature assembly,"The GBM tumor microenvironment is characterized by extensive extracellular matrix (ECM) remodeling and abnormal vasculature. Collagen types I, IV, and XX are abundant in GBM and contribute to tumor stiffness, invasion, and vascular abnormalities. This program includes fibrillar collagens (COL4A3, COL4A4, COL20A1), basement membrane components (LAMB4), ECM glycoproteins (TNR, THSD4), and ECM remodeling enzymes (ADAMTS17, HS6ST2). ECM composition and organization influence cell migration, vascular permeability, and therapeutic resistance.","[""COL4A3"", ""COL4A4"", ""COL20A1"", ""LAMB4"", ""TNR"", ""ADAMTS17"", ""HS6ST2"", ""THSD4""]",8,0.8,"[""Increased tumor microenvironmental stiffness promoting invasive phenotype"", ""Enhanced vascular permeability and edema formation"", ""Creation of hypoxic niches through altered ECM organization and vascular abnormalities"", ""Promotion of mesenchymal GBM state in regions with elevated collagen"", ""Reduced drug penetration due to ECM barrier function"", ""Enhanced cell migration through ECM-rich regions""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,6,Integrin-mediated cell adhesion and migration,"Cell migration and invasion in GBM are fundamentally dependent on integrin-ECM interactions that link the extracellular matrix to the actin cytoskeleton. Integrins like ITGA9 (α9β1 heterodimer) interact with ECM components including thrombospondin, fibronectin, and VEGF isoforms. FERMT1 (fermitin family homolog 1, also called kindlin-1) is a FERM-domain protein that binds integrin cytoplasmic tails and cooperates with talin to activate integrins. This program coordinates cell adhesion dynamics with cell-matrix signaling to enable migration.","[""ITGA9"", ""FERMT1"", ""ALCAM""]",3,0.75,"[""Enhanced cell-matrix adhesion enabling stable interactions with ECM during migration"", ""Increased integrin signaling (\u03b21/\u03b23) promoting proliferation and survival"", ""Rapid adhesion turnover allowing efficient migration through tissue"", ""Sustained migratory phenotype through integrin-dependent signaling"", ""Modulation of cell morphology and actin dynamics at leading edge""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,7,Lipid metabolism and myelin-derived nutrient scavenging,"GBM, particularly mesenchymal-like (MES) GBM cells, exhibit altered lipid metabolism that enables them to utilize myelin-derived lipids from the tumor microenvironment. Lipid-laden macrophages (LLMs) internalize myelin debris and transfer cholesterol and fatty acids to GBM cells through metabolic symbiosis. This program involves lipid biosynthetic enzymes (PLA2G4A, PLPP4, PLAAT1, DGKB, FA2H) that remodel lipids for membrane synthesis and metabolic signaling. The liver X receptor (LXR) pathway activates macrophage myelin uptake, creating a tumor-macrophage metabolic axis.","[""PLA2G4A"", ""PLPP4"", ""PLAAT1"", ""DGKB"", ""FA2H"", ""UGT8""]",6,0.76,"[""Enhanced membrane biosynthesis supporting rapid proliferation"", ""Utilization of exogenous myelin lipids reducing dependence on de novo lipogenesis"", ""Altered signaling lipid composition modulating proliferation and survival pathways"", ""Metabolic symbiosis between MES-like GBM cells and lipid-laden macrophages"", ""Reduced oxidative stress through lipid remodeling"", ""Enhanced mesenchymal phenotype and invasiveness""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,8,Growth factor receptor signaling networks,"GBM cells exhibit dysregulation of multiple growth factor receptor pathways including EGFR, FGF receptors, and ErbB receptors that drive proliferation, survival, and migration. FGF12 is an intracellular FGF homologous factor (FHF) that modulates intracellular signaling. ERBB3 (HER3) is a neuregulin receptor that heterodimerizes with other ErbB family members to activate PI3K-AKT-mTOR and MAPK pathways. VIPR2 is a G-protein coupled receptor for vasoactive intestinal peptide (VIP) that activates cAMP signaling. These receptors converge on mTOR, AKT, and ERK pathways to promote tumor cell proliferation.","[""ERBB3"", ""FGF12"", ""VIPR2"", ""CALCRL""]",4,0.72,"[""Enhanced PI3K-AKT-mTOR signaling promoting anabolic metabolism and proliferation"", ""Sustained MAPK-ERK activation driving proliferation and survival"", ""Increased genomic instability through aberrant growth factor signaling"", ""Cross-talk between multiple growth factor pathways creating redundancy and therapeutic resistance"", ""Amplification of early response genes and cell cycle progression""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,9,Lin28-let-7 axis regulating stemness and differentiation,"The Lin28-let-7 pathway is a conserved heterochronic regulatory axis that controls the balance between self-renewal and differentiation in stem cells and cancer. LIN28B is an RNA-binding protein that blocks biogenesis of the tumor-suppressive let-7 microRNA family by recruiting Terminal Uridylyl Transferase (ZCCHC11) that polyuridylates and marks pre-let-7 for degradation. By repressing let-7, LIN28B maintains expression of oncogenes including MYC, HMGA2, RAS, and pluripotency factors. This program is particularly relevant in GBM where stemness is associated with treatment resistance and recurrence.","[""LIN28B""]",1,0.78,"[""Enhanced and sustained expression of oncogenic transcription factors (MYC, HMGA2)"", ""Maintenance of stemness and resistance to differentiation signals"", ""Increased chemotherapy and radiation resistance"", ""Promotion of epithelial-mesenchymal transition (EMT) phenotype"", ""Enhanced tumor-initiating cell (TIC) properties"", ""Increased metabolic plasticity enabling adaptation to microenvironmental changes""]"
11_OPC_like_1_run1,11,OPC-like 1,11_OPC_like_1,1,10,Developmental transcriptional regulation and cell fate specification,"GBM cells exhibit striking similarity to embryonic neural progenitor cells and recapitulate developmental gene regulatory networks. This program includes key developmental transcription factors (SOX6, EYA1) and regulatory complexes (EYA1-SIX1-BRG1 BAF) that specify cell fate during neural development. SOX6 is part of the SoxD family and promotes neural progenitor maintenance. EYA1 encodes a dual-function protein with both transcriptional activation and protein phosphatase activity; it interacts with SIX1 and chromatin remodeling complexes to specify sensory and neural cell fates. These factors enable developmental plasticity and undifferentiated phenotype in GBM cells.","[""SOX6"", ""EYA1""]",2,0.74,"[""Maintenance of progenitor-like undifferentiated state in GBM cells"", ""Enhanced developmental plasticity enabling adaptation to microenvironmental cues"", ""Activation of neural differentiation programs that are repurposed for invasion"", ""Epigenetic encoding that mirrors developing neural tissue"", ""Sustained expression of stemness-related transcription factors""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,0,Extracellular Matrix Remodeling and Cell Adhesion,"This program encompasses genes encoding structural proteins, proteoglycans, and adhesion molecules that compose and remodel the glioblastoma extracellular matrix. The ECM serves as an active mediator of tumor invasion, immune cell infiltration, and therapeutic resistance through dynamic interactions with tumor and stromal cells. Components include collagen crosslinkers, matricellular proteins, and glycoproteins that facilitate cell-cell contact and cell-matrix interactions critical for GBM progression.","[""COL4A3"", ""COL4A4"", ""COL20A1"", ""TNR"", ""SMOC1"", ""ALCAM"", ""PCDH15"", ""MEGF11"", ""THSD4"", ""LAMB4"", ""ADAMTS17"", ""ITGA9"", ""FERMT1"", ""LRRC7"", ""TNS3"", ""LRFN5""]",16,0.92,"[""Enhanced ECM-mediated tumor cell invasion through sinuous brain tissue"", ""Increased cell-cell contact adhesion promoting collective invasion"", ""Altered leukocyte infiltration and immune suppression through ECM remodeling"", ""Sustained proliferative signaling via integrin-ECM crosstalk"", ""Therapeutic resistance through altered drug penetration in dense ECM""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,1,Ion Channel-Mediated Cell Motility,"This program integrates ion channels and transporters that regulate cellular ion homeostasis, membrane potential, and cell volume dynamics essential for glioblastoma migration and invasion. Potassium, calcium, chloride, and sodium channels modulate cell cycle progression and facilitate the morphological changes necessary for cells to navigate through constrained brain tissue spaces. Dysregulation of these channels contributes to the extensive invasive migration characteristic of GBM.","[""CACNA1E"", ""TRPC4"", ""KCNIP3"", ""ANO3"", ""ANO4"", ""SLC8A3"", ""SLC5A4"", ""SLC26A7"", ""CA10""]",9,0.88,"[""Facilitated cell cycle progression through G1/S and G2/M checkpoints"", ""Enhanced invasive cell migration through rapid morphological transitions"", ""Improved survival under metabolic stress through pH buffering"", ""Increased cell volume dynamics enabling navigation through sinuous extracellular spaces"", ""Sustained proliferation via ion-dependent signaling amplification""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,2,Oligodendrocyte Lineage Progenitor Identity,"This program comprises genes characterizing oligodendrocyte precursor cells (OPCs) and immature oligodendrocytes, cell types implicated as cells-of-origin for glioblastoma. These genes regulate cell fate determination, developmental progression, and maintenance of progenitor cell characteristics. The aberrant expression of OPC-associated genes in GBM reflects the developmental origin of these tumors and their heterogeneous cellular composition including pre-myelinating states.","[""BCAS1"", ""SOX6"", ""MYRF"", ""MOG"", ""OMG"", ""CLDN11"", ""EYA1""]",7,0.85,"[""Maintenance of progenitor cell state and self-renewal capacity"", ""Impaired terminal differentiation with retention of proliferative phenotype"", ""Activation of developmental programs associated with GBM stem cells"", ""Enhanced glioma stemness through aberrant OPC program expression"", ""Tumor heterogeneity driven by multiple OPC-derived cellular states""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,3,Notch Signaling and Stem Cell Maintenance,"This program encompasses genes controlling Notch pathway signaling that maintains glioma stem cell (GSC) self-renewal, stemness capacity, and resistance to differentiation. Delta-like ligands (DLL1, DLL3) and downstream effectors regulate the undifferentiated phenotype characteristic of GSCs. Dysregulation of Notch signaling is associated with poor prognosis and enhanced tumor aggressiveness in glioblastoma.","[""DLL1"", ""DLL3"", ""LIN28B"", ""MIR503HG"", ""MIR217HG""]",5,0.87,"[""Sustained GSC self-renewal and reduced differentiation capacity"", ""Enhanced stem cell marker expression including CD133, nestin, SOX2, OCT4"", ""Increased resistance to apoptosis through Notch-AKT signaling"", ""Promoted epithelial-to-mesenchymal transition and invasion"", ""Improved survival under stress conditions through let-7 suppression""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,4,Lipid Metabolism and Sphingolipid Remodeling,"This program encompasses enzymes and transporters regulating lipid and sphingolipid metabolism, including fatty acid hydroxylation, glycosphingolipid synthesis, and ether lipid degradation. Dysregulated lipid metabolism in GBM contributes to altered membrane composition, enhanced proliferation, migration, and survival signaling. These metabolic alterations create distinct lipid signatures associated with aggressive GBM phenotypes.","[""FA2H"", ""UGT8"", ""PLPP4"", ""PLA2G4A"", ""PLAAT1"", ""AGMO"", ""UGDH"", ""GFPT2"", ""CHST9"", ""HS6ST2""]",10,0.82,"[""Altered membrane fluidity and composition supporting enhanced proliferation"", ""Enhanced ceramide and hexosylceramide accumulation promoting survival signaling"", ""Increased arachidonic acid mobilization supporting inflammatory and pro-tumoral signals"", ""Modified glycosaminoglycan synthesis affecting ECM interactions and cell adhesion"", ""Altered immune cell recognition through lipid antigen modifications""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,5,Cell Migration and Invasion Machinery,"This program integrates genes encoding proteins that directly facilitate glioblastoma cell motility, including cell migration regulators, cytoskeletal modulators, and axon guidance pathway components. These genes coordinate dynamic actin remodeling, cell-matrix interactions, and directional migration enabling GBM cells to infiltrate surrounding brain tissue. Dysregulation of this program drives the extensive invasion characteristic of GBM and is associated with therapeutic resistance.","[""ELMO1"", ""DOCK10"", ""REPS2"", ""LHFPL3-AS1"", ""SLIT1"", ""SEMA3E"", ""KIF21B"", ""LRRC7"", ""TNS3"", ""AFAP1L2"", ""FERMT1""]",11,0.84,"[""Enhanced directional migration toward chemoattractants and away from repellents"", ""Sustained actin polymerization dynamics supporting morphological plasticity"", ""Improved focal adhesion formation and turnover enabling rapid migration"", ""Increased invasive potential through sinuous brain parenchyma"", ""Adaptation to hypoxic and acidic microenvironments during migration""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,6,Growth Factor Receptor Signaling and Proliferation,"This program integrates receptor tyrosine kinases, G protein-coupled receptors, and their associated signaling molecules that drive glioblastoma proliferation. These genes regulate growth factor-dependent cell cycle progression, survival signaling, and metabolic reprogramming. Dysregulation of this program through overexpression or constitutive activation drives unchecked GBM proliferation and is associated with aggressive disease and poor prognosis.","[""AR"", ""FGF12"", ""VIPR2"", ""ERBB3"", ""TACR1"", ""NRSN1"", ""GPR17"", ""CCND1""]",8,0.79,"[""Sustained proliferation through growth factor-dependent cell cycle progression"", ""Enhanced survival signaling through multiple receptor pathways"", ""Increased metabolic flux supporting anabolic cell growth"", ""Amplified ERK and PI3K-AKT pathway activation"", ""Therapeutic resistance through receptor redundancy and pathway crosstalk""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,7,Mesenchymal Transition and Invasion Program,"This program represents genes controlling epithelial-to-mesenchymal transition (EMT) and related developmental plasticity that drives glioblastoma's aggressive phenotype. These genes regulate the shift from adhesive epithelial-like states to migratory mesenchymal-like states, facilitating invasion and therapeutic resistance. Activation of this program is associated with poor prognosis, radiation resistance, and tumor recurrence.","[""LINC00689"", ""NKD1"", ""DISC1"", ""LINC01268"", ""LINC01322"", ""CA10"", ""EYA1"", ""SOX6""]",8,0.76,"[""Shift from adhesive to migratory phenotype"", ""Enhanced invasive capability and reduced differentiation"", ""Acquisition of stem cell characteristics and therapeutic resistance"", ""Increased survival under stress including hypoxia and acidic conditions"", ""Promotion of recurrent tumors with more aggressive phenotype""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,8,Mitochondrial Dynamics and Cellular Metabolism,"This program integrates genes controlling mitochondrial function, energetics, and metabolic adaptation essential for GBM's high proliferative and invasive capacity. These genes regulate ATP production, lipid storage, and metabolic plasticity allowing GBM cells to survive under nutrient-poor and hypoxic conditions. Dysregulation of this program supports the Warburg effect and altered metabolic state characteristic of GBM.","[""DISC1"", ""DGKB"", ""ATP13A5"", ""PLPP4"", ""FA2H""]",5,0.72,"[""Enhanced energy production supporting rapid proliferation and migration"", ""Metabolic flexibility allowing survival under hypoxia and nutrient deprivation"", ""Lipid accumulation in storage organelles providing energy reserves"", ""Enhanced radioresistance through altered mitochondrial lipid composition"", ""Resistance to energy-depleting therapeutic strategies""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,9,Proteolytic Processing and Proteasomal Activity,"This program comprises genes encoding proteases and proteasomal components that regulate protein processing, cellular remodeling, and quality control in glioblastoma. These enzymes process pro-proteins into active forms, degrade regulatory proteins, and remodel the microenvironment. Dysregulation of proteolytic activity contributes to GBM invasion, immune evasion, and therapeutic resistance.","[""PCSK2"", ""PRSS12"", ""TMPRSS9""]",3,0.68,"[""Enhanced ECM remodeling supporting invasion and migration"", ""Processing of pro-inflammatory mediators affecting microenvironment"", ""Immune evasion through altered antigen processing"", ""Increased therapeutic resistance through protease-mediated drug degradation"", ""Amplified growth factor signaling through pro-growth factor activation""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,10,Signal Transduction Modulation and cAMP/Calcium Signaling,"This program encompasses genes regulating intracellular signal transduction, including phosphodiesterases, calcium signaling proteins, and kinase regulators that modulate cellular responses to growth factors, neuropeptides, and stress. These genes fine-tune signaling intensity and duration controlling proliferation, differentiation, and survival. Dysregulation of signal transduction creates sustained pro-tumoral signaling.","[""PDE4A"", ""PDE7B"", ""PRKG2"", ""CALCRL"", ""ARPP21""]",5,0.7,"[""Sustained proliferative signaling through reduced second messenger turnover"", ""Enhanced growth factor responsiveness through cAMP/calcium modulation"", ""Increased invasive capacity through kinase-dependent cytoskeletal remodeling"", ""Altered differentiation responses through calcium signaling dysregulation"", ""Therapeutic resistance through signaling pathway redundancy""]"
11_OPC_like_1_run2,11,OPC-like 1,11_OPC_like_1,2,11,Endosomal Recycling and Receptor Trafficking,This program integrates genes regulating endosomal membrane trafficking and receptor recycling that control cell surface receptor density and signaling duration. These genes mediate the balance between receptor recycling to the cell surface (sustaining signaling) versus degradation in lysosomes (attenuating signaling). Dysregulation of endosomal recycling in GBM promotes sustained growth factor signaling and therapeutic resistance.,"[""MYRIP"", ""ATP13A5""]",2,0.75,"[""Sustained EGFR and other RTK signaling through increased cell surface density"", ""Enhanced proliferative signaling via ERK and Akt pathway amplification"", ""Reduced responsiveness to growth factor withdrawal"", ""Therapeutic resistance to receptor-targeting drugs through increased surface density"", ""Increased invasive capacity via sustained signaling""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,0,Terminal Neuronal Differentiation Blockade,"This program encompasses transcriptional and post-transcriptional factors that normally drive neuronal terminal differentiation and maturation. In GBM, systematic loss or repression of these factors prevents transition from progenitor to mature neuronal phenotype, enabling continued proliferation. Key transcription factors (EBF3, EBF1, MYT1L, RBFOX3) and post-transcriptional regulators (CELF4, SRRM4, RBFOX1) coordinate alternative splicing and translation of neuronal genes. Loss of these programs is particularly notable as EBF3 is inactivated through deletion or hypermethylation in 50-90% of high-grade gliomas.","[""EBF3"", ""EBF1"", ""MYT1L"", ""RBFOX3"", ""RBFOX1"", ""CELF4"", ""SRRM4"", ""ARX"", ""DLX6"", ""UNCX"", ""PRDM8"", ""MEIS2"", ""PBX3"", ""PKNOX2""]",14,0.95,"[""Maintenance of proliferative capacity through suppression of terminal differentiation programs"", ""Retention of neural progenitor-like gene expression patterns enabling continued cell cycle entry"", ""Loss of synaptic maturation markers and structural specialization"", ""Reduced expression of differentiation-dependent apoptotic pathways"", ""Enhanced capacity for migration and invasion relative to differentiated neurons""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,1,GABAergic Synaptic Tumor Promotion,"This program represents a unique tumor-promoting mechanism where GABAergic neurons form functional synapses with GBM cells, particularly in diffuse midline gliomas (DMGs) with H3K27M mutation. GABAergic input through GABA-A receptors produces depolarizing rather than hyperpolarizing currents in GBM cells due to elevated intracellular chloride maintained by NKCC1 transporter. This unusual depolarizing GABA signaling drives tumor cell proliferation and survival. The program includes synaptic vesicle proteins, neurotransmitter transporters, GABA receptors, and the chloride transporter NKCC1 that enables the depolarizing phenotype.","[""GABRB2"", ""GABRA1"", ""SYT1"", ""SYT4"", ""SV2B"", ""SYNPR"", ""GRIN3A"", ""SLC17A6"", ""PLCB1"", ""SLC18A1""]",10,0.88,"[""Increased intracellular calcium flux through depolarization-activated voltage-gated calcium channels"", ""Activation of calcium-dependent growth and survival signaling pathways"", ""Enhanced proliferation and reduced apoptosis in response to GABAergic input"", ""Increased tumor growth in regions with high GABAergic neuron density"", ""GABA-A antagonists (e.g., lorazepam) reduce DMG tumor growth and proliferation"", ""Depolarizing GABA distinguishes H3K27M-DMG from hemispheric high-grade gliomas lacking NKCC1 depolarizing function""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,2,Axon Guidance & Cell Adhesion Dysregulation,"This program encompasses the classical axon guidance molecules and cell adhesion molecules that normally establish correct neuronal connectivity and cell-cell contacts during brain development. These genes regulate repulsive and attractive interactions between neurons and guide axonal pathfinding. In GBM, altered expression of these molecules disrupts normal adhesive properties and enables aberrant cell migration and invasion. Eph receptors and their ephrin ligands regulate bidirectional signaling that sculpts developing axons and dendrites. Robo receptors bind Slit ligands to mediate repulsive guidance. Cadherins maintain homophilic cell-cell adhesion. In GBM, loss or alteration of adhesion molecules enables enhanced motility and invasion through tissue.","[""EPHA3"", ""EPHA5"", ""EPHA7"", ""ROBO3"", ""SLIT1"", ""CDH4"", ""CDH12"", ""CDH18"", ""CDH22"", ""CNTN2"", ""CNTNAP5"", ""FLRT2"", ""MDGA2"", ""LRTM1""]",14,0.82,"[""Reduced adhesion between glioma cells enabling dissociation and migration"", ""Altered axon-like cellular processes affecting glioma cell morphology and directionality"", ""Increased invasiveness through suppressed cell-matrix and cell-cell adhesion mechanisms"", ""Dysregulated responses to repulsive guidance cues that normally confine cells"", ""Enhanced motility through disrupted cadherin-based contact inhibition"", ""Altered signaling downstream of Eph and Robo receptors affecting cytoskeletal dynamics""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,3,Vascular Growth Factor Signaling & Angiogenesis,"This program encompasses receptor tyrosine kinases and their ligands that promote angiogenesis and vascular growth. NRP1 (neuropilin-1) is a VEGF co-receptor that enhances VEGF-165 binding to VEGFR2, amplifying angiogenic signaling. FGFR2 mediates fibroblast growth factor signaling important for vascular development. ERBB4 activation in GBM is associated with shorter survival and promotes tumor growth through ERK activation. KITLG (kit ligand) signals through KIT receptor on hematopoietic and vascular cells. These growth factor pathways drive robust angiogenesis supporting tumor vascularization and nutrient delivery.","[""NRP1"", ""FGFR2"", ""ERBB4"", ""KITLG""]",4,0.75,"[""Enhanced VEGF-dependent endothelial cell recruitment and angiogenesis"", ""Amplified angiogenic signaling through NRP1 co-receptivity with VEGFR2"", ""Increased tumor vascularization supporting nutrient delivery and oxygenation"", ""ERBB4-dependent proliferation and survival signaling in glioma and associated vascular cells"", ""Resistance to anti-EGFR therapeutics through ERBB4 compensatory activation"", ""Increased angiogenesis and tumorigenicity associated with poor patient survival""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,4,Ion Channel & Electrolyte Homeostasis Dysregulation,"This program encompasses ion channels and transporters that maintain cellular electrolyte balance and control neuronal excitability. Potassium channels (KCNQ3, KCNK2, KCNH8) regulate resting membrane potential and electrical activity. Voltage-gated calcium channels, modulated by CACNA2D3 auxiliary subunit, control calcium influx. CACNA2D3 functions as a tumor suppressor and is downregulated in gliomas. The bicarbonate transporter SLC4A10 participates in pH homeostasis. In GBM, dysregulation of these ion channels and transporters contributes to altered electrolyte balance that supports tumor cell survival and potentially creates a depolarized state permissive for abnormal signaling.","[""CACNA2D3"", ""KCNQ3"", ""KCNK2"", ""KCNH8"", ""SLC4A10""]",5,0.68,"[""Altered resting membrane potential affecting cellular signaling thresholds"", ""Dysregulated calcium homeostasis affecting metabolic and signaling processes"", ""Loss of tumor suppressive effects of CACNA2D3 enabling continued proliferation"", ""Altered pH homeostasis supporting metabolic reprogramming"", ""Changes in ion-dependent signaling cascades downstream of calcium and potassium flux"", ""Prognostic significance of ion channel expression profile in predicting GBM survival""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,5,Synaptic Plasticity & Dendritic Maturation,"This program encompasses genes that control the formation, maturation, and plasticity of synaptic connections. Synaptotagmin proteins (SYT1, SYT4) are calcium sensors in presynaptic vesicles that trigger neurotransmitter release. Postsynaptic density proteins and related factors organize the postsynaptic compartment. CELF4, a translational repressor of synaptic proteins, is critical for prenatal synaptic development. Dendritic spine formation and maintenance depend on polarity proteins that compartmentalize spine structure. Aberrant expression of these genes in GBM disrupts synaptic specialization while potentially enhancing migratory and invasive phenotypes.","[""CELF4"", ""SYT1"", ""SYT4"", ""SV2B"", ""SYNPR"", ""INSYN2B"", ""NSG2"", ""NYAP2"", ""LAMP5"", ""NRSN1"", ""GRIP2""]",11,0.72,"[""Loss of synaptic specialization reducing differentiated phenotype"", ""Decreased compartmentalization of dendritic spines affecting cell morphology"", ""Reduced postsynaptic organization and functional synaptic connectivity"", ""Enhanced cellular plasticity enabling migration and invasion"", ""Altered calcium signaling at synapses affecting neuronal communication"", ""Shift from post-mitotic synaptic functions toward proliferative phenotype""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,6,Axonal Maintenance & Cytoskeletal Integrity,"This program encompasses genes that maintain axonal structure, diameter, and conduction velocity through organization of neurofilaments and microtubules. STMN2 (stathmin-2) is critical for establishing and maintaining neurofilament-dependent axoplasmic organization. Loss of STMN2 leads to shrinkage of neurofilament spacing, axonal collapse, and motor and sensory deficits. SV2B regulates presynaptic calcium and synaptic vesicle dynamics affecting axonal function. Dynein motors (DYNC1I1) transport cargo along microtubules. In GBM, dysregulation of axonal maintenance genes may contribute to aberrant cell morphology and altered cellular dynamics.","[""STMN2"", ""SLAIN1"", ""SV2B"", ""DYNC1I1"", ""RND3"", ""ARHGAP18"", ""SPHKAP""]",7,0.65,"[""Altered axonal diameter and conduction velocity affecting cell communication"", ""Disrupted neurofilament spacing leading to reduced axonal stability"", ""Altered synaptic terminal structure and function"", ""Changes in microtubule dynamics affecting cellular transport"", ""Modified cell morphology with reduced axon-like processes"", ""Potential effects on cellular migration through altered cytoskeletal organization""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,7,Apoptosis Resistance & Cell Survival Pathways,"This program encompasses genes controlling cell death and survival decisions. HRK (Harakiri) is a pro-apoptotic BH3-only protein of the Bcl-2 family that regulates apoptosis by interfering with anti-apoptotic Bcl-2 and Bcl-xL proteins. DACH1 and DACH2 are tumor suppressors that activate cell cycle arrest and apoptosis genes while repressing survival and proliferation genes. TP73 encodes p73, a p53-related transcription factor with complex roles in apoptosis and stemness. Loss or downregulation of these pro-death and pro-differentiation factors enables GBM cells to resist apoptosis and maintain viability despite stress.","[""HRK"", ""DACH1"", ""DACH2"", ""TP73""]",4,0.7,"[""Reduced susceptibility to intrinsic apoptotic triggers through loss of pro-apoptotic signaling"", ""Enhanced cell survival signaling through loss of death-promoting transcription factors"", ""Maintenance of stemness properties through altered TP73 function"", ""Reduced responsiveness to genotoxic stress and chemotherapy-induced apoptosis"", ""Enhanced proliferation through loss of cell cycle checkpoint functions"", ""Increased resistance to radiation and chemotherapy""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,8,Retinoic Acid & MAPK-CaMKII Signaling Integration,"This program encompasses genes mediating non-canonical retinoic acid (RA) signaling through cellular retinoic acid binding protein 1 (CRABP1). CRABP1 acts as a signalosome that integrates retinoic acid with MAPK (mitogen-activated protein kinase) and CaMKII (calmodulin-dependent protein kinase II) signaling. CRABP1 suppresses MAPK-dependent cell proliferation by competing with Ras for interaction with RAF kinase, dampening ERK activation. CRABP1 also dampens CaMKII over-activation that could trigger neuronal death. This integrated signaling pathway affects stem cell proliferation, cancer progression, and neuronal survival.","[""CRABP1""]",1,0.62,"[""Enhanced MAPK-dependent proliferation through loss of CRABP1-mediated signal dampening"", ""Increased growth factor responsiveness and proliferative signaling"", ""Reduced retinoic acid-mediated differentiation and growth suppression"", ""Enhanced CaMKII over-activation potentially contributing to altered neuronal phenotype"", ""Increased neural stem cell and glioma stem cell proliferation"", ""Resistance to retinoic acid-mediated growth suppression""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,9,Metabolic Reprogramming & Warburg Effect Activation,"This program encompasses genes involved in metabolic reconfiguration toward aerobic glycolysis (Warburg effect) that characterizes GBM. Protein kinase C (PRKCA) signaling promotes metabolic reprogramming through MAPK pathway activation. Glycosyltransferases and metabolic enzymes (ST6GAL1, PCSK2, ADCY8, HSD11B2, PIP5K1B) support altered glucose, lipid, and nucleotide metabolism. The Warburg effect—preference for glycolysis over oxidative phosphorylation even under normoxia—supports GBM proliferation and contributes to therapy resistance. Hypoxia and metabolic stress activate transcription factors (HIF-1alpha) that drive expression of glycolytic genes.","[""PRKCA"", ""ADCY8"", ""HSD11B2"", ""PCSK2"", ""ST6GAL1"", ""PIP5K1B"", ""DUOX1"", ""SDS""]",8,0.68,"[""Enhanced glucose uptake and glycolytic flux supporting rapid ATP generation"", ""Increased lactate production and acidic microenvironment"", ""Resistance to radiotherapy and chemotherapy through metabolic support of tumor survival"", ""Enhanced lipid and nucleotide synthesis supporting rapid cell division"", ""Reduced oxidative stress from decreased mitochondrial respiration"", ""Support for hypoxic regions of tumor through glycolytic ATP production"", ""Altered tumor microenvironment acidification affecting immune infiltration""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,10,Extracellular Matrix Remodeling & Cell Migration,"This program encompasses genes encoding extracellular matrix (ECM) proteins and enzymes that modify ECM structure, enabling GBM cell migration and invasion. Matrix stiffening through deposition of structural proteins (FRAS1, HMCN1, SPOCK1, SVEP1) and glycosaminoglycan modifications (B3GAT2, B3GLCT, NDST4, HS3ST5) promotes glioma cell invasiveness. ECM stiffness activates mechanotransduction pathways that condition glioma cells for enhanced invasion. Sialyltransferases (ST6GAL1) and other glycosyltransferases modify cell surface glycoproteins affecting cell-cell and cell-matrix interactions. Hyaluronidases (CEMIP2) degrade hyaluronic acid facilitating cell migration.","[""FRAS1"", ""HMCN1"", ""SPOCK1"", ""SVEP1"", ""CEMIP2"", ""B3GAT2"", ""B3GLCT"", ""NDST4"", ""HS3ST5"", ""ST6GAL1"", ""ANTXR2"", ""CRIM1""]",12,0.74,"[""Enhanced ECM stiffness promoting glioma cell invasion and migration"", ""Altered cell-matrix adhesion dynamics reducing stationary cell behavior"", ""Increased mechanotransduction signaling activating pro-invasive pathways"", ""Reduced physical barriers to cell migration through ECM remodeling"", ""Enhanced glycosaminoglycan composition modulating ECM viscoelasticity"", ""Altered cell surface glycosylation affecting cell-cell adhesion and immune recognition"", ""Facilitated tumor cell dissemination through ECM degradation""]"
12_NPC_neuronal_like_3_run1,12,NPC-neuronal-like 3,12_NPC_neuronal_like_3,1,11,G-Protein-Coupled Receptor & Neuroendocrine Signaling,"This program encompasses G-protein-coupled receptors (GPCRs) and associated signaling that drive glioma cell proliferation and survival. SSTR2 (somatostatin receptor 2) is a GPCR highly expressed in neuroendocrine tumors but expression can be downregulated. Recent studies show that SSTR2 interacts with Wnt pathway protein Dvl1 in a ligand-independent manner, targeting SSTR2 for lysosomal degradation. GRK5 (G-protein receptor kinase 5) phosphorylates GPCRs affecting their signaling output and internalization. Adenylyl cyclase (ADCY8) produces cAMP, a key second messenger in GPCR signaling. These pathways affect proliferation, differentiation, and metabolism in GBM.","[""SSTR2"", ""GRK5"", ""ADCY8""]",3,0.58,"[""Altered GPCR signaling affecting cell proliferation and differentiation balance"", ""Enhanced Wnt-Dvl mediated GPCR degradation reducing signaling capacity"", ""Modified cAMP signaling affecting metabolic and proliferative responses"", ""Altered neuroendocrine differentiation state"", ""Potential therapeutic opportunity through Wnt inhibitors boosting SSTR2 expression"", ""Dysregulated GPCR desensitization affecting sustained growth signaling""]"
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,0,Oligodendroglial Differentiation Blockade,,"[""SOX10"", ""MYRF"", ""PLP1"", ""MBP"", ""MOG"", ""MAG"", ""UGT8"", ""FA2H"", ""ENPP6""]",9,0.95,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,1,Neural Stem Cell State Plasticity,,"[""SOX10"", ""FOXG1"", ""EBF2"", ""BMP2"", ""BMPER"", ""DLL3"", ""LIN28B"", ""TFEB""]",8,0.92,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,2,Matrix Metalloproteinase-Driven ECM Degradation,,"[""COL18A1"", ""COL20A1"", ""COL12A1"", ""ADAMTS14"", ""ADAMTSL1"", ""ADAM33"", ""THBS1"", ""SMOC1""]",8,0.88,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,3,Cadherins and Adhesion-Regulated Invasion,,"[""CDH19"", ""CDH8"", ""CADM1"", ""NFASC"", ""FERMT1"", ""ITGB5""]",6,0.85,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,4,Potassium and Calcium Channel-Driven Invasiveness,,"[""KCNS3"", ""P2RX7"", ""P2RX4"", ""ANO3"", ""ITPR2"", ""SLC7A14"", ""SLC8A3""]",7,0.82,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,5,Lipid and Sterol Metabolism Adaptation,,"[""DGKB"", ""PLAAT1"", ""PTGDS"", ""DIO2""]",4,0.87,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,6,Immune Checkpoint and T-Cell Suppression,,"[""PTGDS"", ""CADM1"", ""NFASC"", ""GPR17"", ""DLL3""]",5,0.79,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,7,Notch Pathway-Driven Stemness,,"[""DLL3""]",1,0.81,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,8,Semaphorin-Neuropilin Axis,,"[""SEMA3D"", ""SEMA3E"", ""SEMA4D""]",3,0.76,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,9,Homologous Recombination and DNA Repair,,"[""SAMHD1"", ""DGKB"", ""CABLES1"", ""LIN28B""]",4,0.8,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,10,Transcriptional Regulation of Neural Differentiation,,"[""PRDM16"", ""PRDM8"", ""ZNF365"", ""ZNF469"", ""ZNF536"", ""NPAS1"", ""CA10"", ""AATK""]",8,0.78,[]
13_OPC_like_2_run1,13,OPC-like 2,13_OPC_like_2,1,11,Thyroid Hormone Activation and H2S Metabolism,,"[""DIO2""]",1,0.71,[]
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,0,Oligodendrocyte Differentiation and Myelination,"A developmental gene program where GBM cells in white matter recapitulate oligodendrocyte differentiation pathways through SOX10-MYRF-mediated transcriptional cascades, leading to upregulation of myelin proteins (PLP1, MBP, MAG, MOG) and lipid synthesis enzymes (UGT8, FA2H). This program drives tumor cells toward pre-oligodendrocyte phenotypes with reduced proliferation.","[""SOX10"", ""MYRF"", ""PLP1"", ""MBP"", ""MAG"", ""MOG"", ""UGT8"", ""FA2H"", ""CLDN11"", ""NFASC"", ""ERBB3""]",11,0.95,"[""Tumor cell differentiation to pre-oligodendrocyte state with reduced proliferation"", ""Enhanced myelin protein production and membrane expansion"", ""Increased dependence on white matter injury signals for sustained differentiation"", ""Suppression of stemness and invasive capacity through maturation programs""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,1,White Matter Invasion and Demyelination Response,"GBM cells infiltrate white matter tracts, causing myelin disruption and triggering a glial injury response characterized by OPC activation, astrocyte reactivity, and microglia activation. This program couples tumor infiltration with pathological demyelination, creating paradoxical tumor suppression through endogenous repair mechanisms.","[""SOX10"", ""MOG"", ""PLP1"", ""MBP"", ""MAG"", ""CLDN11"", ""NFASC"", ""ACAN"", ""CHST15"", ""ADAMTS14"", ""COL12A1"", ""COL18A1"", ""COL20A1"", ""P2RX7""]",14,0.88,"[""Progressive white matter damage with myelin loss and axonal degeneration"", ""Activation of endogenous repair programs in normal glia that paradoxically suppress tumor growth"", ""Extracellular matrix remodeling creating barrier to tumor spread"", ""Creation of pro-differentiative microenvironment through injury signals""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,2,GPR17-Mediated OPC Arrest and Tumor Suppression,"GPR17 functions as a negative regulator of oligodendrocyte differentiation, maintaining OPC in undifferentiated state. In GBM, however, GPR17 is overexpressed and paradoxically promotes tumor progression through enhanced cellular motility, proliferation, and epithelial-mesenchymal transition. This creates a context-dependent functional switch.","[""GPR17""]",1,0.82,"[""Prevents differentiation of GBM cells to non-proliferative oligodendrocyte states"", ""Enhances tumor cell motility and invasive capacity"", ""Promotes epithelial-mesenchymal transition phenotypes"", ""Increases treatment resistance through EMT mechanisms"", ""Maintains stemness and proliferative capacity""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,3,Neuron-Glioma Synaptic Plasticity and Growth Promotion,GBM cells form functional synapses with neurons through AMPA receptors and receive activity-dependent neurotrophic signals (BDNF via TrkB) that promote tumor proliferation. This malignant synaptic plasticity co-opts learning-memory mechanisms to enhance glioma growth.,"[""ITPR2"", ""P2RX4"", ""P2RX7"", ""KCNS3"", ""ANO3"", ""TMEM235"", ""SLC1A1"", ""SLC7A14"", ""SYT6"", ""SYT7"", ""ATP6V0A4"", ""NOS1"", ""ADRA1A"", ""GLRA3""]",14,0.9,"[""Enhanced glioma cell proliferation through activity-dependent neurotrophic signaling"", ""Increased membrane depolarization from enhanced AMPA receptor trafficking"", ""Coupling of synaptic strength to tumor growth rate"", ""Suppression of alternative differentiation programs through neuronal activity integration"", ""Increased glutamate release contributing to neuronal excitotoxicity""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,4,Cell Adhesion and Invasion Suppression,"CADM1 and related adhesion molecules function as tumor suppressors in GBM, promoting cell-cell adhesion and suppressing invasion. Low CADM1 expression associates with aggressive tumors, poor prognosis, and enhanced metastatic potential.","[""CADM1"", ""CDH8"", ""CDH19"", ""PKP4"", ""PKP4-AS1""]",5,0.75,"[""Enhanced cell-cell adhesion reducing dissemination"", ""Suppression of invasion through increased junctional stability"", ""Reduced epithelial-mesenchymal transition phenotypes"", ""Decreased metastatic potential"", ""Enhanced apoptosis through signaling pathways""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,5,Semaphorin-Plexin Axon Guidance and Angiogenesis Regulation,"Semaphorin family members (SEMA4D, SEMA3D, SEMA3E) interact with plexin receptors to regulate both neuronal migration/axon guidance and tumor angiogenesis. SEMA4D promotes pro-angiogenic and pro-invasive effects while SEMA3E has anti-angiogenic functions.","[""SEMA4D"", ""SEMA3D"", ""SEMA3E""]",3,0.78,"[""SEMA4D promotes tumor angiogenesis and vascular permeability"", ""SEMA4D enhances tumor invasion through Met/Ron transactivation"", ""SEMA3E provides anti-angiogenic effects opposing SEMA4D"", ""Semaphorins regulate neuronal-glioma interactions through axon guidance mechanisms"", ""Contextual integration of pro- and anti-angiogenic signals determines vascular phenotype""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,6,Thrombospondin-1 Immunosuppression and Vascular Regulation,"THBS1 (thrombospondin-1) acts through CD47 and CD36 receptors to suppress anti-tumor immunity by inhibiting CD8+ T cell activation and promoting T cell exhaustion. THBS1 also provides anti-angiogenic functions through CD36, creating hypovascular tumor microenvironments that support metastasis.","[""THBS1""]",1,0.82,"[""Suppression of CD8+ T cell infiltration and activation in tumor microenvironment"", ""Enhanced T cell exhaustion through checkpoint pathways"", ""Reduced vascularization creating hypoxic microenvironment"", ""Enhanced metastatic potential through immune evasion and reduced vascular penetration"", ""Increased myeloid-derived suppressor cell function""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,7,Immune Checkpoint and Phagocytosis Regulation,CD22 and P2RX7 regulate immune checkpoint signaling that suppresses anti-tumor immunity. CD22 on B cells recruits tyrosine phosphatase SHP-1 to inhibit B cell and microglial phagocytic capacity. P2RX7 on microglia promotes neuroinflammation and tumor-supporting gliosis.,"[""CD22"", ""P2RX7"", ""P2RX4""]",3,0.79,"[""Suppression of B cell differentiation and antibody production in tumor microenvironment"", ""Inhibition of microglial phagocytosis of tumor cells and debris"", ""Enhanced neuroinflammation through P2RX7-mediated inflammasome activation"", ""Increased pro-inflammatory cytokine production creating tumor-supporting environment"", ""Impaired anti-tumor immune responses""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,8,Lipid Transport and Myelin Lipid Homeostasis,ABCA2 and ATP8A2 regulate intracellular lipid trafficking and phospholipid asymmetry essential for myelin membrane formation. These transporters control cholesterol and phospholipid sequestration affecting myelin protein expression and potentially influencing glioma cell membrane organization.,"[""ABCA2"", ""ATP8A2""]",2,0.71,"[""Altered myelin lipid composition and membrane organization"", ""Modified sterol-responsive gene expression in oligodendrocytes and gliomas"", ""Enhanced cholesterol sequestration affecting myelin protein trafficking"", ""Potential impact on glioma cell membrane fluidity and receptor signaling"", ""Modified susceptibility to lipid-dependent signaling pathways""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,9,Kinesin-Mediated Intracellular Transport and Neuronal Development,KIF21B and KIF21A represent kinesin motor proteins with specialized roles in dendritic targeting and axonal transport. KIF21B enrichment in dendrites and regulation by neuronal activity suggests roles in activity-dependent dendritic plasticity relevant to neuron-glioma interactions.,"[""KIF21B"", ""TUBB4A"", ""DNAH10""]",3,0.68,"[""Activity-dependent dendritic plasticity and morphological remodeling"", ""Enhanced dendritic cargo transport including receptors and signaling molecules"", ""Potential coupling of neuronal activity to glioma cell dendritic formation"", ""Regulation of AMPA receptor trafficking in response to synaptic activity"", ""Support for synaptic plasticity mechanisms""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,10,Notch Signaling and Intratumoral Heterogeneity,DLL3 and Notch pathway components regulate glioma stem cell heterogeneity and differentiation state transitions. Notch signaling maintains stemness properties in cancer-initiating cells while DLL3 modulates heterogeneity through lateral inhibition mechanisms.,"[""DLL3""]",1,0.76,"[""Regulation of GSC stemness versus differentiation transitions"", ""Control of intratumoral cellular heterogeneity through lateral inhibition"", ""Maintenance of stem-like gene expression programs in subset of GSCs"", ""Support for classical and mesenchymal GBM subtypes"", ""Enhanced invasiveness through stem cell property maintenance""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,11,BMP Signaling and Tumor Angiogenesis,BMP2 and BMPER regulate tumor angiogenesis through p38 MAPK and Id1 signaling in endothelial cells. BMP signaling promotes vascular development supporting tumor growth and potentially influences myelin-associated signaling.,"[""BMP2"", ""BMPER""]",2,0.72,"[""Enhanced tumor angiogenesis supporting vascular development"", ""Increased endothelial cell migration and tube formation"", ""Cooperative signaling with VEGF for angiogenic responses"", ""Potential enhancement of tumor perfusion and nutrient delivery"", ""Support for both normoxic and hypoxic tumor regions""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,12,Glutamate Excitotoxicity and Neuronal Damage,"SLC1A1, SLC7A14 and other glutamate transporters regulate extracellular glutamate levels. In GBM, reduced glutamate transporter expression and enhanced cystine-glutamate exchange contribute to glutamate accumulation causing neuronal excitotoxicity and seizures.","[""SLC1A1"", ""SLC7A14"", ""SLC8A3"", ""GLRA3"", ""ADRA1A"", ""NOS1""]",6,0.8,"[""Enhanced extracellular glutamate accumulation causing neuronal excitotoxicity"", ""Increased seizure susceptibility in glioma patients"", ""Increased cystine uptake supporting tumor antioxidant defense"", ""Enhanced tumor cell survival through ferroptosis inhibition"", ""Impaired glutamate homeostasis in tumor microenvironment""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,13,Transcriptional Regulation of Oligodendroglial Programs,"Multiple transcription factors (SOX10, OLIG family, NKX2-2, MYRF, EBF2) orchestrate oligodendrocyte lineage specification, OPC maintenance, and terminal differentiation. In GBM, dysregulation of these factors controls differentiation state transitions and competency for myelin programs.","[""SOX10"", ""MYRF"", ""EBF2""]",3,0.73,"[""Control of GBM cell commitment to oligodendrocyte lineage competency"", ""Regulation of OPC vs. mature oligodendrocyte phenotype in tumor cells"", ""Enhanced myelin gene expression in white matter-infiltrating GBM cells"", ""Support for differentiation-driven tumor suppression in select GBM contexts"", ""Coupling of transcriptional programs to white matter environment signals""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,14,Neuronal Activity-Dependent Dendritic Plasticity in GBM,"SNAP25, dendritic cytoskeletal proteins, and activity-regulated transcription factors mediate neuronal activity-dependent dendritic formation and synaptic plasticity. In GBM, aberrant dendritic extension enhances neuron-glioma synaptic integration.","[""SYT6"", ""SYT7"", ""MYT1L"", ""NPAS1"", ""TUBB4A""]",5,0.68,"[""Enhanced dendritic formation in GBM cells increasing synaptic surface area"", ""Increased glutamate metabolism supporting both glutamine cycling and synaptic transmission"", ""Enhanced neuron-glioma synaptic integration through dendritic morphology"", ""Support for activity-dependent BDNF signaling through synaptic localization"", ""Potential coupling of dendritic plasticity to membrane depolarization and proliferation""]"
13_OPC_like_2_run2,13,OPC-like 2,13_OPC_like_2,2,15,Tumor Microenvironment Remodeling and Hypoxia Response,"TFEB, PDE1C, and metabolic regulators coordinate responses to hypoxic tumor microenvironments, nutrient scarcity, and stromal interactions. Enhanced autophagy, metabolic flexibility, and lysosomal function support GBM survival in challenging microenvironments.","[""TFEB"", ""PDE1C"", ""PTGER3""]",3,0.62,"[""Enhanced tumor cell survival under hypoxic and nutrient-poor conditions"", ""Increased autophagy supporting metabolic flexibility and tumor progression"", ""Enhanced lysosomal biogenesis and protein turnover"", ""Integration of environmental stress signals to control metabolism"", ""Support for glioma adaptation to diverse microenvironmental niches""]"
